publication_id,tool,quote,best_match_source,best_match,similarity
1528,PRECIS-2,The costs used are shown in Table 1.,fulltext,The costs used are shown in Table 1.,100.0
1528,PRECIS-2,"People with multiple sclerosis were screened on the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and those with low mood were recruited.",fulltext,"People with multiple sclerosis were screened on the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and those with low mood were recruited.",100.0
1528,PRECIS-2,"Those who were not able to complete the outcome measures, such as people with visual problems, were visited by a researcher who was unaware of their group allocation, who completed the questionnaires with them.",fulltext,"Those who were not able to complete the outcome measures, such as people with visual problems, were visited by a researcher who was unaware of their group allocation, who completed the questionnaires with them.",100.0
1528,PRECIS-2,The costs were assessed from a service use questionnaire and information provided on medication.,fulltext,The costs were assessed from a service use questionnaire and information provided on medication.,100.0
1528,PRECIS-2,Participants allocated to the control group received all other rehabilitation routinely provided and were offered the opportunity to attend groups once they had completed the study.,fulltext,Participants allocated to the control group received all other rehabilitation routinely provided and were offered the opportunity to attend groups once they had completed the study.,100.0
1528,PRECIS-2,The trial's primary outcome was to evaluate the cost effectiveness of a psychological adjustment group shown to be clinically effective in comparison with usual care for people with multiple sclerosis.,fulltext, To evaluate the cost effectiveness of a psychological adjustment group shown to be clinically effective in comparison with usual care for people with multiple sclerosis.,84.5771144278607
1528,PRECIS-2,The analysis was conducted from the perspective of the UK National Health Service (NHS).,fulltext,The analysis was conducted from the perspective of the UK National Health Service (NHS).,100.0
1528,PRECIS-2,"Participants were included who scored >2 on the General Health Questionnaire 12, 7 on the anxiety and depression subscales of the Hospital Anxiety and Depression Scale.",fulltext,"participants were included who scored >2 on the General Health Questionnaire 12, 7 a measure of psychological distress, or >7 on the anxiety and depression subscales of the Hospital Anxiety and Depression Scale,",100.0
1528,PRECIS-2,Participants allocated to the intervention group were invited to attend a psychological adjustment group for six sessions over 12 weeks.,fulltext,se allocated to intervention were invited to attend a psychological adjustment group for six sessions over 12 weeks.,84.55882352941177
1528,PRECIS-2,"Four and eight months after random allocation, participants were sent a booklet of outcome questionnaires to complete and return by post.",fulltext,"Four and eight months after random allocation, participants were sent a booklet of outcome questionnaires to complete and return by post.",100.0
1528,PRECIS-2,Participants were recruited for a randomized trial of adjustment groups for people with multiple sclerosis and low mood between June 2008 and September 2009.,fulltext,Participants were recruited for a randomized trial of adjustment groups for people with multiple sclerosis and low mood between June 2008 and September 2009.,100.0
1528,PRECIS-2,The groups involved teaching people to recognize symptoms of distress and introduced them to strategies to improve their mood.,fulltext,The groups involved teaching people to recognise symptoms of distress and introduced them to strategies to improve their mood.,99.20634920634922
1528,PRECIS-2,"The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.",fulltext,"The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.",100.0
1529,PRECIS-2,"The FHM was effective in relieving depression, stress, fatigue, and to some extent, anxiety.",fulltext,"The FHM was effective in relieving depression, stress, fatigue, and to some extent, anxiety.",100.0
1529,PRECIS-2,"Because of being implemented easily, being safe and accessible, causing no risk to the patient and his/her family as well as no costs, which is currently one of the concerns of health care system, FHM is recommended to be conducted on patients with psychiatric disorders especially MS.",fulltext,"Because of being implemented easily, being safe and accessible, causing no risk to the patient and his/her family as well as no costs, which is currently one of the concerns of health care system, FHM is recommended to be conducted on patients with psychiatric disorders especially MS.",100.0
1529,PRECIS-2,"We gratefully thank the MS patients for their warm and sincere cooperation with this study despite many problems, specific to patients with chronic diseases, they faced.",fulltext," cooperation with this study despite many problems, specific to patients with chronic diseases, they faced.",63.31360946745562
1529,PRECIS-2,"We recommend further studies be conducted on supplementary therapies, alongside pharmacotherapies, and patients with MS and other diseases who are predisposed to specific mental disorders.",fulltext,"We recommend further studies be conducted on supplementary therapies, alongside pharmacotherapies, and patients with MS and other diseases who are predisposed to specific mental disorders.",100.0
1567,PRECIS-2,The project staff used a script to screen potential participants and explain the study requirements to those who called the toll-free number and met eligibility criteria.,fulltext,The project staff used a script to screen potential participants and explain the study requirements to those who called the toll-free number and met eligibility criteria.,100.0
1567,PRECIS-2,"Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",fulltext,"Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",100.0
1567,PRECIS-2,"The facilitator prescribed exercises from a study-specific protocol addressing the most common deficits experienced by persons with MS (attention, memory, flexibility, and problem solving).",fulltext,"The facilitator prescribed exercises from a study-specific protocol addressing the most common deficits experienced by persons with MS (attention, memory, flexibility, and problem solving).",100.0
1567,PRECIS-2,Persons with MS (N ¼ 183) with cognitive concerns were randomly assigned to either the 8-week MAPSS-MS intervention or usual care plus freely available computer games.,fulltext,Persons with MS (N ¼ 183) with cognitive concerns were randomly assigned to either the 8week MAPSS-MS intervention or usual care plus freely available computer games.,99.40119760479041
1567,PRECIS-2,The computer component enabled participants to engage in practice sessions without leaving their homes.,fulltext,The computer component enabled participants (N ¼ 63) to engage in practice sessions without leaving their homes.,100.0
1567,PRECIS-2,The games/tasks were arranged so that the most basic cognitive skills (attention) were addressed first.,fulltext,The games/tasks (see Table 1) were arranged so that the most basic cognitive skills (attention) were addressed first.,100.0
1567,PRECIS-2,The debilitating and widespread effects of Multiple Sclerosis (MS) on cognition are thought to occur in 50e75% of persons with the disease.,fulltext,The debilitating and widespread effects of Multiple Sclerosis (MS) on cognition are thought to occur in 50e75% of persons with the disease.,100.0
1567,PRECIS-2,"The trial was conducted in three large metropolitan communities in Texas: Houston, San Antonio and Dallas.",fulltext,"cruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas.",81.13207547169812
1567,PRECIS-2,"The primary purpose of this study was to determine the effectiveness of a novel computer-assisted cognitive rehabilitation intervention MAPSS-MS (Memory, Attention, Problem Solving Skills in MS) in a multi-site trial with persons with MS.",fulltext,"The primary purpose of this study was to determine the effectiveness of a novel computerassisted cognitive rehabilitation intervention MAPSS-MS (Memory, Attention, Problem Solving Skills in MS) in a multi-site trial with persons with MS.",99.57983193277312
1567,PRECIS-2,"Participants completed self-report and performance measures of cognitive functioning, compensatory strategies and depression at baseline, immediately after the MAPSS-MS intervention, and three and six months post-intervention.",fulltext,"Participants completed self-report and performance measures of cognitive functioning, compensatory strategies and depression at baseline, immediately after the MAPSS-MS intervention, and three and six months postintervention.",99.5575221238938
1567,PRECIS-2,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",prompt,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",100.0
1567,PRECIS-2,"Neuropsychological testing and questionnaire data were collected from all subjects at baseline, following completion of the intervention, and 3 and 6 months post-intervention.",fulltext,"Neuropsychological testing and questionnaire data were collected from all subjects at baseline, following completion of the intervention, and 3 and 6 months post-intervention.",100.0
1567,PRECIS-2,"The effects of the intervention on outcomes were assessed over an 8-month period, with measurements at baseline, immediately after the 8-week MAPPS intervention, and at 3 and 6 months post-intervention.",fulltext,"The effects of the intervention on outcomes were assessed over an 8-month period, with measurements at baseline, immediately after the 8-week MAPPS intervention, and at 3 and 6 months postintervention.",99.5049504950495
1567,PRECIS-2,The 347 persons who were initially screened as 'eligible' were later contacted by phone to invite their participation during specific dates.,fulltext,The 347 persons who were initially screened as 'eligible' were later contacted by phone to invite their participation during specific dates.,100.0
1567,PRECIS-2,The purpose of this study was to test the refined MAPSS-MS intervention in a larger multi-site trial with a six-month follow-up.,fulltext,The purpose of this study was to test the refined MAPSS-MS intervention in a larger multi-site trial with a six-month follow-up.,100.0
1567,PRECIS-2,Statistical significance was set at p < .05.,fulltext,Statistical significance was set at p < .05.,100.0
1568,PRECIS-2,"Patients were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society. Inclusion criteria were (1) 18–60 years of age, (2) ⩽2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",fulltext,"Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society. Inclusion criteria were (1) 18–60 years of age, (2) ⩽2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",100.0
1568,PRECIS-2,"In brief, the exercise intervention included 3892 minutes of aerobic exercise at an average inten-sity of 76.2% HRmax.",fulltext,"In brief, the exercise intervention included 3892 minutes of aerobic exercise at an average intensity of 76.2% HRma",97.45762711864407
1568,PRECIS-2,The exercise sessions con-sisted of continuous sessions lasting 30–60 minutes with an intensity of 60%–80% HRmax and interval training sessions lasting 30--60 minutes with an inter-val duration of 1--10 minutes and intensities varying from 65%--95% HRmax.,fulltext,The exercise sessions consisted of continuous sessions lasting 30–60 minutes with an intensity of 60%–80% HRmax and interval training sessions lasting 30–60 minutes with an interval duration of 1–10 minutes and intensities varying from 65%–95% HRma,97.25490196078431
1568,PRECIS-2,The number of relapses in the study period was obtained from the medical records of the included patients in the RCT by project nurses (blinded to group allocation) and from The Danish MS Registry for the population-based control group. All relapses were confirmed by neurologists (also blinded to group allocation) according to the guidelines from the Danish National Neurological Association.,fulltext,"The number of relapses in the study period was obtained from the medical records of the included Figure 1. Flow diagram of study phases. None of the dropouts were, to the knowledge of the authors, related to the exercise intervention. M Riemenschneider, LG Hvid et al. journals.sagepub.com/home/msj 1623 patients in the RCT by project nurses (blinded to group allocation) and from The Danish MS Registry for the population-based control group. All relapses were confirmed by neurologists (also blinded to group allocation) according to the guidelines from the Danish National Neurological Association.",100.0
1568,PRECIS-2,"Only for the two RCT groups, a multivariate repeated measurements mixed effects regression model was used to analyse longitudinal data with time and group as fixed effects. Time is incorporated in PBVC as a result of the SIENA analysis, and the model for this outcome therefore only included group as fixed effect.",fulltext,"Only for the two RCT groups, a multivariate repeated measurements mixed effects regression model was used to analyse longitudinal data with time and group as fixed effects. Time is incorporated in PBVC as a result of the SIENA analysis, and the model for this outcome therefore only included group as fixed effect.",100.0
1568,PRECIS-2,"The supervised exercise sessions were performed twice weekly for the full study period of 48 weeks, and was planned on the basis of four principles (adapted from Stathopoulos and Felson Duchan) (13): (1) individual tailoring, (2) application of exercise types matching the goal of the intervention, (3) progressive overload and (4) sufficient intensity to induce the desired effects of the intervention.",fulltext,"The supervised exercise sessions were performed twice weekly for the full study period of 48 weeks, and was planned on the basis of four principles (adapted from Stathopoulos and Felson Duchan) 13 : (1) individual tailoring, (2) application of exercise types matching the goal of the intervention, (3) progressive overload and (4) sufficient intensity to induce the desired effects of the intervention.",99.75186104218362
1568,PRECIS-2,"The flow of patients through the different study phases is presented in Figure 1. None of the dropouts were, to the knowledge of the authors, related to the exercise intervention.",fulltext," study phases. None of the dropouts were, to the knowledge of the authors, related to the exercise intervention.",62.56983240223464
1568,PRECIS-2,"The purpose of providing health educational sessions were primarily to facilitate adherence in the control group, as a previous study showed no effect of health education on MS-related symptoms and a null effect on the outcomes of the present study was therefore expected.",fulltext,"The purpose of providing health educational sessions were primarily to facilitate adherence in the control group, as a previous study showed no effect of health education on MS-related symptoms and a null effect on the outcomes of the present study was therefore expected.",100.0
1568,PRECIS-2,"All patients were scanned using the exact same 3-Tesla MRI scanner (MAGNETOM Skyra, Siemens Medical Systems, Erlangen, Germany) at the same location, for all patients, and at all timepoints.",fulltext,"All patients were scanned using the exact same 3-Tesla MRI scanner (MAGNETOM Skyra, Siemens Medical Systems, Erlangen, Germany) at the same location, for all patients, and at all timepoints.",100.0
1568,PRECIS-2,"Global brain atrophy rate was quantified by the two most common methods found in the MS literature. First, as percentage brain volume change (PBVC) determined by the automated longitudinal brain change analysis tool, SIENA, part of FSL, (15) using improved brain masks (16) and second as percentage change of brain parenchymal fraction (BPF).",fulltext,"Global brain atrophy rate was quantified by the two most common methods found in the MS literature. First, as percentage brain volume change (PBVC) determined by the automated longitudinal brain change analysis tool, SIENA, part of FSL, (15) using improved brain masks (16) and second as percentage change of brain parenchymal fraction (BPF).",100.0
1568,PRECIS-2,"A Poisson regression controlling for a priori defined potential confounding variables (age, gender and time since diagnosis) and expressed as an incidence-rate-ratio was applied to compare the annual relapse rate between the RCT groups.",fulltext,"A Poisson regression controlling for a priori defined potential confounding variables (age, gender and time since diagnosis) and expressed as an incidence-rate-ratio was applied to compare the annual relapse rate between the RCT groups.",100.0
1568,PRECIS-2,Patients were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society.,fulltext,Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society.,100.0
1568,PRECIS-2,Eligibility was confirmed by project nurses based on patients’ medical records. Patients gave informed written consent prior to inclusion.,fulltext,Eligibility was confirmed by project nurses based on patients’ medical records. Patients gave informed written consent prior to inclusion.,100.0
1568,PRECIS-2,"The exercise intervention was planned as high-intense aerobic exercise, monitored relative to the patients’ individual maximal heart rate (HRmax), and pro-gressed within and between 4 meso cycles of 12 weeks.",fulltext,"the exercise intervention was planned as high-intense aerobic exercise, monitored relative to the patients’ individual maximal heart rate (HRmax), and progressed within and between 4 meso cycles of 12 weeks.",99.51923076923077
1568,PRECIS-2,The relapse rate and the global brain atrophy rate were the primary outcomes of this study.,fulltext,The relapse rate and the global brain atrophy rate were the primary outcomes of this study.,100.0
1568,PRECIS-2,In addition to usual care the control group of this study received four 1.5-hour health educational sessions throughout the study periods of 48 weeks.,fulltext,In addition to usual care the control group of this study received four 1.5-hour health educational He,68.0
1568,PRECIS-2,The study is approved by The Central Denmark Region Committees on Health Research Ethics (1-10-72-388-17) and registered at the Danish Data Protection Agency (2016-051-000001 (706)) and clinicaltrials.gov (NCT03322761).,fulltext,The study is approved by The Central Denmark Region Committees on Health Research Ethics (1-10-72-388-17) and registered at the Danish Data Protection Agency (2016-051-000001 (706)) and clinicaltrials.gov (NCT03322761).,100.0
1570,PRECIS-2,Comparison of the average primary and final EDSS using the paired samples t.test showed a significant statistical difference (P < 0.05).,fulltext,Comparison of the average primary and final EDSS using the paired samples t.test showed a significant statistical difference (P < 0.05).,100.0
1570,PRECIS-2,"For comparison of the primary and final EDSS in each group, the relapse rate between the groups and side effects between the drugs, the paired samples t.test, the One-Way ANOVA test and the Pearson- chi-square were used.",fulltext,"For comparison of the primary and final EDSS in each group, the relapse rate between the groups and side effects between the drugs, the paired samples t.test, the One-Way ANOVA test and the Pearson- chi-square were used.",100.0
1570,PRECIS-2,"We aimed to compare the therapeutic effect of Avonex (Av), Betaferon (Be) & Rebif (Re) on the Expanded Disability Status Scale (EDSS) in Multiple Sclerosis (MS).",fulltext,"We aimed to compare the therapeutic effect of Avonex (Av), Betaferon (Be) & Rebif (Re) on the Expanded Disability Status Scale (EDSS) in Multiple Sclerosis (MS).",100.0
1570,PRECIS-2,"The average age was 31.11 ± 8.62 years, 80% being female.",fulltext," Average age was 31.11 ± 8.62 years, 80% being female.",94.73684210526316
1570,PRECIS-2,Finally analysis was performed using SPSS v13.,fulltext,Finally analysis was performed using SPSS v13.,100.0
1570,PRECIS-2,"The therapeutic effect of Avonex, Rebif and Betaferon on EDSS and Relapse in Multiple Sclerosis: A Comparative Study",fulltext,"The therapeutic effect of Avonex, Rebif and Betaferon on EDSS and Relapse in Multiple Sclerosis: A Comparative Study",100.0
1570,PRECIS-2,The total sample volume was 90 patients divided into three equal groups.,fulltext,The total sample volume was 90 patients divided into three equal groups.,100.0
1570,PRECIS-2,"The patients were divided into three equal groups: group 1 received Av, group 2 received Re and group 3 received Be, and after 24 months, comparison was done by calculating primary and final EDSS and the relapse rate.",fulltext,"The patients were divided into three equal groups: group 1 received Av, group 2 received Re and group 3 received Be, and after 24 months, comparison was done by calculating primary and final EDSS and the relapse rate.",100.0
1570,PRECIS-2,Ninety patients were included in this study with an average age of 31.11± 8.62 with a minimum of 14 and maximum age of 50.72(80%) were female and 18(20%) were male.,fulltext,Ninety patients were included in this study with an average age of 31.11± 8.62 with a minimum of 14 and maximum age of 50.72(80%) were female and 18(20%) were male.,100.0
1570,PRECIS-2,"The patients in all three groups were evaluated at the end of months 6, 12, 18, 24 and in case of development of reactions were excluded from the study.",fulltext,"The patients in all three groups were evaluated at the end of months 6, 12, 18, 24 and in case of development of reactions were excluded from the study.",100.0
1769,PRECIS-2,The dose of corticotrophin was adjusted to produce just enough 'mooning' of the face to be appreciated by the physician in charge of the trial and the dose was not increased during a relapse.,fulltext,"The dose of corticotrophin was adjusted to produce just enough "" mooning "" of the face to be appreciated by the physician in charge of the trial and the dose was not increased during a relapse.",100.0
1769,PRECIS-2,There was no evidence that treatment prevented deterioration or reduced the number or severity of the relapses when compared with 169 control patients observed and scored in a similar way for the same period of time.,fulltext,There was no evidence that treatment prevented deterioration or reduced the number or severity of the relapses when compared with 169 control patients observed and scored in a similar way for the same period of time.,100.0
1769,PRECIS-2,All cases were seen at three-monthly intervals and scored on the Kurtzke (1961) scale.,fulltext,All cases were seen at three-monthly intervals and scored on the Kurtzke (1961) scale;,100.0
1769,PRECIS-2,Both treated and control groups were given aneurin 100 mg. by injection monthly.,fulltext,Both treated and control groups were given aneurin 100 mg. by injection monthly.,100.0
1769,PRECIS-2,The trial's primary analysis is to assess the long-term treatment of multiple sclerosis with corticotrophin.,fulltext, LONG-TERM TREATMENT OF MULTIPLE SCLEROSIS WITH CORTICOTROPHIN ,58.33333333333333
1769,PRECIS-2,The trial's primary outcome is to assess the long-term treatment of multiple sclerosis with corticotrophin.,fulltext, LONG-TERM TREATMENT OF MULTIPLE SCLEROSIS WITH CORTICOTROPHIN ,58.87850467289719
1769,PRECIS-2,"The treated group were given corticotrophin (’ Acthar ’ gel) in a dosage which varied between 15 and 25 units daily, potassium chloride orally, and a low-salt diet.",fulltext,"The treated group were given corticotrophin (’ Acthar ’ gel) in a dosage which varied between 15 and 25 units daily, potassium chloride orally, and a low-salt diet.",100.0
1769,PRECIS-2,Patients with diabetes mellitus or hypertension or who gave a history of psychiatric illness or peptic ulcer were not admitted to the treated group.,fulltext,Patients with diabetes mellitus or hypertension or who gave a history of psychiatric illness or peptic ulcer were not admitted to the treated group.,100.0
1769,PRECIS-2,"This controlled study was started in 1963 in three cities-Belfast, Leeds, and Manchester. It could not be a double-blind study.",fulltext,"This controlled study was started in 1963 in three citiesBelfast, Leeds, and Manchester. It could not be a doubleblind study.",98.4251968503937
1769,PRECIS-2,Patients with multiple sclerosis were randomly selected into treated and control groups; only patients who could walk with or without walking aids were admitted to the trial.,fulltext,"Patients with multiple sclerosis were randomly selected into treated and control groups; only patients who could walk with or without walking aids were admitted to the trial,",100.0
1769,PRECIS-2,"In Manchester, patients who had relapsed in the previous eighteen months only were admitted to the trial.",fulltext,"In Manchester, patients who had relapsed in the previous eighteen months only were admitted to the trial.",100.0
1769,PRECIS-2,Relapses lasting longer than twenty-four hours were also scored by a system in the three centres.,fulltext,relapses lasting longer than twenty-four hours were also scored by a system in the three centres.,100.0
1769,PRECIS-2,Initially and at yearly intervals the thoracolumbar spine of the treated group was X-rayed for osteoporosis.,fulltext,Initially and at yearly intervals the thoracolumbar spine of the treated group was X-rayed for osteoporosis.,100.0
1769,PRECIS-2,Similar studies were carried out at the same time in three cities and this had the added advantage that they could control one another.,fulltext,"similar studies were carried out at the same time in three cities and this had the added advantage that they could "" control "" one another.",100.0
1771,PRECIS-2,"At baseline (T0), after 24 (T24) and after 48 (T48) weeks, participants performed the BRB-N, the Major Depression Inventory (MDI), and a cardiorespiratory fitness test (VO2-max test). Each test session was separated by at least 48 hours from the last exercise bout.",fulltext,"At baseline (T0), after 24 (T24) and after 48 (T48) weeks, participants performed the BRB-N, the Major Depression Inventory (MDI), and a cardiorespiratory fitness test (VO 2 -max test). Each test session was separated by at least 48 hours from the last exercise bout.",100.0
1771,PRECIS-2,The present study conforms to the CONSORT 2010 guidelines. It represents secondary data analysis from a randomized controlled trial investigating the effects of aerobic exercise on brain health and cognition in pwMS. This trial is registered at ClinicalTrials.gov (NCT02661555).,fulltext,The present study conforms to the CONSORT 2010 guidelines. 22 It represents secondary data analysis from a randomized controlled trial investigating the effects of aerobic exercise on brain health and cognition in pwMS. This trial is registered at ClinicalTrials. gov (NCT02661555).,100.0
1771,PRECIS-2,"Exercise adherence was high with 44.8 ± 2.6 completed sessions, corresponding to 93.3 ± 5.4% of the planned sessions.",fulltext,"Exercise adherence was high with 44.8 ± 2.6 completed sessions, corresponding to 93.3 ± 5.4% of the planned sessions.",100.0
1771,PRECIS-2,"All longitudi-nal data for the total group and the cognitively impaired subgroup were analyzed using an intention-to-treat linear mixed effects model with time and group as the factors of interest. Age, sex, education level, MDI score, and MS type were a priori classified as important covariates and were therefore included in the model when analyzing cognitive performance outcomes.",fulltext,"All longitudinal data for the total group and the cognitively impaired subgroup were analyzed using an intention-to-treat linear mixed effects model with time and group as the factors of interest. Age, sex, education level, MDI score, and MS type were a priori classified as important covariates and were therefore included in the model when analyzing cognitive performance outcomes.",99.73958333333334
1771,PRECIS-2,"Participants were recruited between April 2016 and October 2017. From a total of 148 patients invited to participate, 86 were enrolled.",fulltext,"Participants were recruited between April 2016 and October 2017. From a total of 148 patients invited to participate, 86 were enrolled.",100.0
1771,PRECIS-2,"Supervised PAE sessions were conducted twice weekly during the 24 weeks, with one continuous and one interval exercise session performed each week. In brief, the session volume increased from 30 to 60 minutes during the intervention while the intensity increased from 65% to 95% of individual maximum heart rate (HR max). For further details on exercise modality options and the progressing volume and intensity of the exercise sessions, see Langeskov-Christensen et al. (23).",fulltext,"Supervised PAE sessions were conducted twice weekly during the 24 weeks, with one continuous and one interval exercise session performed each week. In brief, the session volume increased from 30 to 60 minutes during the intervention while the intensity M Langeskov-Christensen, LG Hvid et al. journals.sagepub.com/home/msj 3 increased from 65% to 95% of individual maximum heart rate (HR max ). For further details on exercise modality options and the progressing volume and intensity of the exercise sessions, see LangeskovChristensen et al. 23 O",99.36974789915966
1771,PRECIS-2,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)). For inclusion and exclusion criteria, see Langeskov-Christensen et al. (24). At inclusion, a neurologist examined participants to determine the Expanded Disability Status Scale (EDSS) score, unless a recent score (<6 months) followed by a disease stable period existed.",fulltext,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)). For inclusion and exclusion criteria, see LangeskovChristensen et al. 24 At inclusion, a neurologist examined participants to determine the Expanded Disability Status Scale (EDSS) score, unless a recent score (<6 months) followed by a disease stable period existed.",99.13793103448276
1772,PRECIS-2,All outcomes were evaluated after 6 months of treatment.,fulltext,All outcomes were evaluated after 6 months of treatment.,100.0
1772,PRECIS-2,"Study enrollment was completed in October 2011. Of 1053 patients randomized to treatment, 790 were randomized to fingolimod 0.5 mg and 263 were randomized to an iDMT.",fulltext,"s Study enrollment was completed in October 2011. Of 1053 patients randomized to treatment, 790 were randomized to fingolimod 0.5 mg and 263 were randomized to an iDM",98.79518072289156
1772,PRECIS-2,"EPOC was a 6-month, randomized, open-label, multicenter, phase 4 study conducted in the USA and Canada.",fulltext,"EPOC was a 6-month, randomized, open-label, multicenter, phase 4 study conducted in the USA and Canada.",100.0
1772,PRECIS-2,The primary endpoint was the change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score.,fulltext,The primary endpoint was the change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score.,100.0
1772,PRECIS-2,Patients were required to have been naïve to fingolimod treatment.,fulltext,. Patients were required to have been naïve to fingolimod treatmen,96.96969696969697
1772,PRECIS-2,"For the primary endpoint, enrollment of 1000 patients (750 fingolimod; 250 iDMT) would provide 90% power to detect a significant difference between fingolimod and each iDMT group in the change from baseline, assuming an effect size of 0.25, a significance level of 5% and a 10% rate of unevaluable patients.",fulltext,"For the primary endpoint, enrollment of 1000 patients (750 fingolimod; 250 iDMT) would provide 90% power to detect a significant difference between fingolimod and each iDMT group in the change from baseline, assuming an effect size of 0.25, a significance level of 5% and a 10% rate of unevaluable patients.",100.0
1772,PRECIS-2,"The protocol and informed consent form were reviewed and approved by an institutional review board (Quorum Review) at each study center, and every patient provided written informed consent.",fulltext,". The protocol and informed consent form were reviewed and approved by an institutional review board (Quorum Review) at each study center, and every patient provided written informed consen",98.94179894179894
1772,PRECIS-2,"Patients were excluded from the study for any of the following reasons: chronic immune system disease other than MS; immunodeficiency; malignancy other than localized basal cell carcinoma within the past 5 years; a history of cardiac arrest, myocardial infarction, ischemic heart disease or coronary spasm within the past 6 months; Mobitz type II second-degree heart block, third-degree atrioventricular block or an increased corrected QT (QTc) interval (>470 ms); having undergone a bone marrow transplant; a history of alcohol abuse within the past 5 years.",fulltext,"a Patients were excluded from the study for any of the following reasons: chronic immune system disease other than MS; immunodeficiency; malignancy other than localized basal cell carcinoma within the past 5 years; a history of cardiac arrest, myocardial infarction, ischemic heart disease or coronary spasm within the past 6 months; Mobitz type II second-degree heart block, third-degree atrioventricular block or an increased corrected QT (QTc) interval (>470 ms); having undergone a bone marrow transplant; a history of alcohol abuse within the past 5 year",99.6422182468694
1772,PRECIS-2,The primary endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months.,fulltext,t The primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 month,98.85714285714286
1772,PRECIS-2,"Further exclusion criteria at the time of screening were: macular edema; active systemic infection; a negative test for Varicella zoster immunoglobulin G antibodies; positive tests for hepatitis B, hepatitis C or human immunodeficiency virus; tuberculosis; uncontrolled diabetes; uncontrolled or poorly controlled hypertension or asthma; cardiac failure; severe respiratory disease or pulmonary fibrosis; chronic liver or biliary disease.",fulltext,". Further exclusion criteria at the time of screening were: macular edema; active systemic infection; a negative test for Varicella zoster immunoglobulin G antibodies; positive tests for hepatitis B, hepatitis C or human immunodeficiency virus; tuberculosis; uncontrolled diabetes; uncontrolled or poorly controlled hypertension or asthma; cardiac failure; severe respiratory disease or pulmonary fibrosis; chronic liver or biliary diseas",99.5433789954338
1772,PRECIS-2,Patients were required to have received a single iDMT (except natalizumab) continuously for at least 6 months prior to study initiation and to be candidates for therapy change.,fulltext,Patients were required to have received a single iDMT (except natalizumab) continuously for at least 6 months prior to study initiation and to be candidates for therapy change.,100.0
1772,PRECIS-2,"The four iDMTs were subcutaneous (SC) IFN beta-1b (Extavia®, Novartis Pharma AG, Basel, Switzerland, or Betaseron®, Bayer AG, Leverkusen, Germany) 0.25 mg every other day, IM IFN beta-1a (Avonex®, Biogen Idec, Cambridge, MA, USA) 30 μg once weekly, SC IFN beta-1a (Rebif®, Merck Serono, Darmstadt, Germany, and Pfizer Inc., New York City, NY, USA) 22 or 44 μg three times weekly, or SC GA (Copaxone®, Teva Pharmaceutical Industries Ltd, Petah Tikva, Israel) 20 mg once daily.",fulltext,"The four iDMTs were subcutaneous (SC) IFN beta-1b (Extavia®, Novartis Pharma AG, Basel, Switzerland, or Betaseron®, Bayer AG, Leverkusen, Germany) 0.25 mg every other day, IM IFN beta-1a (Avonex®, Biogen Idec, Cambridge, MA, USA) 30 μg once weekly, SC IFN beta-1a (Rebif®, Merck Serono, Darmstadt, Germany, and Pfizer Inc., New York City, NY, USA) 22 or 44 μg three times weekly, or SC GA (Copaxone®, Teva Pharmaceutical Industries Ltd, Petah Tikva, Israel) 20 mg once dail",99.57894736842105
1772,PRECIS-2,"Patients randomized to the iDMT group either remained on the same therapy or, following consultation with a physician, were switched immediately to another approved iDMT.",fulltext,"Patients randomized to the iDMT group either remained on the same therapy or, following consultation with a physician, were switched immediately to another approved iDMT.",100.0
1773,PRECIS-2,"Testing was performed on three different occasions: before (week 0) and after (week 12) the training program, and after the detraining period (week 24).",fulltext,"Testing was performed on three different occasions: before (week 0) and after (week 12) the training program, and after the detraining period (week 24).",100.0
1773,PRECIS-2,"The EG increased MVIC and muscle power after the training period, although the training did not affect muscle endurance. After 12 weeks of detraining, MVIC returned to pre-training values but muscle power was still greater than pre-training values in the EG.",fulltext,"The EG increased MVIC and muscle power after the training period, although the training did not affect muscle endurance. After 12 weeks of detraining, MVIC returned to pre-training values but muscle power was still greater than pre-training values in the EG.",100.0
1773,PRECIS-2, Bonferroni post-hoc comparisons.,fulltext, Bonferroni post-hoc comparisons.,100.0
1773,PRECIS-2, All participants from the EG completed more than 75% of the sessions included in the resistance training program.,fulltext, All participants from the EG completed more than 75% of the sessions included in the resistance training program.,100.0
1773,PRECIS-2, The patients were continuously supervised by physical therapists.,fulltext, The patients were continuously supervised by physical therapists.,100.0
1773,PRECIS-2,Score: [X],prompt,Score: [X],100.0
1773,PRECIS-2,"After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",fulltext,"After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",100.0
1773,PRECIS-2,All participants were recruited among six MS rehabilitation centers within the region of Castilla y Le´on (Spain),fulltext,All participants were recruited among six MS rehabilitation centers within the region of Castilla y Le´on (Spain),100.0
1773,PRECIS-2,All testing procedures were selected according to previous studies,fulltext,All testing procedures were selected according to previous studies,100.0
1773,PRECIS-2,Subjects performed coupled concentric-eccentric bilateral seated knee extension training using a weight stack machine,fulltext,Subjects performed coupled concentric-eccentric bilateral seated knee extension training using a weight stack machine,100.0
1773,PRECIS-2,"Participants were randomly assigned to two different groups, the exercise group (EG) or the control group (CG). The EG, which included 16 women and 14 men (49.6 ± 11.0 yr), performed 12 weeks of resistance training followed by a detraining period where resistance exercise or other structured physical activity was avoided. The CG, which did not follow any resistance training during the study period, included 7 women and 5 men (46.2 ± 7.5 yr).",fulltext,"Participants were randomly assigned to two different groups, the exercise group (EG) or the control group (CG). The EG, which included 16 women and 14 men (49.6 ± 11.0 yr), performed 12 weeks of resistance training followed by a detraining period where resistance exercise or other structured physical activity was avoided. The CG, which did not follow any resistance training during the study period, included 7 women and 5 men (46.2 ± 7.5 yr).",100.0
1773,PRECIS-2, Each participant completed the tests in a single session. Subjects were individually informed about the test procedures before initiating them.,fulltext, Each participant completed the tests in a single session. Subjects were individually informed about the test procedures before initiating them.,100.0
1773,PRECIS-2,The EG performed 12 weeks of resistance training followed by a detraining period where resistance exercise or other structured physical activity was avoided. The CG did not follow any resistance training during the study period.,fulltext," performed 12 weeks of resistance training followed by a detraining period where resistance exercise or other structured physical activity was avoided. The CG, which did not follow any resistance training during the study period,",97.36842105263158
1773,PRECIS-2,Adherence to the training intervention (e.g. EG) averaged 22.9 ± 1.5 sessions from a total of 24 planned sessions,fulltext,Adherence to the training intervention (e.g. EG) averaged 22.9 ± 1.5 sessions from a total of 24 planned sessions,100.0
1773,PRECIS-2," After a medical evaluation that confirmed patients’ aptitude and absence of contraindications to carry out the procedures involved in the study, subjects signed a written informed consent form to participate.",fulltext," After a medical evaluation that confirmed patients’ aptitude and absence of contraindications to carry out the procedures involved in the study, subjects signed a written informed consent form to participate.",100.0
1773,PRECIS-2,Score: [NA],prompt,Score: [NA],100.0
1773,PRECIS-2,Two-way ANOVA with repeated measurements for group and time,fulltext,Two-way ANOVA with repeated measurements for group and time,100.0
650,PRECIS-2,Patients with score DFT >4 and DS >3 were eligible for trial participation.,fulltext,Patients with score DFT >4 and DS >3 were eligible for trial participation.,100.0
650,PRECIS-2,Patients were asked to return the completed questionnaire to the research centre and to give informed consent to be approached if they were found to be eligible for research follow-up measurements.,fulltext,Patients were asked to return the completed questionnaire to the research centre and to give informed consent to be approached if they were found to be eligible for research follow-up measurements.,100.0
650,PRECIS-2,"SMS included detection of patients with emotional distress and reduced daily functioning, and supporting them when needed through problem solving and reattribution techniques.",fulltext,"SMS included detection of patients with emotional distress and reduced daily functioning, and supporting them when needed through problem solving and reattribution techniques.",100.0
650,PRECIS-2,"In some trials, eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given.",prompt,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given,",99.5850622406639
650,PRECIS-2,These data were used to evaluate whether patients were exposed to SMS.,fulltext,These data were used to evaluate whether patients were exposed to SMS.,100.0
650,PRECIS-2,"PNs supported patients in the processes of defining problems and finding solutions themselves, by applying problem-solving and reattribution techniques.",fulltext,"PNs supported patients in the processes of defining problems and finding solutions themselves, by applying problem-solving and reattribution techniques.",100.0
650,PRECIS-2,"In the year following the training, PNs in the intervention arm recorded process measures and outcomes of SMS on a specific registration form.",fulltext,"In the year following the training, PNs in the intervention arm recorded process measures and outcomes of SMS on a specific registration form.",100.0
650,PRECIS-2,"Linear and logistic multilevel models were used with an unstructured covariance structure for repeated measures, and patients and PNs as random factors.",fulltext,", linear and logistic multilevel models were used with an unstructured covariance structure for repeated measures, and patients and PNs as random factor",98.68421052631578
650,PRECIS-2,Analyses were performed on an intention-to-treat basis.,fulltext,Analyses were performed on an intention-to-treat basis.,100.0
650,PRECIS-2,The study was conducted within a regional organisation of GPs (a so-called ‘care group’) in the South of the Netherlands.,fulltext, regional organisation of GPs (a so-called ‘care group’) in the South of the Netherlands ,73.55371900826447
650,PRECIS-2,"Patients could use information from a diary in which they recorded symptoms, thoughts, worries, feelings, and behaviour.",fulltext,"Patients could use information from a diary in which they recorded symptoms, thoughts, worries, feelings, and behaviour.",100.0
650,PRECIS-2,The study involved practice nurses (n=40) providing care to approximately 4000 patients with diabetes.,fulltext,The study involved practice nurses (n=40) providing care to approximately 4000 patients with diabetes.,100.0
650,PRECIS-2,"Within a week after receiving the screening questionnaire at our research centre, eligible patients were sent an invitation letter together with an informed consent form for trial participation and the baseline measurement.",fulltext,"Within a week after receiving the screening questionnaire at our research centre, eligible patients were sent an invitation letter together with an informed consent form for trial participation and the baseline measurement.",100.0
650,PRECIS-2,The study was conducted between November 2011 and February 2013 and was registered in a Dutch public trial registry [NTR2764].,fulltext,The study was conducted between November 2011 and February 2013 and was registered in a Dutch public trial registry [NTR2764].,100.0
650,PRECIS-2,Financial reimbursement for the extra time spent on SMS was added to the bundled payment arrangement for diabetes care.,fulltext,Financial reimbursement for the extra time spent on SMS was added to the bundled payment arrangement for diabetes care.,100.0
650,PRECIS-2,Both problem solving and reattribution techniques were intended to result in action plans indicating how patients would achieve their personal goals.,fulltext,Both problem solving and reattribution techniques were intended to result in action plans indicating how patients would achieve their personal goals.,100.0
650,PRECIS-2,Outcomes were measured at baseline and at 4-month and 12-month follow-ups.,fulltext,Outcomes were measured at baseline and at 4-month and 12-month follow-ups.,100.0
650,PRECIS-2,"During three 8 h training sessions, PNs in the intervention arm were trained to integrate the detection and follow-up phase of SMS into their daily practice.",fulltext,"During three 8 h training sessions, PNs in the intervention arm were trained to integrate the detection and follow-up phase of SMS into their daily practice.",100.0
650,PRECIS-2,PNs were blinded regarding the outcomes of the recruitment procedure and study participation of their patients.,fulltext,PNs were blinded regarding the outcomes of the recruitment procedure and study participation of their patients.,100.0
650,PRECIS-2,The primary outcome measure was a dichotomised score on a Visual Analogue Scale that measured the perceived effect of diabetes on daily functioning.,fulltext,The primary outcome measure was a dichotomised score on a Visual Analogue Scale that measured the perceived effect of diabetes on daily functioning.,100.0
650,PRECIS-2,"The secondary measures included patients’ diabetes-related distress, quality of life, autonomy and participation, self-efficacy, self-management and glycaemic control.",fulltext," Secondary measures included patients’ diabetes-related distress, quality of life, autonomy and participation, self-efficacy, selfmanagement and glycaemic control.",97.60479041916167
650,PRECIS-2,The intervention strategy derived from the principles of learning theory has been described elsewhere.,fulltext,The intervention strategy derived from the principles of learning theory has been described elsewhere.,100.0
650,PRECIS-2,The enclosed self-administered questionnaire consisted of the screening instruments that intervention PNs would also apply for SMS in their routine practice.,fulltext,The enclosed self-administered questionnaire consisted of the screening instruments that intervention PNs would also apply for SMS in their routine practice.,100.0
650,PRECIS-2,"To ensure that all participants of the intervention and control arms started with a score DFT >4, indicating a perceived burden of diabetes, we used the dichotomised research-led screening outcomes at baseline.",fulltext,"To ensure that all participants of the intervention and control arms started with a score DFT >4, indicating a perceived burden of diabetes, we used the dichotomised research-led screening outcomes at baseline.",100.0
650,PRECIS-2,The time interval between the researcher-driven self-administered screening questionnaire and the face-to-face nurse-led detection procedure in the consultation room needed to be as short as possible.,fulltext,The time interval between the researcher-driven self-administered screening questionnaire and the face-to-face nurse-led detection procedure in the consultation room needed to be as short as possible.,100.0
650,PRECIS-2,Patients with type 2 diabetes (n=264) selected by a self-administered questionnaire aimed at measuring emotional distress and diabetes-related reduced daily functioning.,fulltext,Patients with type 2 diabetes (n=264) selected by a self-administered questionnaire aimed at measuring emotional distress and diabetes-related reduced daily functioning.,100.0
651,PRECIS-2,The primary outcome measure was the MiniAQLQ score.,fulltext,The primary outcome measure was the MiniAQLQ score.,100.0
651,PRECIS-2,"The validated 15-item MiniAQLQ is scored from 1 to 7, with higher scores indicating less impairment and a minimal clinically important difference (MID) of 0.5.",fulltext,"The validated 15-item MiniAQLQ is scored from 1 to 7, with higher scores indicating less impairment and a minimal clinically important difference (MID) of 0.5.",100.0
651,PRECIS-2,"We conducted two parallel, multicenter, pragmatic trials to evaluate the real-world effectiveness of a leukotriene-receptor antagonist (LTRA) as compared with either an inhaled glucocorticoid for first-line asthma-controller therapy or a long-acting beta 2 -agonist (LABA) as add-on therapy in patients already receiving inhaled glucocorticoid therapy. Eligible primary care patients 12 to 80 years of age had impaired asthma-related quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score ≤6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score ≥1).",fulltext,"We conducted two parallel, multicenter, pragmatic trials to evaluate the real-world effectiveness of a leukotriene-receptor antagonist (LTRA) as compared with either an inhaled glucocorticoid for first-line asthma-controller therapy or a long-acting beta 2 agonist (LABA) as add-on therapy in patients already receiving inhaled glucocorticoid therapy. Eligible primary care patients 12 to 80 years of age had impaired asthmarelated quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score ≤6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score ≥1).",99.66044142614601
651,PRECIS-2,The protocol discouraged substantial treatment changes between randomization and the 2-month visit.,fulltext,The protocol discouraged substantial treatment changes between randomization and the 2-month visit.,100.0
651,PRECIS-2,"Analysis of covariance was used, with treatment as a fixed effect and the baseline value as a covariate.",fulltext,"Analysis of covariance was used, with treatment ",46.15384615384615
651,PRECIS-2,"The two trials, which were conducted at 53 primary care practices in the United Kingdom, enrolled patients 12 to 80 years of age with a physician’s diagnosis of asthma.",fulltext,"The two trials, which were conducted at 53 primary care practices in the United Kingdom, enrolled patients 12 to 80 years of age with a physician’s diagnosis of asthma.",100.0
651,PRECIS-2,"Patients were responsible for obtaining their own medications, as would occur in real life.",fulltext,"Patients were responsible for obtaining their own medications, as would occur in real life.",100.0
651,PRECIS-2,Eligible primary care patients 12 to 80 years of age had impaired asthma-related quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score ≤6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score ≥1).,fulltext,Eligible primary care patients 12 to 80 years of age had impaired asthmarelated quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score ≤6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score ≥1).,99.57627118644068
651,PRECIS-2,Clinical and lung-function data were recorded by clinic staff who were aware of the treatment assignments.,fulltext,Clinical and lung-function data were recorded by clinic staff who were aware of the treatment assignments.,100.0
651,PRECIS-2,"For each of the assigned treatments, choices of individual drugs and devices were made according to normal clinical practice and British asthma guidelines.",fulltext,"For each of the assigned treatments, choices of individual drugs and devices were made according to normal clinical practice and British asthma guidelines.",100.0
651,PRECIS-2,"We used a validated, shortened version of the ACQ (excluding percent of predicted normal forced expiratory volume in one second but including short-acting bronchodilator use), on which scores range from 0 to 6, with higher scores indicating worse asthma control and an MID of 0.5.",fulltext,"We used a validated, shortened version of the ACQ (excluding percent of predicted normal forced expiratory volume in one second but including short-acting bronchodilator use), on which scores range from 0 to 6, with higher scores indicating worse asthma control and an MID of 0.5.",100.0
655,PRECIS-2,"Recruited patients (recruitment visit, −1) attended an initial 8-week outpatient-based PR programme conducted in each hospital rehabilitation department.",fulltext,"Recruited patients (recruitment visit, −1) attended an initial 8-week outpatient-based PR programme conducted in each hospital rehabilitation department.",100.0
655,PRECIS-2,"A patient in the IG arm was classified as a non-complier if he/she did not perform scheduled exercises for at least 8 consecutive weeks, unless there were clear clinical reasons not to.",fulltext," patient in the IG arm was classified as a non-complier if he/she did not perform scheduled exercises for at least 8 consecutive weeks, unless there were clear clinical reasons not to.",99.45945945945947
655,PRECIS-2,"The BODE index, a multidimensional grading system, was also used.",fulltext,"The BODE index, a multidimensional grading system, was also used.",100.0
655,PRECIS-2,"Patients in the CG received usual care, that is, they were advised to exercise regularly (at least walking for 1 hour a day) and provided with general educational material, following current clinical practice at participating sites.",fulltext,"Patients in the CG received usual care, that is, they were advised to exercise regularly (at least walking for 1 hour a day) and provided with general educational material, following current clinical practice at participating sites.",100.0
655,PRECIS-2,Patients were considered non-adherent if they did not attend any follow-up appointments and there was no clear clinical justification for not attending.,fulltext,Patients were considered non-adherent if they did not attend any 2 follow-up appointments and there was no clear clinical justification for not attending.,100.0
655,PRECIS-2,Exercise tolerance (the ability to sustain exercise) was assessed using distance covered in the 6MWT.,fulltext,Exercise tolerance (the ability to sustain exercise) was assessed using distance covered in the 6MWT.,100.0
655,PRECIS-2,Missing values were not imputed. All patients were analyzed in the group to which they were randomized.,fulltext,Missing values were not imputed. All patients were analyzed in the group to which they were randomized.,100.0
655,PRECIS-2,"The main efficacy analysis used analysis of covariance (ANCOVA) techniques to test for differences between groups in outcome variables at the 12-month visit, adjusted for baseline values.",fulltext,"The main efficacy analysis used analysis of covariance (ANCOVA) techniques to test for differences between groups in outcome variables at the 12-month visit, adjusted for baseline values.",100.0
655,PRECIS-2,"Patient selection criteria were having a diagnosis of moderate-to-severe COPD (a Body mass index, Airflow obstruction, dyspnoea and Exercise capacity [BODE] index score of 3--7) according to international guidelines.",fulltext,"Patient selection criteria were having a diagnosis of moderate-to-severe COPD (a Body mass index, Airflow obstruction, dyspnoea and Exercise capacity [BODE] index score of 3–7) according to international guidelines ",99.53703703703704
655,PRECIS-2,Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital.,fulltext,Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital.,100.0
655,PRECIS-2,"Following completion of this programme, patients were randomly allocated (baseline visit, 0) to either the TelePR programme [intervention group (IG)] or the standard, usual care programme [control group (CG)]. Allocation was stratified by centre and based on randomly permuted blocks of variable size with a 1:1 allocation ratio.",fulltext,"Following completion of this programme, patients were randomly allocated (baseline visit, 0) to either the TelePR programme [intervention group (IG)] or the standard, usual care programme [control group (CG)]. Allocation was stratified by centre and based on randomly permuted blocks of variable size with a 1:1 allocation ratio.",100.0
655,PRECIS-2,"Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital. They were provided with, for the 12-month follow-up period, a telerehabilitation kit (mobile phone, pulse oximeter, dumbbells and exercise bicycle) along with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session.",fulltext,"Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital. They were provided with, for the 12-month follow-up period, a telerehabilitation kit (mobile phone, pulse oximeter, dumbbells and exercise bicycle) along with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session ",100.0
655,PRECIS-2,"At each follow-up visit, the general health status of the patient was assessed, medical treatment was revised and optimized, educational reinforcement was provided, 6-minute walk test (6MWT) and spirometry tests were carried out and HRQoL measures were taken.",fulltext,"At each follow-up visit, the general health status of the patient was assessed, medical treatment was revised and optimized, educational reinforcement was provided, 6-minute walk test (6MWT) and spirometry tests were carried out and HRQoL measures were taken.",100.0
655,PRECIS-2,The hospital-based outpatient programme consisted of three training sessions a week which included 30 min of weight lifting and 30 min of leg cycle ergometry along with four educational sessions which included chest physiotherapy training.,fulltext,The hospital-based outpatient programme consisted of three training sessions a week which included 30 min of weight lifting J.B. Galdiz et al. / Arch Bronconeumol. 2021;57(3):195–204 197 and 30 min of leg cycle ergometry along with four educational sessions which included chest physiotherapy training ,100.0
655,PRECIS-2,"The study was carried out in accordance with the principles of the Declaration of Helsinki and started after receiving authorization from the Spanish Agency for Medicines and Health Products and the approval of the Basque Country Ethics Committee, as well as the local Ethics Committee and Director at each institution. All patients gave written informed consent.",fulltext,"The study was carried out in accordance with the principles of the Declaration of Helsinki and started after receiving authorization from the Spanish Agency for Medicines and Health Products and the approval of the Basque Country Ethics Committee, as well as the local Ethics Committee and Director at each institution. All patients gave written informed consent.",100.0
655,PRECIS-2,Health-related quality of life (HRQoL) was measured using a generic instrument (SF-36) and the Chronic Respiratory Disease Questionnaire (CRQ).,fulltext,Health-related quality of life (HRQoL) was measured using a generic instrument (SF-36) 12 and the Chronic Respiratory Disease Questionnaire (CRQ).,100.0
655,PRECIS-2,"Lastly, BODE scores were calculated at each follow-up visit for the IG and at baseline and 12-month visits for the CG.",fulltext,"Lastly, BODE scores were calculated at each follow-up visit for the IG and at baseline and 12-month visits for the CG.",100.0
655,PRECIS-2,"At each visit, patients were advised to continue doing exercise and attending follow-up appointments even if they decided not to comply with the assigned maintenance exercises, supporting the intention-to-treat principle.",fulltext,"At each visit, patients were advised to continue doing exercise and attending follow-up appointments even if they decided not to comply with the assigned maintenance exercises, supporting the intention-to-treat principle ",100.0
655,PRECIS-2,"After the randomization visit, follow-up appointments were arranged for both groups at 3, 9 and 12 months.",fulltext,"After the randomization visit, follow-up appointments were arranged for both groups at 3, 9 and 12 months.",100.0
657,PRECIS-2,"The GroupCoreDIST intervention was conducted with groups of 3 participants (1 group had 4 participants), for 60 minutes 3 times per week.",fulltext,"The GroupCoreDIST intervention was conducted with groups of 3 participants (1 group had 4 participants), for 60 minutes 3 times per week.",100.0
657,PRECIS-2,"Assessments were conducted at baseline and at weeks 7, 18, and 30.",fulltext,"Assessments were conducted at baseline and at weeks 7, 18, and 30.",100.0
657,PRECIS-2,"Outcomes were measured with the Trunk Impairment Scale–Norwegian Version, Mini Balance Evaluation Systems Test, and Patient Global Impression of Change–Balance.",fulltext,"Outcomes were measured with the Trunk Impairment Scale–Norwegian Version, Mini Balance Evaluation Systems Test, and Patient Global Impression of Change–Balance.",100.0
657,PRECIS-2,Participants allocated to the intervention group were divided into 13 training groups by B.N. and E.C.A. according to geography.,fulltext,Participants allocated to the intervention group were divided into 13 training groups by B.N. and E.C.A. according to geography.,100.0
657,PRECIS-2,"In August 2015, 1 of the MS nurses at the Department of Neurology, Nordland Hospital Trust in Bodø, Norway, sent out invitation letters with a consent form to 160 persons with MS who were registered at the MS outpatient clinic, had EDSS scores of 0 to 7, and lived in 1 of the 6 municipalities included in the study.",fulltext,"In August 2015, 1 of the MS nurses at the Department of Neurology, Nordland Hospital Trust in Bodø, Norway, sent out invitation letters with a consent form to 160 persons with MS who were registered at the MS outpatient clinic, had EDSS scores of 0 to 7, and lived in 1 of the 6 municipalities included in the study.",100.0
657,PRECIS-2,Two assessors masked with regard to the group allocation carried out the assessments.,fulltext,Two assessors masked with regard to the group allocation carried out the assessments.,100.0
657,PRECIS-2,Six neurological physical therapists conducted the intervention after being trained in GroupCoreDIST for 5 days.,fulltext,Six neurological physical therapists conducted the intervention after being trained in GroupCoreDIST for 5 days.,100.0
657,PRECIS-2,Assessments at all time points took place at a Norwegian hospital.,fulltext,Assessments at all time points took place at a Norwegian hospital.,100.0
657,PRECIS-2,"The inclusion criteria were as follows: (1) diagnosed with MS in accordance with the McDonald criteria; (2) registered at the MS outpatient clinic; (3) living in 1 of 6 selected municipalities; (4) aged 18 years or older; (5) capable of providing signed written consent; and (6) EDSS score between 1 and 6.5 (1 = minor disability, 6.5 = able to walk 20 m with or without a walking aid).",fulltext,"The inclusion criteria were as follows: (1) diagnosed with MS in accordance with the McDonald criteria 27 ; (2) registered at the MS outpatient clinic; (3) living in 1 of 6 selected municipalities; (4) aged 18 years or older; (5) capable of providing signed written informed consent; and (6) EDSS score between 1 and 6.5 (1 = minor disability, 6.5 = able to walk 20 m with or without a walking aid).",100.0
657,PRECIS-2,"The physical therapists individualized the exercises by tailoring them according to each individual’s symptoms, disability level, and general well-being, and they intensified the exercises by increasing number of repetitions, level of difficulty, and/or by adding motor-cognitive dual tasks as movement quality improved.",fulltext,"The physical therapists individualized the exercises by tailoring them according to each individual’s symptoms, disability level, and general well-being, and they intensified the exercises by increasing number of repetitions, level of difficulty, and/or by adding motor-cognitive dual tasks as movement quality improved.",100.0
657,PRECIS-2,"All participants with postintervention test assessment scores were included, although some had missing observations.",fulltext,"All participants with postintervention test assessment scores were included, although some had missing observations.",100.0
657,PRECIS-2,"The trial's primary outcome was to compare the immediate and long-term effects of a 6-week individualized, group-based, comprehensive core stability intervention (GroupCoreDIST) with standard care on balance and trunk control in individuals with MS.",fulltext," was to compare the immediate and long-term effects of a 6-week individualized, group-based, comprehensive core stability intervention (GroupCoreDIST) with standard care on balance and trunk control in individuals with MS.",89.1566265060241
657,PRECIS-2,The exclusion criteria were as follows: (1) pregnancy at time of examination; (2) exacerbation in the previous 2 weeks before enrollment; and (3) other acute conditions compromising balance.,fulltext,The exclusion criteria were as follows: (1) pregnancy at time of examination; (2) exacerbation in the previous 2 weeks before enrollment; and (3) other acute conditions compromising balance.,100.0
657,PRECIS-2,Standard care included the usual care for individuals with MS in the same municipalities.,fulltext,Standard care included the usual care for individuals with MS in the same municipalities.,100.0
657,PRECIS-2,"The physical therapists had varied experience (between 7--25 years) and certification (2 had both a master’s degree in neurological physical therapy and were clinical specialists in neurological physical therapy, 1 was a clinical specialist in neurological physical therapy, and 3 were generalists in physical therapy).",fulltext,"The physical therapists had varied experience (between 7–25 years) and certification (2 had both a master’s degree in neurological physical therapy and were clinical specialists in neurological physical therapy, 1 was a clinical specialist in neurological physical therapy, and 3 were generalists in physical therapy).",99.68652037617555
657,PRECIS-2,Repeated-measures mixed models were used for statistical analysis.,fulltext,Repeated-measures mixed models were used for statistical analysis.,100.0
657,PRECIS-2,Participants were encouraged not to seek any physical therapy other than GroupCoreDIST during the 6 weeks of the intervention.,fulltext,Participants in the intervention group were encouraged not to seek any physical therapy other than GroupCoreDIST during the 6 weeks of the intervention.,100.0
657,PRECIS-2,Ninety-three persons returned signed written informed consent.,fulltext,Ninety-three persons returned signed written informed consent.,100.0
657,PRECIS-2,"The assessors had received 3 days of training in the standardized test procedures, and each was trained to apply uniform scoring criteria to all the participants and to perform scoring equivalently to the other assessor.",fulltext,"The assessors had received 3 days of training in the standardized test procedures, and each was trained to apply uniform scoring criteria to all the participants and to perform scoring equivalently to the other assessor.",100.0
657,PRECIS-2,Eighty people with Expanded Disability Status scores of 1 to 6.5 participated in this trial.,fulltext,Eighty people with Expanded Disability Status scores of 1 to 6.5 participated in this trial.,100.0
657,PRECIS-2,"Enrollment started in September 2015, and follow-up was completed in September 2016.",fulltext,"Enrollment started in September 2015, and follow-up was completed in September 2016.",100.0
657,PRECIS-2,"The control group continued their regular routine and were encouraged to maintain their current level of physical activity and to seek any health care required, including physical therapy.",fulltext,"The control group continued their regular routine and were encouraged to maintain their current level of physical activity and to seek any health care required, including physical therapy.",100.0
657,PRECIS-2,The GroupCoreDIST intervention was conducted by 6 physical therapists in 6 municipalities in Norway.,fulltext,The GroupCoreDIST intervention was conducted by 6 physical therapists in 6 municipalities in Norway.,100.0
662,PRECIS-2,Participants were sent a headset and webcam together with instructions of how to set up Skype.,fulltext,Participants were sent a headset and webcam together with instructions of how to set up Skype.,100.0
662,PRECIS-2,"Exclusion criteria were severe cognitive impairment, as determined by a score of 20 or smaller on the Telephone Interview for Cognitive Status-Modified (TICS-M) and high suicide risk, as assessed by a score of 20 or greater on the Clinical Outcome of Routine Evaluation (CORE-10).",fulltext,"Exclusion criteria were severe cognitive impairment, as determined by a score of 20 or smaller on the Telephone Interview for Cognitive Status-Modified (TICS-M) 19 and high suicide risk, as assessed by a score of 20 or greater on the Clinical Outcome of Routine Evaluation (CORE-10).",100.0
662,PRECIS-2,"The format and manual for the mindfulness group, including length of sessions and individual mindfulness practices, were developed in partnership with patients with MS through initial experimental case studies.",fulltext,"The format and manual for the mindfulness group, including length of sessions and individual mindfulness practices, were developed in partnership with patients with MS through initial experimental case studies.",100.0
662,PRECIS-2,Treatment effects on the primary and secondary outcomes were estimated using linear mixed modelling where the outcome variables at the two post-intervention time points were the dependent variable.,fulltext,Treatment effects on the primary and secondary outcomes were estimated using linear mixed modelling where the outcome variables at the two post-intervention time points were the dependent variable.,100.0
662,PRECIS-2,The content of the manual was adapted from the Mindfulness-Based Cognitive Therapy (MBCT) course book.,fulltext,The content of the manual was adapted from the Mindfulness-Based Cognitive Therapy (MBCT) course book.,100.0
662,PRECIS-2,The treatment phase took place between February 2013 and July 2013. We delivered the programme in eight hour-long sessions over an eight-week period via Skype video conferences.,fulltext,The treatment phase took place between February 2013 and July 2013. We delivered the programme in eight hour-long sessions over an eight-week period via Skype video conferences.,100.0
662,PRECIS-2,We recruited potential participants through adverts on the MS Society website and from National Health Service (NHS) MS centres across the UK.,fulltext,We recruited potential participants through adverts on the MS Society website and from National Health Service (NHS) MS centres across the UK.,100.0
662,PRECIS-2,The GHQ is designed to measure general levels of distress. The GHQ is uncontaminated by the experience of MS-related somatic symptoms and is the most treatment-responsive measure of psychological distress in MS.,fulltext,The GHQ 17 is designed to measure general levels of distress. The GHQ is uncontaminated by the experience of MS-related somatic symptoms and is the most treatment-responsive measure of psychological distress in MS.,100.0
662,PRECIS-2,Participants were randomly assigned to the eight-week intervention (n = 19) or a waiting-list control group (n = 21).,fulltext,participants were randomly assigned to the eight-week intervention (n = 19) or a waitinglist control group (n = 21).,99.14529914529915
662,PRECIS-2,"Each session started with a 10-minute mindful-ness practice, followed by discussion of this practice and the homework practice of the previous week. Then new concepts (e.g. acceptance, relating to thoughts and self-compassion) were introduced.",fulltext,"Each session started with a 10-minute mindfulness practice, followed by discussion of this practice and the homework practice of the previous week. Then new concepts (e.g. acceptance, relating to thoughts and self-compassion) were introduced.",99.58847736625515
662,PRECIS-2,"Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).",fulltext,"Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).",100.0
662,PRECIS-2,We conducted all group comparisons on an intention-to-treat basis where we analysed participants in the group to which they were randomised.,fulltext,We conducted all group comparisons on an intention-to-treat basis where we analysed participants in the group to which they were randomised.,100.0
662,PRECIS-2,"Feedback from people with progressive MS who took part in the series of experimental case-studies (n = 6, Expanded Disability Status Scale (EDSS) range = 6.5--7.5) emphasised that we needed to account for compromised concentration, fatigue, mobility and problems with sitting in one posture during mindfulness home practices.",fulltext,"Feedback from people with progressive MS who took part in the series of experimental case-studies (n = 6, Expanded Disability Status Scale (EDSS) range = 6.5–7.5) emphasised that we needed to account for compromised concentration, fatigue, mobility and problems with sitting in one posture during mindfulness home practices.",99.6923076923077
662,PRECIS-2,"Participants were encouraged to keep a diary of home practice, but, in fact, very few did record it.",fulltext,"Participants were encouraged to keep a diary of home practice, but, in fact, very few did record it.",100.0
662,PRECIS-2,Higher scores on this scale represent high distress.,fulltext,Higher scores on this scale represent high distress.,100.0
662,PRECIS-2,Qualitative interviews (n = 15) were conducted with people who took part in the mindfulness groups on their experiences of the intervention. These will be reported in detail elsewhere.,fulltext,Qualitative interviews (n = 15) were conducted with people who took part in the mindfulness groups on their experiences of the intervention. These will be reported in detail elsewhere.,100.0
662,PRECIS-2,"Participants completed standardised questionnaires to measure mood, impact of MS and symptom severity, quality of life and service costs at baseline, post-intervention and three-month follow-up.",fulltext,"Participants completed standardised questionnaires to measure mood, impact of MS and symptom severity, quality of life and service costs at baseline, post-intervention and threemonth follow-up.",99.48453608247422
662,PRECIS-2,"Participants were also provided with audio compact discs (CDs) produced specifically for this course, which reflected challenges of MS, such as lack of sensations or difficulties retaining a posture.",fulltext,"ices reflected challenges of MS, such as lack of sensations or difficulties retaining a posture.",48.24120603015075
663,PRECIS-2,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics and targeted advertisements sent out via the Danish MS Society. The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait perfor-mance and spasticity within the past 8 weeks.",fulltext,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society. The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks.",99.81981981981983
663,PRECIS-2,"Intervention. PRT. PRT consisted of 21-hour training sessions over 10 weeks (two sessions/week). Each session started with a 10-minute warm-up on a stationary bicycle or treadmill. The program predominantly targeted knee and hip flexion and extension where the exercises progressed from three sets of 10 repetitions at 15 RM toward four sets of 8 repetitions at 8 RM (Table 1). The exercises were conducted in machines that targeted the specified muscle groups, but type of machines could vary between centers.",fulltext,"Intervention PRT. PRT consisted of 21-hour training sessions over 10 weeks (two sessions/week). Each session started with a 10-minute warm-up on a stationary bicycle or treadmill. The program predominantly targeted knee and hip flexion and extension where the exercises progressed from three sets of 10 repetitions at 15 RM toward four sets of 8 repetitions at 8 RM (Table 1). 17 The exercises were conducted in machines that targeted the specified muscle groups, but type of machines could vary between centers.",99.80392156862746
663,PRECIS-2,The follow-up test was performed within 7 days of the last intervention session or after the last day of being on the waitlist.,fulltext,The follow-up test was performed within 7 days of the last intervention session or after the last day of being on the waitlist.,100.0
663,PRECIS-2,Some of the principles of progression in BMCT involve alteration of exercises toward an increased level of challenge via adjustments such as increased cognitive demands or alteration of sensory information.,fulltext,Some of the principles of progression in BMCT involve alteration of exercises toward an increased level of challenge 9 via adjustments such as increased cognitive demands 10 or alteration of sensory information.,100.0
663,PRECIS-2,The main underly- ing mechanisms in PRT relate to muscle hypertrophy and improved neural activation.,fulltext,The main underly- ing mechanisms in PRT relate to muscle hypertrophy and improved neural activation.,100.0
663,PRECIS-2,"Physiotherapists with experience in providing BMCT managed the programs. The therapists were instructed to aim for a level of difficulty, where the participants experienced failure but still reached successful execution in more than 50% of the attempts/time.",fulltext,"Physiotherapists with experience in providing BMCT managed the programs. The therapists were instructed to aim for a level of difficulty, where the participants experienced failure but still reached successful execution in more than 50% of the attempts/time.",100.0
663,PRECIS-2,"After baseline testing (conducted at a university research facility), three concealed envelopes, each containing the name of one intervention (PRT, BMCT, or CON), were randomly drawn, and one intervention was then allocated to each of the three clinics.",fulltext,"After baseline testing (conducted at a university research facility), three concealed envelopes, each containing the name of one intervention (PRT, BMCT, or CON), were randomly drawn, and one intervention was then allocated to each of the three clinics.",100.0
663,PRECIS-2,BMCT. The BMCT intervention consisted of 20 1-hour training sessions over 10 weeks (two sessions/week). All sessions started with a 10-minute warm-up on a stationary bicycle or treadmill.,fulltext,BMCT. The BMCT intervention consisted of 20 1-hour training sessions over 10 weeks (two sessions/ week). All sessions started with a 10-minute warm-up on a stationary bicycle or treadmill.,100.0
663,PRECIS-2,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",prompt,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",100.0
663,PRECIS-2,"Mixed-effects model analysis of covariance was used to measure differences at post-test, taking into account the pre-test score. Group (BMCT vs PRT vs CON) and pre-test score were set as fixed effects, while subjects were nested within centers (the different clinics in charge of the training) and set as random effects.",fulltext,"Mixed-effects model analysis of covariance was used to measure differences at posttest, taking into account the pre-test score. Group (BMCT vs PRT vs CON) and pre-test score were set as fixed effects, while subjects were nested within centers (the different clinics in charge of the training) and set as random effects.",99.6875
663,PRECIS-2,All training sessions were supervised by physiotherapists who were trained to deliver the intervention.,fulltext,All training sessions were supervised by physiotherapists who were trained to deliver the intervention.,100.0
663,PRECIS-2,"Eligibility according to criteria that concern co-morbidity, disease activity, medication, and EDSS score was provided by neurologists based on journal records. Furthermore, it was registered if participants changed disease modifying medication and/or started/terminated medical treatment affecting gait (e.g. fampridine) during the study.",fulltext,"Eligibility according to criteria that concerned co-morbidity, disease activity, medication, and EDSS score was provided by neurologists based on journal records. Furthermore, it was registered if participants changed disease modifying medication and/ or started/terminated medical treatment affecting gait (e.g. fampridine) during the study.",100.0
663,PRECIS-2,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics and targeted advertisements sent out via the Danish MS Society.",fulltext,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society.",100.0
663,PRECIS-2,Primary outcomes were the T25FW and the SSST.,fulltext,Primary outcomes were the T25FW and the SSST.,100.0
663,PRECIS-2,Patients who had a relapse during the course of the study continued the study if possible or dropped out if it was considered a health risk to continue.,fulltext,Patients who had a relapse during the course of the study continued the study if possible or dropped out if it was considered a health risk to continue.,100.0
664,PRECIS-2,Details of supervised and home-exercise sessions were recorded in an exercise log.,fulltext,Details of supervised and home-exercise sessions were recorded in an exercise log.,100.0
664,PRECIS-2,"During weeks 1--6, participants attended two supervised sessions per week at a university exercise research facility and engaged in one additional self-directed exercise session in their home environment.",fulltext,"During weeks 1–6, participants attended two supervised sessions per week at a university exercise research facility and engaged in one additional self-directed exercise session in their home environment.",99.50980392156863
664,PRECIS-2,An exercise physiologist supervised the delivery of the intervention but with physiotherapist input during the early stages of the programme.,fulltext,An exercise physiologist supervised the delivery of the intervention but with physiotherapist input during the early stages of the programme.,100.0
664,PRECIS-2,"The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria, with an Expanded Disability Status Scale (EDSS) score of 1.0--6.5, and able to walk a 10-metre distance; aged 18--65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",fulltext,"The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria, 9 with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",99.51807228915662
664,PRECIS-2,"During weeks 7--12, participants attended the centre once per week and completed two additional self-directed exercise sessions in their home or local community.",fulltext,During weeks 7–12 participants attended the centre once per week and completed two additional self-directed exercise sessions in their home or local community.,98.75776397515527
664,PRECIS-2,"Studies show that aerobic exercise, resistance exercise and combined programmes bring health benefits to PwMS.",fulltext,"Studies show that aerobic exercise, resistance exercise and combined programmes bring health benefits to PwMS.",100.0
664,PRECIS-2,"Participants were asked to complete short bouts (e.g. 5 × 3 minutes, with two-minute rest intervals) of low to moderate intensity aerobic exercise (e.g. stepping ergometer, cycle-ergometer, treadmill walking, rowing ergometer, arm-cranking) at 50%--69% of predicted maximum heart rate (220--age) or 12--14 on the Borg Ratings of Perceived Exertion Scale.",fulltext,"Participants were asked to complete short bouts (e.g. 5 × 3 minutes, with twominute rest intervals) of low to moderate intensity aerobic exercise (e.g. stepping ergometer, cycle-ergometer, treadmill walking, rowing ergometer, arm-cranking) at 50%– 69% of predicted maximum heart rate (220–age) or 12–14 on the Borg Ratings of Perceived Exertion Scale.",99.15254237288136
664,PRECIS-2,The primary outcome was self-reported exercise behaviour (Godin Leisure Time Exercise Questionnaire (GLTEQ)).,fulltext,The primary outcome was self-reported exercise behaviour (Godin Leisure Time Exercise Questionnaire (GLTEQ)).,100.0
664,PRECIS-2,Participants were excluded if they had comorbid conditions impairing the ability to be physically active three times per week; unwilling to be randomised; living more than 20 miles from the trial centre; already engaged in structured exercise or brisk walking ≥ 3 times per week for ≥ 30 minutes per session for at least six months.,fulltext,a were comorbid conditions impairing the ability to be physically active three times per week; unwilling to be randomised; living more than 20 miles from the trial centre; already engaged in structured exercise or brisk walking ≥ 3 times per week for ≥ 30 minutes per session for at least six months.,90.36144578313254
664,PRECIS-2,A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,fulltext,A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,100.0
664,PRECIS-2,"The GLTEQ asks participants to recall the frequency of strenuous, moderate and mild intensity exercise for periods >15 minutes over the past seven days and is a valid measure of habitual exercise in PwMS.",fulltext,"The GLTEQ asks participants to recall the frequency of strenuous, moderate and mild intensity exercise for periods >15 minutes over the past seven days and is a valid measure of habitual exercise in PwMS.",100.0
664,PRECIS-2,"The programme was designed to be pragmatic and accessible, taking into account exercise preferences and giving choices.",fulltext,"The programme was designed to be pragmatic and accessible, taking into account exercise preferences and giving choices.",100.0
664,PRECIS-2,"Repeated-measures mixed modelling was used to compare outcomes between the randomised groups at the three- and nine-month follow-ups, adjusting for baseline score, EDSS and gender.",fulltext,"Repeated-measures mixed modelling was used to compare outcomes between the randomised groups at the three- and nine-month follow-ups, adjusting for baseline score, EDSS and gender.",100.0
664,PRECIS-2,"Daily movement and step counts were objectively assessed using an accelerometer (Actigraph GT2M accelerometer, Actigraph, LLC, FL, USA), worn on the waist during waking hours, except when bathing/showering or swimming.",fulltext,"Daily movement and step counts were objectively assessed using an accelerometer (Actigraph GT2M accelerometer, Actigraph, LLC, FL, USA), worn on the waist during waking hours, except when bathing/showering or swimming.",100.0
664,PRECIS-2,Aerobic exercise was the core exercise modality as it is accessible (i.e. includes community-based walking exercise) and does not require equipment.,fulltext,Aerobic exercise was the core exercise modality as it is accessible (i.e. includes community-based walking exercise) and does not require equipment.,100.0
664,PRECIS-2,"Outcomes were assessed at baseline, and at three months and nine months after randomisation.",fulltext,"Outcomes were assessed at baseline, and at three months (post-intervention) and nine months after randomisation.",100.0
664,PRECIS-2,"All analyses were by intention to treat, whereby participants were analysed in the arm to which they were randomised irrespective of whether they complied with the intervention.",fulltext,"All analyses were by intention to treat, whereby participants were analysed in the arm to which they were randomised irrespective of whether they complied with the intervention.",100.0
664,PRECIS-2,Participants were assessed by a consultant neurologist with an interest in MS prior to entering the trial.,fulltext,patients were assessed by a consultant neurologist with an interest in MS prior to entering the trial.,95.28301886792453
666,PRECIS-2,"The efficacy of glatiramer acetate (GA; Copaxone®, Teva Pharmaceuticals) both 20 mg/mL once daily (GA20) and 40 mg/mL three times weekly (GA40) has been well established (Khan et al., 2013), and GA40 has demonstrated a better tolerability profile than GA20 (Wolinsky et al., 2015).",fulltext,"The efficacy of glatiramer acetate (GA; Copaxone ® , Teva Pharmaceuticals) both 20 mg/mL once daily (GA20) and 40 mg/mL three times weekly (GA40) has been well established (Khan et al., 2013), and GA40 has demonstrated a better tolerability profile than GA20 (Wolinsky et al., 2015).",100.0
666,PRECIS-2,The primary endpoint was patient overall satisfaction with the medication as measured by the single-item MSQ 7-point scale (1 = extremely dissatisfied to 7 = extremely satisfied).,fulltext,The primary endpoint was patient overall satisfaction with the medication as measured by the single-item MSQ 7-point scale (1 = extremely dissatisfied to 7 = extremely satisfied) ,100.0
666,PRECIS-2,"Patient-reported endpoints were analyzed based on the full analysis set (FAS), which included all patients in the ITT population who received at least 1 dose of study drug and had at least 1 post-baseline assessment. Safety analyses were performed on the safety analysis set, which included all patients who received at least 1 dose of a study drug.",fulltext,"Patient-reported endpoints were analyzed based on the full analysis set (FAS), which included all patients in the ITT population who received at least 1 dose of study drug and had at least 1 post-baseline assessment. Safety analyses were performed on the safety analysis set, which included all patients who received at least 1 dose of a study drug.",100.0
666,PRECIS-2,"Patients in the study received treatment for 6 months, and the study was conducted during a period starting in August 2015 and ending in January 2017.",fulltext,"Patients in the study received treatment for 6 months, and the study was conducted during a period starting in August 2015 and ending in January 2017.",100.0
666,PRECIS-2,"Adherence to treatment when the dosing schedule differs is complicated, because missing one dose has potentially differential impacts on treatment. Thus, adherence was measured using the self-reported MS-TAQ.",fulltext,"Adherence to treatment when the dosing schedule differs is complicated, because missing one dose has potentially differential impacts on treatment. Thus, adherence was measured using the self-reported MS-TAQ.",100.0
666,PRECIS-2,"The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries (Russia, Poland, Italy, France, Croatia, US [including Puerto Rico], Mexico, Spain, Austria, Turkey, Belgium, Argentina, Germany, and Finland) across different geographic regions.",fulltext,"The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries (Russia, Poland, Italy, France, Croatia, US [including Puerto Rico], Mexico, Spain, Austria, Turkey, Belgium, Argentina, Germany, and Finland) across different geographic regions.",100.0
666,PRECIS-2,"Safety assessments were recorded in clinic visits and included adverse events (AEs) throughout the study, vital sign measurements, concomitant medication usage, and clinical laboratory test results at screening and Months 1, 3, and 6.",fulltext,"Safety assessments were recorded in clinic visits and included adverse events (AEs) throughout the study, vital sign measurements, concomitant medication usage, and clinical laboratory test results at screening and Months 1, 3, and 6.",100.0
666,PRECIS-2,"Patients who perceive their medication to be ineffective or inconvenient are less likely to be adherent to treatment, with potentially significant consequences on long-term clinical outcomes. Many patients with multiple sclerosis (MS) are nonadherent to treatment despite demonstrated efficacy of disease-modifying therapies (DMTs).",fulltext,"Patients who perceive their medication to be ineffective or inconvenient are less likely to be adherent to treatment, with potentially significant consequences on long-term clinical outcomes. Many patients with multiple sclerosis (MS) are nonadherent to treatment despite demonstrated efficacy of disease-modifying therapies (DMTs).",100.0
666,PRECIS-2,"In the present study, an open-label design was necessary, because the difference in frequency of administration between the GA20 and GA40 formulations is at the heart of the study, meaning that a double-blind design was not feasible, nor was the use of a double-dummy approach that would equalize the frequency of drug administration suitable for a clinical trial designed to compare, among other things, patient perceptions of treatment convenience.",fulltext,"In the present study, an open-label design was necessary, because the difference in frequency of administration between the GA20 and GA40 formulations is at the heart of the study, meaning that a double-blind design was not feasible, nor was the use of a double-dummy approach that would equalize the frequency of drug administration suitable for a clinical trial designed to compare, among other things, patient perceptions of treatment convenience.",100.0
668,PRECIS-2,"Volunteers were excluded if they had an acute exacerbation of MS within 2 months of starting the program, had benign or progres-sive/relapsing types of MS, had a serious unstable medical condition, had any concurrent condition, for example stroke, or had participated in a PRT program in the 6 months before training started.",fulltext,"Volunteers were excluded if they had an acute exacerbation of MS within 2 months of starting the program, had benign or progressive/relapsing types of MS, had a serious unstable medical condition, had any concurrent condition, for example stroke, or had participated in a PRT program in the 6 months before training started.",99.6923076923077
668,PRECIS-2,"All exercises were completed on weight machines. The training intensity was based on recommendations of the American College of Sports Medicine (2009) and consisted of two sets of 10–12 repetitions of each exercise, at a training intensity of 10–12 repetition maximum (that is, only 12 consecutive repetitions of each exercise could be completed before muscle fatigue was reached). The weight lifted was increased when two sets of 12 repetitions of an exercise could be completed. Two-minute rest periods were given between each exercise set.",fulltext,"All exercises were completed on weight machines. The training intensity was based on recommendations of the American College of Sports Medicine (2009) 7 and consisted of two sets of 10–12 repetitions of each exercise, at a training intensity of 10–12 repetition maximum (that is, only 12 consecutive repetitions of each exercise could be completed before muscle fatigue was reached). The weight lifted was increased when two sets of 12 repetitions of an exercise could be completed. Two-minute rest periods were given between each exercise set.",100.0
668,PRECIS-2,"Each exercise session was completed in around 45 min, and at the end of each session there was a 30-min recovery period when the participants had refreshments and time to socialize.",fulltext,"Each exercise session was completed in around 45 min, and at the end of each session there was a 30-min recovery period when the participants had refreshments and time to socialize.",100.0
668,PRECIS-2,Participants were asked to return to their usual activities and not to continue or commence resistance training until after the follow-up assessment session.,fulltext,participants were asked to return to their usual activities and not to continue or commence resistance training until after the follow-up assessment session.,100.0
668,PRECIS-2,"Recruitment information flyers were sent by mail to all potential participants registered on the mailing lists of both organizations. If interested, volunteers were asked to contact one of the researchers (KD) by telephone, during which volunteers were screened to ensure they satisfied the inclusion criteria.",fulltext,"Recruitment information flyers were sent by mail to all potential participants registered on the mailing lists of both organizations. If interested, volunteers were asked to contact one of the researchers (KD) by telephone, during which volunteers were screened to ensure they satisfied the inclusion criteria.",100.0
668,PRECIS-2,"Outcome measurements were taken three times: at baseline, after 10 weeks to determine the immediate effects of the intervention, and after a further 12 weeks (week 22) to determine if any benefits from the program had been sustained.",fulltext,"Outcome measurements were taken three times: at baseline, after 10 weeks to determine the immediate effects of the intervention, and after a further 12 weeks (week 22) to determine if any benefits from the program had been sustained.",100.0
668,PRECIS-2,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",fulltext,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",100.0
668,PRECIS-2,"People had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",fulltext,"people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score 19 of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",100.0
668,PRECIS-2,The trial's primary outcome was to examine the immediate effects of a supervised PRT program on walking function in people with relapsing–remitting MS who had difficulty walking.,fulltext,the primary aim of this randomized controlled trial was to examine the immediate effects of a supervised PRT program on walking function in people with relapsing–remitting MS who had difficulty walking.,94.3820224719101
668,PRECIS-2,"To determine if any improvements were maintained 12 weeks after a complete break from training. It was hypothesized that compared with a control group, people with MS who participated in PRT would: 1. walk further over 2 min, and their maximum walking speed over 10 m would be faster.",fulltext,"to determine if any improvements were maintained 12 weeks after a complete break from training. It was hypothesized that compared with a control group, people with MS who participated in PRT would: 1. walk further over 2 min, and their maximum walking speed over 10 m would be faster;",100.0
669,PRECIS-2,"Adults diagnosed with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.",fulltext,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.",94.5945945945946
669,PRECIS-2,"Measures were physical (VO 2max, sit-to-stand test, Six-Minute Walk Test (6MWT), Multiple Sclerosis Walking Scale-12 (MSWS-12)) and cognitive function (Rao’s Brief Repeatable Battery (BRB), Paced Auditory Serial Attention Test (PASAT)), fatigue (Fatigue Scale for Motor and Cognitive Function (FSMC)), quality of life (Multiple Sclerosis Impact Scale-29 (MSIS-29)), and imaging.",fulltext,"Measures were physical (VO 2max , sit-to-stand test, Six-Minute Walk Test (6MWT), Multiple Sclerosis Walking Scale-12 (MSWS-12)) and cognitive function (Rao’s Brief Repeatable Battery (BRB), Paced Auditory Serial Attention Test (PASAT)), fatigue (Fatigue Scale for Motor and Cognitive Function (FSMC)), quality of life (Multiple Sclerosis Impact Scale-29 (MSIS-29)), and imaging.",100.0
669,PRECIS-2,"The primary outcome measures were physical fitness, walking capacity and perceived ability, functional mobility, and quality of life.",fulltext,"The primary outcome measures were physical fitness, walking capacity and perceived ability, functional mobility, and quality of life.",100.0
669,PRECIS-2,"Intention-to-treat analysis was performed. The group (EXP–WLC), time (0--12 weeks), and the group × time interaction effects were investigated.",fulltext,"Intention-to-treat analysis was performed. The group (EXP–WLC), time (0–12 weeks), and the group × time interaction effects were investigated.",99.3006993006993
669,PRECIS-2,pwMS who performed a 12-week running training program with the aim to run 5 km on a public event were compared with a waitlist control group.,fulltext,pwMS who performed a 12-week running training program with the aim to run 5 km on a public event were compared with a waitlist control group.,100.0
669,PRECIS-2,Adults with MS were included based on the ability to walk 5 km without rest or use of assistive device.,fulltext,Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.,100.0
669,PRECIS-2,Exclusion criteria were reports to have run 5 km in the preceding 6 months or a relapse occurring in the preceding 3 months.,fulltext,Exclusion criteria were reports to have run 5 km in the preceding 6 months or a relapse occurring in the preceding 3 months.,100.0
669,PRECIS-2,pwMS received training instructions by email. They were asked to train three times weekly according to a personalized training intensity schedule that was based on their baseline aerobic capacity.,fulltext,pwMS received training instructions by email. They were asked to train three times weekly according to a personalized training intensity schedule that was based on their baseline aerobic capacity.,100.0
669,PRECIS-2,Interested pwMS attended an information session and jointly walked 5 km for verification of their ability.,fulltext,Interested pwMS attended an information session and jointly walked 5 km for verification of their ability.,100.0
669,PRECIS-2,Participants were asked to weekly upload data to allow remote supervision of the training adherence by the research assistant.,fulltext,Participants were asked to weekly upload data to allow remote supervision of the training adherence by the research assistant.,100.0
669,PRECIS-2,Two group training sessions were organized (weeks 4 and 8) at a 400-m outdoor running track at KULeuven.,fulltext,Two group training sessions were organized (weeks 4 and 8) at a 400-m outdoor running track at KULeuven.,100.0
669,PRECIS-2,Brain volumes and diffusion tensor imaging (DTI) were quantified using FSL-SIENA/FIRST and FSL-TBSS.,fulltext,Brain volumes and diffusion tensor imaging (DTI) were quantified using FSL-SIENA/FIRST and FSL-TBSS.,100.0
670,PRECIS-2,"Clients attending the clinic were interviewed, and their case histories recorded. The research project was explained, and written informed consent was obtained. The Multiple Sclerosis Self-Efficacy (MSSE) survey was then given to the client to complete.",fulltext,"Clients attending the clinic were interviewed, and their case histories recorded. The research project was explained, and written informed consent was obtained. The Multiple Sclerosis Self-Efficacy (MSSE) survey was then given to the client to complete.",100.0
670,PRECIS-2,"The MS specialty clinic is busy, which is to be expected given reports that 57.1% of the multiple sclerosis population use Complimentary and Alternative Medical/Health therapies in general, and more specifically, that 23.3% access massage therapy as a treatment option.",fulltext,"The MS specialty clinic is busy, which is to be expected given reports that 57.1% of the multiple sclerosis population use Complimentary and Alternative Medical/Health therapies in general, and more specifically, that 23.3% access massage therapy as a treatment option ",100.0
670,PRECIS-2,"Studies indicate that higher self-efficacy scores are reflective of an improved ability to adjust to multiple sclerosis. This improved adjustment then leads to reduced psychological morbidities such as stress, anxiety and depression, which will result in improved quality of life.",fulltext,"Studies indicate that higher self-efficacy scores are reflective of an improved ability to adjust to multiple sclerosis (Schnek et al., 1995; Wassem, 1992). This improved adjustment then leads to reduced psychological morbidities such as stress, anxiety and depression, which will result in improved quality of life.",100.0
670,PRECIS-2,During the recruitment period fifteen participants were randomly assigned to treatment and waitlist control groups.,fulltext,During the recruitment period fifteen participants were randomly assigned to treatment and waitlist control groups.,100.0
670,PRECIS-2,"The outcome measures for the current research were the scores yielded by the Multiple Sclerosis Self Efficacy (MSSE) survey. For both treatment and control groups, self-efficacy scores were obtained before the first treatment, mid-treatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.",fulltext,"The outcome measures for the current research were the scores yielded by the Multiple Sclerosis Self Efficacy (MSSE) survey. For both treatment and control groups, self-efficacy scores were obtained before the first treatment, midtreatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.",99.74489795918367
670,PRECIS-2,The intervention involved a series of weekly one hour therapeutic massage treatments conducted over eight weeks and a subsequent eight week follow up period. All treatments were delivered by supervised student therapists in the final term of their two year massage therapy program.,fulltext,The intervention involved a series of weekly one hour therapeutic massage treatments conducted over eight weeks and a subsequent eight week follow up period. All treatments were delivered by supervised student therapists in the final term of their two year massage therapy program.,100.0
670,PRECIS-2,"Massage therapy is aligned with the wellness paradigm of health and health care, which speaks to a holistic client centered approach to treatment. Accordingly, if the current research was to conform to the requirements of model fit/ecological validity, it was incumbent on the therapists to construct individualized treatment plans recognizing the importance of the client’s physical, psychological and emotional needs.",fulltext,"Massage therapy is aligned with the wellness paradigm of health and health care (Alexander, 2006; Yates, 2004), which speaks to a holistic client centered approach to treatment. Accordingly, if the current research was to conform to the requirements of model fit/ecological validity (Menard, 2003; Mason et al., 2002), it was incumbent on the therapists to construct individualized treatment plans recognizing the importance of the client’s physical, psychological and emotional needs.",100.0
670,PRECIS-2,"The MSSE instrument has been accepted as a valid and reliable measurement tool, and to date has not been refuted as such.",fulltext,"The MSSE instrument has been accepted as a valid and reliable measurement tool, and to date has not been refuted as such.",100.0
671,PRECIS-2,"Key inclusion criteria were age older than 18 years, a diagnosis of progressive multiple sclerosis (primary or secondary) according to McDonald’s criteria, and a score of 6·5–8·0 on the Expanded Disability Status Scale (EDSS).",fulltext,"Key inclusion criteria were age older than 18 years, a diagnosis of pro gressive multiple sclerosis (primary or secondary) accord ing to McDonald’s criteria, 21 and a score of 6·5–8·0 on the Expanded Disability Status Scale (EDSS).",100.0
671,PRECIS-2,"Participants were recruited through eight health care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",fulltext,"Participants were recruited through eight health care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",100.0
671,PRECIS-2,All participants received their usual health and social service input throughout the study period.,fulltext,All participants received their usual health and social service input throughout the study period.,100.0
671,PRECIS-2,"Key exclusion criteria were being within 3 months of ceasing a multiple sclerosis disease modifying drug, receiving steroid treatment within the preceding month, or participating in another clinical trial.",fulltext,"Key exclusion criteria were being within 3 months of ceasing a multiple sclerosis disease modifying drug, receiving steroid treat ment within the preced ing month, or participating in another clinical trial.",100.0
671,PRECIS-2,"Participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary.",fulltext,"Participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary.",100.0
671,PRECIS-2,"Participants were recruited through eight health care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK. Individuals were invited consecutively until the allocated number of standing frames (dependent on commissioning costs) at each health care organisation had been reached.",fulltext,"Participants were recruited through eight health care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK. Individuals were invited consecutively until the allocated number of standing frames (dependent on commissioning costs) at each health care organisation had been reached.",100.0
671,PRECIS-2,The primary clinical outcome was motor function as measured by the Amended Motor Club Assessment (AMCA) score at the primary endpoint of 36 weeks post randomisation.,fulltext,The prim ary outcome was motor function as measured by the Amended Motor Club Assessment (AMCA) score 23 at the primary endpoint of 36 weeks post randomisation.,94.54545454545455
671,PRECIS-2,"The primary analysis of the primary outcome, AMCA score at 36 weeks, followed a modified intention to treat approach, regardless of compliance to the intervention, but did exclude patients who were deemed ineligible after randomisation, those who withdrew from the trial and were unwilling for their previously collected data to be used, or those who did not provide baseline and week 36 measurements.",fulltext,"The primary analysis of the primary outcome, AMCA score at 36 weeks, followed a modified intention to treat approach, regardless of compliance to the inter vention, but did exclude patients who were deemed ineligible after randomisation, those who withdrew from the trial and were unwilling for their previously collected data to be used, or those who did not provide baseline and week 36 measurements ",100.0
673,PRECIS-2,"All interventions took place in groups of eight, for an hour per week, for 10 weeks.",fulltext,"All interventions took place in groups of eight, for an hour per week, for 10 weeks.",100.0
673,PRECIS-2,"Persons with MS were excluded if they had a previous relapse or began steroid therapy in the 12 weeks prior to participating in the first assessment, were pregnant, or had a comorbidity that severely impacted their ability to safely participate in exercise.",fulltext,"Persons with MS were excluded if they had a previous relapse or began steroid therapy in the 12 weeks prior to participating in the first assessment, were pregnant, or had a comorbidity that severely impacted their ability to safely participate in exercise.",100.0
673,PRECIS-2,The study was approved by each ethics committee in the 10 regions of Ireland where the study took place. Written informed consent was obtained from each participant.,fulltext,The study was approved by each ethics committee in the 10 regions of Ireland where the study took place. Written informed consent was obtained from each participant.,100.0
673,PRECIS-2,"Participants were referred to the project by themselves, their care-giver, MSI, chartered physiotherapists, neurologists, general practitioners or clinical nurse specialists.",fulltext,"participants were referred to the project by themselves, their care-giver, MSI, chartered physiotherapists, neurologists, general practitioners or clinical nurse specialists.",100.0
673,PRECIS-2,"They were delivered in community centres such as local gyms, hotels and health centres.",fulltext,"They were delivered in community centres such as local gyms, hotels and health centres.",100.0
673,PRECIS-2,"The FI-led classes were not pre-defined, as the aim was to establish whether these classes were effective when encountered by those with MS in the community.",fulltext,"The FI-led classes were not pre-defined, as the aim was to establish whether these classes were effective when encountered by those with MS in the community.",100.0
673,PRECIS-2,"The yoga intervention was also not predefined, and detailed descriptions of the classes were gathered by nine of the instructors.",fulltext,"The yoga intervention was also not predefined, and detailed descriptions of the classes were gathered by nine of the instructors.",100.0
673,PRECIS-2,All statistical analyses were conducted using Predictive Analytics Software (PASW) Statistics 17.,fulltext,All statistical analyses were conducted using Predictive Analytics Software (PASW) Statistics 17.,100.0
673,PRECIS-2,"Outcome was assessed at week 24 for the intervention groups only, as it was felt that withholding a potentially beneficial treatment for longer than 12 weeks, from the controls, could be considered unethical.",fulltext,"Outcome was assessed at week 24 for the intervention groups only, as it was felt that withholding a potentially beneficial treatment for longer than 12 weeks, from the controls, could be considered unethical.",100.0
673,PRECIS-2,"Other measures were the MSIS-29v2’s psychological component, the Modified Fatigue Impact Scale (MFIS) and the Six-Minute Walk Test (6MWT).",fulltext,"Other measures were the MSIS-29v2’s psychological component, the Modified Fatigue Impact Scale (MFIS) 15 and the Six-Minute Walk Test (6MWT).",100.0
673,PRECIS-2,Repeated Measures ANOVA was conducted for the MSIS-29v2 physical subscale and the MFIS.,fulltext,Repeated Measures ANOVA was conducted for the MSIS-29v2 physical subscale and the MFIS.,100.0
673,PRECIS-2,"Although repeated measures ANOVA is the preferred method to analyse RCTs with pre and post data for four groups, the p-values for the normality tests were < 0.05 and the histograms revealed skewed data, thus assumptions for parametric testing were not met for the MSIS-29, v2 psychological component or the 6MWT.",fulltext,"Although repeated measures ANOVA is the preferred method to analyse RCTs with pre and post data for four groups, the p-values for the normality tests were < 0.05 and the histograms revealed skewed data, thus assumptions for parametric testing were not met for the MSIS-29, v2 psychological component or the 6MWT.",100.0
673,PRECIS-2,"In addition to the once-weekly class, participants were advised to exercise aerobically in the mode of their choice (walking, cycling, swimming or running), with the aim of exercising for 30 minutes, twice a week, at an intensity of 65% of the heart rate max, or a Borg’s rate of perceived exertion of 11–14.",fulltext,"In addition to the once-weekly class, participants were advised to exercise aerobically in the mode of their choice (walking, cycling, swimming or running), with the aim of exercising for 30 minutes, twice a week, at an intensity of 65% of the heart rate max, or a Borg’s rate of perceived exertion of 11–14.",100.0
673,PRECIS-2,"The primary outcome measure was the physical component of the Multiple Sclerosis Impact Scale-29, version 2 (MSIS-29v2), a patient-reported outcome measure that assesses the physical impact of MS.",fulltext,"The primary outcome measure was the physical component of the Multiple Sclerosis Impact Scale29, version 2 (MSIS-29v2), a patient-reported outcome measure that assesses the physical impact of MS.",99.48979591836735
673,PRECIS-2,"Participants were randomised in groups of eight to physiotherapist (PT)-led exercise (n = 80), yoga (n = 77), fitness instructor (FI)-led exercise (n = 86) and they took part in weekly community-based group exercise sessions. Those in the control group were asked not to change of their exercise habits (n = 71).",fulltext,"Participants were randomised in groups of eight to physiotherapist (PT)-led exercise (n = 80), yoga (n = 77), fitness instructor (FI)-led exercise (n = 86) and they took part in weekly community-based group exercise sessions. Those in the control group were asked not to change of their exercise habits (n = 71).",100.0
673,PRECIS-2,"Trained assessors tested the participants in week 1, participants exercised during weeks 2–11 and then were assessed again at week 12.",fulltext,"Trained assessors tested the participants in week 1, participants exercised during weeks 2–11 and then were assessed again at week 12.",100.0
673,PRECIS-2,Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist.,fulltext,Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist.,100.0
673,PRECIS-2,The PT-led exercise provided was pre-defined. It consisted of a circuit-style class of exercises that were either resisted by body weight or by the addition of free weights.,fulltext,The PT-led exercise provided was pre-defined. It consisted of a circuit-style class of exercises that were either resisted by body weight or by the addition of free weights.,100.0
674,PRECIS-2,"Blinded raters performed EDSS assessments at baseline, every 3 months, and when relapse was suspected.",fulltext,"Blinded raters performed EDSS assessments at baseline, every 3 months, and when relapse was suspected.",100.0
674,PRECIS-2,"In some trials, such as surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given.",prompt,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given,",96.7479674796748
674,PRECIS-2,"The trial included patients with RRMS who had experienced at least one relapse during treatment with interferon-b or glatiramer acetate, and who had received these treatments for at least six months.",fulltext,in patients with RRMS with inadequate response to prior DMTs ($1 relapse during IFN-b or glatiramer acetate [GA] treatment [received,49.74874371859297
674,PRECIS-2,"The trial's primary outcome is relevant to participants, as it measures disability improvement in patients with RRMS and inadequate response to prior disease-modifying therapies.",fulltext," In patients with RRMS and inadequate response to prior disease-modifying therapies,",47.19101123595506
674,PRECIS-2,"The trial used identical resources, provider expertise, and organisation of care delivery in the intervention arm of the trial and those available in usual care.",prompt," resources, provider expertise and the organisation of care delivery in the intervention arm of the trial and those available in usual care?",84.472049689441
674,PRECIS-2,"Patients were also assessed using the 4-component, MSFC plus SLCLA score incorporating Z scores from binocular, 1.25% contrast test-",fulltext,"Patients were also assessed using the 4-component, MSFC plus SLCLA score incorporating Z scores from binocular, 1.25% contrast test-",100.0
674,PRECIS-2,"The trial used no more than usual follow-up of participants, as it measured disability improvement in patients with RRMS and inadequate response to prior disease-modifying therapies.",fulltext," In patients with RRMS and inadequate response to prior disease-modifying therapies,",46.15384615384615
674,PRECIS-2,The trial used intention to treat with all available data in the analysis of the primary outcome.,prompt, intention to treat with all available data; score 1 for a very explanatory analysis th,59.79381443298969
674,PRECIS-2,The trial used identical flexibility in how the intervention was delivered as that used in usual care.,prompt, flexibility in how the intervention is delivered and the flexibility likely in usual care?,69.6078431372549
674,PRECIS-2,"The trial was conducted at multiple centers in the United States, Europe, and Canada.",fulltext, the manuscript was conducted,23.529411764705888
675,PRECIS-2,"MBI closely followed the program of mindfulness-based stress reduction and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10 –15 participants/group; exercises did not exceed patients’ level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills. Each class covered specific exercises and topics within the context of mindfulness training, i.e., practices during lying, sitting, and dynamic yoga postures, as well as during everyday life, e.g., stressful situations and social interactions. Mindfulness exercises included observation of sensory, affective, and cognitive domains of perceptible experience. The all-day retreat integrated familiar exercises and presented new ones.",fulltext,"MBI closely followed the program of mindfulness-based stress reduction 23 and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10 –15 participants/group; exercises did not exceed patients’ level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills. Each class covered specific exercises and topics within the context of mindfulness training, i.e., practices during lying, sitting, and dynamic yoga postures, as well as during everyday life, e.g., stressful situations and social interactions. Mindfulness exercises included observation of sensory, affective, and cognitive domains of perceptible experience. The all-day retreat integrated familiar exercises and presented new ones.",100.0
675,PRECIS-2,A total of 150 patients were randomly assigned to the intervention (n  76) or to UC (n  74).,fulltext,A total of 150 patients were randomly assigned to the intervention (n  76) or to UC (n  74).,100.0
675,PRECIS-2,"All patients in the usual care (UC) group (and in the MBI group) received regular, currently optimal medical care during the duration of the study, as provided by the neurology department of the hospital. This included one medical examination at preintervention and another at 6 months postintervention, with additional measures as individually required.",fulltext,"All patients in the usual care (UC) group (and in the MBI group) received regular, currently optimal medical care during the duration of the study, as provided by the neurology department of the hospital. This included one medical examination at preintervention and another at 6 months postintervention, with additional measures as individually required.",100.0
675,PRECIS-2,"Excluded were patients with reported or medically recorded diagnoses of current serious psychological disorders other than depression and anxiety syndromes, evidence of dementia as indicated by testing below the fifth percentile in at least 3 of 6 dimensions of neuropsychological functioning (i.e., attention and concentration, processing speed, executive function, verbal memory, and verbal processing), other currently life-threatening or severely disabling physical disorders, current MS exacerbation, symptomatic MS medication altered in the last 3 months, other disorders of the CNS, pregnancy, or inability to speak or read German.",fulltext,"Excluded were patients with reported or medically recorded diagnoses of current serious psychological disorders other than depression and anxiety syndromes, evidence of dementia as indicated by testing below the fifth percentile in at least 3 of 6 dimensions of neuropsychological functioning (i.e., attention and concentration, processing speed, executive function, verbal memory, and verbal processing), other currently life-threatening or severely disabling physical disorders, current MS exacerbation, symptomatic MS medication altered in the last 3 months, other disorders of the CNS, pregnancy, or inability to speak or read German.",100.0
675,PRECIS-2,"Employing intention-to-treat analysis, MBI, compared with UC, improved nonphysical dimensions of primary outcomes at postintervention and follow-up (p  0.002); effect sizes, 0.4–0.9 posttreatment and 0.3--0.5 at follow-up. When analyses were repeated among subgroups with clinically relevant levels of preintervention depression, fatigue, or anxiety, postintervention and follow-up effects remained significant and effect sizes were larger than for the total sample.",fulltext,"Employing intention-to-treat analysis, MBI, compared with UC, improved nonphysical dimensions of primary outcomes at postintervention and follow-up (p  0.002); effect sizes, 0.4–0.9 posttreatment and 0.3–0.5 at follow-up. When analyses were repeated among subgroups with clinically relevant levels of preintervention depression, fatigue, or anxiety, postintervention and follow-up effects remained significant and effect sizes were larger than for the total sample.",99.78586723768737
675,PRECIS-2,A total of 164 patients self-referred to the study. Eleven were excluded and 3 declined to participate (figure 1). The remaining 150 patients were randomized.,fulltext,A total of 164 patients self-referred to the study. Eleven were excluded and 3 declined to participate (figure 1). The remaining 150 patients were randomized.,100.0
675,PRECIS-2,"The study was approved by the Ethics Commission of Both Basels and is registered at www.controlled-trials.com, ISRCTN21643919. All participants completed written informed consent.",fulltext,"The study was approved by the Ethics Commission of Both Basels and is registered at www.controlled-trials.com, ISRCTN21643919. All participants completed written informed consent.",100.0
675,PRECIS-2,"Primary outcomes of HRQOL, depression, and fatigue were validated PRO measures, administered at preintervention, postintervention, and 6-month follow-up. Secondary measures included anxiety, perceived personal goal attainment after MBI, and self-reported homework adherence. Reported outcome measurements occurred within 2 weeks before and after intervention and 6 months postintervention.",fulltext,"Primary outcomes of HRQOL, depression, and fatigue were validated PRO measures, administered at preintervention, postintervention, and 6-month follow-up. Secondary measures included anxiety, perceived personal goal attainment after MBI, and self-reported homework adherence. Reported outcome measurements occurred within 2 weeks before and after intervention and 6 months postintervention.",100.0
675,PRECIS-2,"Objective: Health-related quality of life (HRQOL) is often much reduced among individuals with multiple sclerosis (MS), and incidences of depression, fatigue, and anxiety are high. We examined effects of a mindfulness-based intervention (MBI) compared to usual care (UC) upon HRQOL, depression, and fatigue among adults with relapsing-remitting or secondary progressive MS.",fulltext,"Objective: Health-related quality of life (HRQOL) is often much reduced among individuals with multiple sclerosis (MS), and incidences of depression, fatigue, and anxiety are high. We examined effects of a mindfulness-based intervention (MBI) compared to usual care (UC) upon HRQOL, depression, and fatigue among adults with relapsing-remitting or secondary progressive MS.",100.0
675,PRECIS-2,The study was conducted from February 2007 to March 2009.,fulltext,The study was conducted from February 2007 to March 2009.,100.0
677,PRECIS-2,"the following exercises are part of the H-caD system: key, light bulb, book, jar, writing, checkers and key-board tasks.",fulltext,"the following exercises are part of the H-caD system: key, light bulb, book, jar, writing, checkers and keyboard tasks.",99.16666666666667
677,PRECIS-2,a month after t2 a follow up measurement was performed (t3) for the intervention group.,fulltext,a month after t2 a follow up measurement was performed (t3) for the intervention group.,100.0
677,PRECIS-2,"the portable unit, which is usually indicated with the acronym “PU”, is an improved version of a prototype of a home activity desk which was developed in the framework of the european project H-caD (home-care activity desk) (www.iss.it/doc.).",fulltext,"the portable unit, which is usually indicated with the acronym “PU”, is an improved version of a prototype of a home activity desk which was developed in the framework of the european project H-caD (home-care activity desk) (www.iss.it/doc.).",100.0
677,PRECIS-2,the third measurement (t2) was performed after the month of H-caD intervention for the intervention group and 2 months after baseline for the control group.,fulltext,the third measurement (t2) was performed after the month of H-caD intervention for the intervention group and 2 months after baseline for the control group.,100.0
677,PRECIS-2,"exclusions were: a) disturbed upper limb function not related to MS, tBI or stroke;",fulltext,"exclusions were: a) disturbed upper limb function not related to MS, tBI or stroke;",100.0
677,PRECIS-2,the study design was partly a randomized multicenter clinical trial (rct) to compare the results of the control group which received usual care and general exercises to the intervention group which used the H-caD system at home for one month.,fulltext,the study design was partly a randomized multicenter clinical trial (rct) to compare the results of the control group which received usual care and general exercises to the intervention group which used the H-caD system at home for one month.,100.0
677,PRECIS-2,the instrumented desk allows the execution and monitoring of a configurable set of home exercises the professionals may purposely design to improve the main arm functions.,fulltext,the instrumented desk allows the execution and monitoring of a configurable set of home exercises the professionals may purposely design to improve the main arm functions.,100.0
677,PRECIS-2,the clinical study to evaluate the H-caD home rehabilitation treatment system by demonstrating the clinical effectiveness was a key action of the project.,fulltext,the clinical study to evaluate the H-caD home rehabilitation treatment system by demonstrating the clinical effectiveness was a key action of the project.,100.0
677,PRECIS-2,"the actual intervention with the H-caD system at home consisted of one month, whereby the patients had an average of one training session a day lasting 30 minutes for at least 5 days a week.",fulltext,"the actual intervention with the H-caD system at home consisted of one month, whereby the patients had an average of one training session a day lasting 30 minutes for at least 5 days a week.",100.0
677,PRECIS-2,the ara test was chosen as the main outcome measure because all the patients were able to perform the total test compared to the WMFt test where the patient has to stand up for some exercises - impossible for wheelchair bound patients.,fulltext,the ara test was chosen as the main outcome measure because all the patients were able to perform the total test compared to the WMFt test where the patient has to stand up for some exercises - impossible for wheelchair bound patients.,100.0
677,PRECIS-2,"the main research question in this validation trial clinical assessment of the HeLLODOc tele-rehabilitation service was: is the use of the H-caD system for one month at least as good as usual care for the arm/hand function in stroke, tBI and MS patients?",fulltext,"ele-rehAbIlItAtIon clInIcAl trIAl was: is the use of the H-caD system for one month at least as good as usual care for the arm/hand function in stroke, tBI and MS patients?",65.35433070866141
677,PRECIS-2,"the hypothesis is that the H-caD system is at least as effective as the usual care for arm/hand function, measured with outcome measures for arm/hand function, given to the stroke, tBI and MS patients when they are living at home.",fulltext,"the hypothesis is that the H-caD system is at least as effective as the usual care for arm/hand function, measured with outcome measures for arm/hand function, given to the stroke, tBI and MS patients when they are living at home.",100.0
677,PRECIS-2,"during the training month subjects improved on the individual H-caD exercises but, as in the usual care group, the arm/hand function remained at the same level.",fulltext,"during the training month subjects improved on the individual H-caD exercises but, as in the usual care group, the arm/hand function remained at the same level.",100.0
677,PRECIS-2,"the subjects were eligible for recruiting if they met the following criteria: (1) age > 18 years; (2) established diagnosis of the specific pathological condition MS, stroke or tBI;",fulltext,"the subjects were eligible for recruiting if they met the following criteria: (1) age > 18 years; (2) established diagnosis of the specific pathological condition MS, stroke or tBI;",100.0
677,PRECIS-2,the main outcome measures were the ara test and the NHPt.,fulltext,the main outcome parameters were the ara test and the NHPt.,92.98245614035088
677,PRECIS-2,"Patients were recruited from Unità Organica di riabilitazione Intensiva Neuromotoria (UOrIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis centre (NMSc, Belgium). UOrIN included stroke patients, FPING tBI patients and NMSc MS patients.",fulltext,"Patients were recruited from Unità Organica di riabilitazione Intensiva Neuromotoria (UOrIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis centre (NMSc, Belgium). UOrIN included stroke patients, FPING tBI patients and NMSc MS patients.",100.0
677,PRECIS-2,the study also comprised a patient-control design for the intervention group to investigate if the H-caD system maintained the same functional ability in the group of patients who underwent the intervention of the H-caD system compared to usual care they received before and after the intervention.,fulltext,the study also comprised a patient-control design for the intervention group to investigate if the HcaD system maintained the same functional ability in the group of patients who underwent the intervention of the H-caD system compared to usual care they received before and after the intervention.,99.66442953020133
677,PRECIS-2,"besides clinical effectiveness, the user satisfaction of the H-caD system has been investigated using VaS scales.",fulltext,"besides clinical effectiveness, the user satisfaction of the H-caD system has been investigated using VaS scales.",100.0
678,PRECIS-2,"In addition to continuing to receive usual services (see below), patients in the fast-track group received care from a PCT.",fulltext,"In addition to continuing to receive usual services (see below), patients in the fast-track group received care from a PCT.",100.0
678,PRECIS-2,"Inclusion criteria were patients in South East London, living with MS and deemed (by clinicians) to have one or more of unresolved symptoms, psychoso-social concerns, end-of-life issues, progressive illness, or complex needs (i.e., palliative care needs).",fulltext,"Inclusion criteria were patients in South East London, living with MS and deemed (by clinicians) to have one or more of unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs (i.e., palliative care needs).",98.82352941176471
678,PRECIS-2,We conducted face-to-face interviews with patients and gave self-complete questionnaires to caregivers.,fulltext,We conducted face-to-face interviews with patients and gave self-complete questionnaires to caregivers.,100.0
678,PRECIS-2,"Patients had one to three contacts (visits and/or phone calls) from the PCT, although a small number (around 12%) were referred for longer-term ‘‘community’’ palliative care.",fulltext,"Patients had one to three contacts (visits and/or phone calls) from the PCT, although a small number (around 12%) were referred for longer-term ‘‘community’’ palliative care.",100.0
678,PRECIS-2,"For patients randomized to the control group, community and hospital services (including neurologists, MS nurses, re-habilitation, neurological, and social services) were offered as usual.",fulltext,"For patients randomized to the control group, community and hospital services (including neurologists, MS nurses, rehabilitation, neurological, and social services) were offered as usual.",99.46808510638297
678,PRECIS-2,"After baseline interview, patients were randomly allocated to either a multiprofessional palliative care team (PCT) immediately (fast track) or the control care group who continued best usual care for three months and then were offered the PCT.",fulltext,"After baseline interview, patients were randomly allocated to either a multiprofessional palliative care team (PCT) immediately (fast track) or the control care group who continued best usual care for three months and then were offered the PCT.",100.0
678,PRECIS-2,"Our standardized questionnaires included the Palliative Care Outcome Scale (POS-8), comprising eight questions on anxiety, patient and carer concerns, and practical needs, each rated 0e4; a single-item POS pain score (rated 0 [best] to 4 [worst]); and caregivers’ burden (using the 12-item version of the Zarit Carer Burden Inventory [ZBI]).",fulltext,"Our standardized questionnaires included the Palliative Care Outcome Scale (POS8), 24,25 comprising eight questions on anxiety, patient and carer concerns, and practical needs, each rated 0e4; a single-item POS pain score (rated 0 [best] to 4 [worst]); and caregivers’ burden (using the 12-item version of the Zarit Carer Burden Inventory [ZBI]).",99.70674486803519
678,PRECIS-2,Patients in South East London who were severely affected by MS were referred by clinicians to the trial.,fulltext,Patients in South East London who were severely affected by MS were referred by clinicians to the trial.,100.0
678,PRECIS-2,"We collected outcome and cost data at baseline (before randomization) and at 6, 12, 18 (only control groupdafter they received the PCT), and 24 weeks.",fulltext,"We collected outcome and cost data at baseline (before randomization) and at 6, 12, 18 (only control groupdafter they received PCT), and 24 weeks.",97.33333333333334
678,PRECIS-2,Higher scores represent greater problems on all the scales.,fulltext,Higher scores represent greater problems on all the scales.,100.0
678,PRECIS-2,"Reasons for drop out, no interview, and refusal were recorded whenever possible.",fulltext,"Reasons for drop out, no interview, and refusal were recorded whenever possible.",100.0
678,PRECIS-2,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",prompt,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",100.0
678,PRECIS-2,Exclusion criteria included if the referring staff or the screening deemed patients had very urgent needs or were deteriorating rapidly when imme-diate referral to the service was offered.,fulltext,Exclusion criteria included if the referring staff or the screening deemed patients had very urgent needs or were deteriorating rapidly when immediate referral to the service was offered.,99.46808510638297
678,PRECIS-2,"After consent and baseline interview, the researcher e-mailed relevant data to independent statisticians who conducted the randomization using the minimization method to give an equal balance of gender, age, date of diagnosis, and according to whether patients could or could not communicate.",fulltext,"After consent and baseline interview, the researcher e-mailed relevant data to independent statisticians who conducted the randomization using the minimization method 21 to give an equal balance of gender, age, date of diagnosis, and according to whether patients could or could not communicate.",100.0
678,PRECIS-2,"We tested the differences between the two arms (expressed as differences between follow-up and baseline interviews) using one-way analysis of variance (ANOVA), checking statistical assumptions and adjusting for baseline scores.",fulltext,"We tested the differences between the two arms (expressed as differences between follow-up and baseline interviews) using one-way analysis of variance (ANOVA), checking statistical assumptions and adjusting for baseline scores.",100.0
678,PRECIS-2,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT.",fulltext,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT.",100.0
678,PRECIS-2,"Patients were randomized to receive either the PCT immediately (fast track) or usual best practice alone (control) for 12 weeks, after which they were offered the service.",fulltext,"Patients were randomized to receive either the PCT immediately (fast track) or usual best practice alone (control) for 12 weeks, after which they were offered the service.",100.0
679,PRECIS-2,"Patients were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands.",fulltext,"pants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands.",97.3913043478261
679,PRECIS-2,"Eligibility criteria for support partners: willing and capable of participating in the investigations, and having access to the internet.",fulltext,"Eligibility criteria for support partners: willing and capable of participating in the investigations, and having access to the internet.",100.0
679,PRECIS-2,For patients the completion of the questionnaires took about 45 minutes and for partners about five minutes per time point.,fulltext,For patients the completion of the questionnaires took about 45 minutes and for partners about five minutes per time point.,100.0
679,PRECIS-2,The MS diagnosis was not confirmed by a neurologist.,fulltext, was not confirmed by a neurologist.,69.23076923076923
679,PRECIS-2,"The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES), at six months.",fulltext,"The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES), at six months.",100.0
679,PRECIS-2,"The MSSES is a specific and sensitive self-report questionnaire consisting of two 9-items subscales for control and functional self-efficacy, with a high internal consistency and test-retest reliability.",fulltext,"The MSSES is a specific and sensitive self-report questionnaire consisting of two 9-items subscales for control and functional self-efficacy, with a high internal consistency and test-retest reliability ",100.0
679,PRECIS-2,"CDT’s components are large group sessions, small group sessions, consultations (carrousel), a theatre evening, and start of the day with a joint activity (optional).",fulltext,"CDT’s components are large group sessions, small group sessions, consultations (carrousel), a theatre evening, and start of the day with a joint activity (optional) ",100.0
679,PRECIS-2,Hedges’ g was used to calculate the effect size for the primary outcome in order to understand the effect of the intervention.,fulltext,Hedges’ g was used to calculate the effect size for the primary outcome in order to understand the effect of the intervention.,100.0
679,PRECIS-2,"Before starting the first CDT of the observational study, team members held two plenary sessions, in which the psychiatrist and psychiatric nurse informed the other members about this social cognitive theory-based approach, and during which the team became familiar with the concept, and each team member’s specific contribution to CDT.",fulltext,"Before starting the first CDT of the observational study, team members held two plenary sessions, in which the psychiatrist and psychiatric nurse informed the other members about this social cognitive theory-based approach, and during which the team became familiar with the concept, and each team member’s specific contribution to CDT.",100.0
679,PRECIS-2,"The number of sessions, their schedule, and their duration are presented in the Appendix (see App 1).",fulltext,"The number of sessions, their schedule, and their duration are presented in the Appendix (see App 1).",100.0
679,PRECIS-2,The criterion of EDSS ≤4.0 was checked by assessing whether the patient was self-sufficient and able to walk ≤500 meters without aid or rest.,fulltext,The criterion of EDSS ≤4.0 was checked by assessing whether the patient was self-sufficient and able to walk ≤500 meters without aid or rest.,100.0
679,PRECIS-2,Interested patients were contacted by a registered nurse experienced in MS (MH) by phone to check diagnosis and eligibility criteria.,fulltext,Interested patients were contacted by a registered nurse experienced in MS (MH) by phone to check diagnosis and eligibility criteria.,100.0
679,PRECIS-2,All professional team members were formally trained in their respective disciplines and all members were experienced in the field of MS.,fulltext,All professional team members were formally trained in their respective disciplines and all members were experienced in the field of MS.,100.0
679,PRECIS-2,During the consultations they had a professional and informative role. In the small group sessions every team member focused on its own area of interest.,fulltext,During the consultations they had a professional and informative role. In the small group sessions every team member focused on its own area of interest.,100.0
679,PRECIS-2,"Small group sessions form the actual training. Depending on their individual goals the participants sign up for the training groups ‘Body’, ‘Feeling’ or ‘Life’, to work out their aims and to experiment whether they can reduce their stressors.",fulltext,"Small group sessions form the actual training [9]. Depending on their individual goals the participants sign up for the training groups ‘Body’, ‘Feeling’ or ‘Life’, to work out their aims and to experiment whether they can reduce their stressors.",100.0
679,PRECIS-2,"The MSSES-C measures confidence with managing symptoms and coping with the demands of illness, and the MSSES-F measures confidence with regard to functional abilities.",fulltext,"The MSSES-C measures confidence with managing symptoms and coping with the demands of illness, and the MSSES-F measures confidence with regard to functional abilities.",100.0
679,PRECIS-2,On the informal theatre evening the participants practice to change roles and to show their potentials by openly experimenting. They do their best to perform before each other and the team. The jointly created evening performance increases the cohesion within the group and teaches participants to find an equilibrium between consuming and action.,fulltext,On the informal theatre evening the participants practice to change roles and to show their potentials by openly experimenting. They do their best to perform before each other and the team. The jointly created evening performance increases the cohesion within the group and learns participants to find an equilibrium between consuming and action ,98.84726224783861
679,PRECIS-2,"The members respected and understood the participants’ individual qualities and differences, and they stimulated, defied and confronted them to explore and push their boundaries.",fulltext,"The members respected and understood the participants’ individual qualities and differences, and they stimulated, defied and confronted them to explore and push their boundaries ",100.0
679,PRECIS-2,"All endpoints were analyzed according to the intention-to-treat principle using an ANCOVA with the 6-month value as dependent variable, and condition, baseline value, disease duration and gender as independent variables.",fulltext,"All endpoints were analyzed according to the intention-to-treat principle using an ANCOVA with the 6-month value as dependent variable, and condition, baseline value, disease duration and gender as independent variables.",100.0
679,PRECIS-2,During an optional joint activity (walk in the woods) at the start of the day the participants experiment with physical challenges and with the management of their energy.,fulltext,During an optional joint activity (walk in the woods) at the start of the day the participants experiment with physical challenges and with the management of their energy.,100.0
679,PRECIS-2,The enrolment started February 2013 and ended April 2016.,fulltext,The enrolment started February 2013 and ended April 2016.,100.0
679,PRECIS-2,"Large group sessions include plenary sessions–where participants make optimal use of their existing potentials, learn how to support and encourage other participants, and experiment how to give the required feedback to the multidisciplinary team–, and group sessions in which half of the participants take part–where they examine and identify which stressors have to be addressed most, and formulate one or two realizable individual aims.",fulltext,"Large group sessions include plenary sessions–where participants make optimal use of their existing potentials, learn how to support and encourage other participants, and experiment how to give the required feedback to the multidisciplinary team–, and group sessions in which half of the participants take part–where they examine and identify which stressors have to be addressed most, and formulate one or two realizable individual aims.",100.0
679,PRECIS-2,"Assessments were at baseline and at one, three and six months follow-up via online questionnaires (www.ms4ri.nl).",fulltext,"Assessments were at baseline and at one, three and six months follow-up via online questionnaires (www.ms4ri.nl).",100.0
679,PRECIS-2,"In addition, to assess the degree of disability, the EDSS score was further quantified on-site by an experienced neurologist, prior to the start of CDT, in patients randomized to the intervention; and in those control patients who chose to receive CDT after study completion.",fulltext,"In addition, to assess the degree of disability, the EDSS score was further quantified on-site by an experienced neurologist, prior to the start of CDT, in patients randomized to the intervention; and in those control patients who chose to receive CDT after study completion.",100.0
679,PRECIS-2,Data were acquired with use of the open source online application LimeSurvey1 in compliance with European Union regulations concerning online medical data.,fulltext,Data were acquired with use of the open source online application LimeSurvey1 in compliance with European Union regulations concerning online medical data.,100.0
679,PRECIS-2,"The study population was low-disability RRMS patients with or without support partner. Eligibility criteria for patients: diagnosis RRMS since at least one year, EDSS score ≤4.0, no symptoms suggestive of a relapse, no relapse in the preceding four weeks, willing and capable of participating in the investigations, and having access to the internet for performing the web-based assessments.",fulltext,"The study population was low-disability RRMS patients with or without support partner. Eligibility criteria for patients: diagnosis RRMS since at least one year, EDSS score ≤4.0, no symptoms suggestive of a relapse, no relapse in the preceding four weeks, willing and capable of participating in the investigations, and having access to the internet for performing the web-based assessments.",100.0
679,PRECIS-2,"Each item is scored from 10 (very uncertain) to 100 (very certain), and addition of the item scores yields the MSSES Control (MSSES-C) and Function (MSSES-F) scores (minimum 90, maximum 900).",fulltext,"Each item is scored from 10 (very uncertain) to 100 (very certain), and addition of the item scores yields the MSSES Control (MSSES-C) and Function (MSSES-F) scores (minimum 90, maximum 900).",100.0
679,PRECIS-2,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS.",fulltext,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS.",100.0
679,PRECIS-2,"CDT was given during three consecutive days in Zorghotel Spelderholt, Beekbergen, the Netherlands, a facility especially equipped for the accommodation of people with impaired health.",fulltext,"CDT was given during three consecutive days in Zorghotel Spelderholt, Beekbergen, the Netherlands, a facility especially equipped for the accommodation of people with impaired health.",100.0
681,PRECIS-2,"From initial telephone consultation five people did not fit the inclusion criteria, three had relatively high levels of mobility, and two were interested but could not commit the time. Thus 36 people were invited for screening.",fulltext,"From initial telephone consultation five people did not fit the inclusion criteria, three had relatively high levels of mobility, and two were interested but could not commit the time. Thus 36 people were invited for screening.",100.0
681,PRECIS-2,Outcome measures were carried out within the local hospital’s rehabilitation unit.,fulltext,Outcome measures were carried out within the local hospital’s rehabilitation unit.,100.0
681,PRECIS-2,Participants were provided with exercise progress cards and were asked to record which level they performed each exercise at each session.,fulltext,Participants were provided with exercise progress cards and were asked to record which level they performed each exercise at each session.,100.0
681,PRECIS-2,"The intervention group received 12 weeks of twice weekly, 60-minute group exercise sessions, including mobility, balance and resistance exercises. The control group received usual care.",fulltext,"The intervention group received 12 weeks of twice weekly, 60-minute group exercise sessions, including mobility, balance and resistance exercises. The control group received usual care.",100.0
681,PRECIS-2,Participants were randomly assigned to the intervention or control group using a computer program (Microsoft Excel 2003).,fulltext,participants were allocated to Site A’s intervention group. A computer program (Microsoft Excel 2003) ,76.03305785123968
681,PRECIS-2,"Potential participants were excluded if they had experienced exacerbation of their multiple sclerosis symptoms three months prior to the study, or had any medical condition which may preclude them from taking part in the exercise intervention.",fulltext,"Potential participants were excluded if they had experienced exacerbation of their multiple sclerosis symptoms three months prior to the study, or had any medical condition which may preclude them from taking part in the exercise intervention.",100.0
681,PRECIS-2,"Through discussion with the instructors, participants chose which level of each exercise they deemed appropriate and also when and how each exercise should be progressed.",fulltext,"Through discussion with the instructors, participants chose which level of each exercise they deemed appropriate and also when and how each exercise should be progressed.",100.0
681,PRECIS-2,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",prompt,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",100.0
681,PRECIS-2,"Outcome measures were carried out within the local hospital’s rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).",fulltext,"Outcome measures were carried out within the local hospital’s rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).",100.0
681,PRECIS-2,Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets. Forty-three potential participants expressed an interest in participating.,fulltext,Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets. Forty-three potential participants expressed an interest in participating.,100.0
681,PRECIS-2,"The primary outcome measure was 25-foot (7.6 m) walk time, secondary outcomes assessed walking endurance, balance, physical function, leg strength, body mass index, activity levels, fatigue, anxiety and depression, quality of life and goal attainment.",fulltext,"The primary outcome measure was 25-foot (7.6 m) walk time, secondary outcomes assessed walking endurance, balance, physical function, leg strength, body mass index, activity levels, fatigue, anxiety and depression, quality of life and goal attainment.",100.0
681,PRECIS-2,All data included in the analysis of the primary outcome. Intention to treat with all available data.,prompt,"all data included in the analysis of the primary outcome? For example, score 5 for a very pragmatic approach using intention to treat with all available data;",100.0
681,PRECIS-2,The intervention took place at two different geographical locations (Site A and Site B).,fulltext,The intervention took place at two different geographical locations (Site A and Site B).,100.0
681,PRECIS-2,"Participants were recruited from this register. Participants had a confirmed diagnosis of multiple sclerosis, an Extended Disability Status Scale score of 5 (ambulatory without aid or rest for 580 m) to 6.5 (constant bilateral assistance required to walk about 20 m without resting), stable rehabilitation and drug therapy for 30 days before entry into the study, cognitive scores of over 24 on the Mini-Mental State Examination and access to the intervention sites using their own or public transport.",fulltext,"Participants were recruited from this register. Participants had a confirmed diagnosis of multiple sclerosis, an Extended Disability Status Scale 33 score of 5 (ambulatory without aid or rest for 580 Clinical Rehabilitation 26(7) about 200 m) to 6.5 (constant bilateral assistance required to walk about 20 m without resting), stable rehabilitation and drug therapy for 30 days before entry into the study, cognitive scores of over 24 on the Mini-Mental State Examination 34 and access to the intervention sites using their own or public transport.",100.0
684,PRECIS-2,"All outcome variables were summarized and comparisons made between groups and over time. Outcome variables that could be shown to be analysed using parametric procedures (e.g. FIM), were analysed using a two-factor repeated measures ANOVA with the two factors being time (0, 8 and 16) and group (1,2), thus allowing for possible interaction effects to assess whether groups react differently over time. Lower level outcome variables were analysed using appropriate nonparametric procedures. Relationships between outcome measures were assessed using appropriate correlation methods. All analyses were performed on SPSS v16 and tests were at the 5% level of significance. Where there were problems with missing data due to dropouts/non-completion, the simple repeated measures ANOVA was replaced with a general linear model where missing data are estimated within the model",fulltext,"All outcome variables were summarized and comparisons made between groups and over time. Outcome variables that could be shown to be analysed using parametric procedures (e.g. FIM), were analysed using a two-factor repeated measures ANOVA with the two factors being time (0, 8 and 16) and group (1,2), thus allowing for possible interaction effects to assess whether groups react differently over time. Lower level outcome variables were analysed using appropriate nonparametric procedures. Relationships between outcome measures were assessed using appropriate correlation methods. All analyses were performed on SPSS v16 and tests were at the 5% level of significance. Where there were problems with missing data due to dropouts/non-completion, the simple repeated measures ANOVA was replaced with a general linear model where missing data are estimated within the model",100.0
684,PRECIS-2,Subjects were assessed at the beginning and at the end of the eight-week intervention period (i.e. either physiotherapy or control) and then again eight weeks later,fulltext,Subjects in both groups were assessed at the beginning and at the end of the eight-week intervention period (i.e. either physiotherapy or control) and then again eight weeks later,100.0
684,PRECIS-2,"For those who were able, functional ability was assessed using the timed 10-metre walk and the timed sit to stand. The timed walk has been shown to be valid and reliable in patients with neurological conditions. Similarly, the time taken for subjects to rise from a standard hospital chair was recorded with a stop watch",fulltext,"For those who were able, functional ability was assessed using the timed 10-metre walk and the timed sit to stand. The timed walk has been shown to be valid and reliable in patients with neurological conditions. 20 Similarly, the 722 Clinical Rehabilitation 25(8) time taken for subjects to rise from a standard hospital chair was recorded with a stop watch",100.0
684,PRECIS-2,"Subjects assigned to Group 1 received physiotherapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist within their home. Each session lasted up to 60 minutes, and a task-specific programme included upper and lower limb strengthening using thera-band, mobile pedals, and weights. Repetition of tasks such as sit to stand, gait, balance (using gym balls and sit fits) and stretching activities were used depending on the subjects previously identified goals",fulltext,"Subjects assigned to Group 1 received physiotherapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist within their home. Each session lasted up to 60 minutes, and a task-specific programme included upper and lower limb strengthening using theraband, mobile pedals, and weights. Repetition of tasks such as sit to stand, gait, balance (using gym balls and sit fits) and stretching activities were used depending on the subjects previously identified goals",99.79253112033194
684,PRECIS-2,"Subjects assigned to Group 2 received usual care, i.e. had no specific physiotherapy interven- tion for the duration of the eight weeks, although physiotherapy could be provided by existing domiciliary physiotherapy services",fulltext,"Subjects assigned to Group 2 received usual care, i.e. had no specific physiotherapy interven- tion for the duration of the eight weeks, although physiotherapy could be provided by existing domiciliary physiotherapy services",100.0
684,PRECIS-2,"The following outcome measures were recorded at baseline, post-intervention (Week 8) and at follow-up (Week 16). Primary outcome measure; Multiple Sclerosis Impact Scale (MSIS29) and secondary outcome measures assessed physical impairment, MS symptoms, quality of life, mood, and disability",fulltext,"The following outcome measures were recorded at baseline, post-intervention (Week 8) and at follow-up (Week 16). Primary outcome measure; Multiple Sclerosis Impact Scale (MSIS29) and secondary outcome measures assessed physical impairment, MS symptoms, quality of life, mood, and disability",100.0
684,PRECIS-2,"People moderately to severely affected by MS were recruited from the MS Service, NHS Ayrshire and Arran",fulltext,"People moderately to severely affected by MS were recruited from the MS Service, NHS Ayrshire and Arran",100.0
684,PRECIS-2,"People with MS who were medically stable were selected where cognitive function was adequate, as assessed by a Mini Mental State Examination score of 23 or over",fulltext,"People with MS who were medically stable were selected where cognitive function was adequate, as assessed by a Mini Mental State Examination score of 23 or over",100.0
684,PRECIS-2,"Subjects were assessed at the beginning and at the end of the eight-week intervention period (i.e. either physiotherapy or control) and then again eight weeks later. To improve the reliability of the data, all assessments were undertaken at the Douglas Grant Rehabilitation Centre, Irvine, and the assessor remained blind to the subjects’ treatment group allocation",fulltext,"Subjects in both groups were assessed at the beginning and at the end of the eight-week intervention period (i.e. either physiotherapy or control) and then again eight weeks later. To improve the reliability of the data, all assessments were undertaken at the Douglas Grant Rehabilitation Centre, Irvine, and the assessor remained blind to the subjects’ treatment group allocation",100.0
685,PRECIS-2,"Those in the control group received no intervention, but were just assessed at baseline and follow-up.",fulltext,"Those in the control group received no intervention, but were just assessed at baseline and follow-up.",100.0
685,PRECIS-2,"Participants were volunteers with MS who were recruited through voluntary organizations, were community based and lived in West Lon- don and in counties contiguous with Greater London.",fulltext,"Participants were volunteers with MS who were recruited through voluntary organizations, were community based and lived in West Lon- don and in counties contiguous with Greater London.",100.0
685,PRECIS-2,"Scale scores on the outcome measures in the control and intervention group were compared in two ways. The clinical impact of the intervention was assessed using change scores and an effect size statistic. The change score was calculated by subtracting the average initial score from the  nal score, and the effect size statistic was calculated by dividing this by the standard deviation of the initial score.",fulltext,"Scale scores on the outcome measures in the control and intervention group were compared in two ways. The clinical impact of the intervention was assessed using change scores and an effect size statistic. The change score was calculated by subtracting the average initial score from the  nal score, and the effect size statistic was calculated by dividing this by the standard deviation of the initial score.",100.0
685,PRECIS-2,Assessments were conducted at baseline and again six months later.,fulltext,Assessments were conducted at baseline and again six months later.,100.0
685,PRECIS-2,"Participants were assigned to group or one to one sessions by the health professional in consultation with each person, and based on their needs and wishes.",fulltext,"s were assigned to group or one to one sessions by the health professional in consultation with each person, and based on their needs and wishes.",92.94871794871796
685,PRECIS-2,The study was conducted with people with MS living in the community.,fulltext,The study was conducted with people with MS living in the community.,100.0
685,PRECIS-2,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",prompt,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",100.0
685,PRECIS-2,Two hundred and seventy-eight people with MS were invited to take part in the study. One hundred and eighty-nine people consented to take part (68%). Of these 183 began the study and 169 (92.3%) completed it.,fulltext,Two hundred and seventy-eight people with MS were invited to take part in the study. One hundred and eighty-nine people consented to take part (68%). Of these 183 began the study and 169 (92.3%) completed it.,100.0
685,PRECIS-2,The only selection criterion was that the diagnosis of MS was con rmed by the general practitioner. There were no exclusion criteria.,fulltext,The only selection criterion was that the diagnosis of MS was con rmed by the general practitioner. There were no exclusion criteria.,100.0
685,PRECIS-2,"The hypotheses were that there would be signi cant improvements in (a) independence in daily living, (b) need for assistance with activities, (c) functional mobility and (d) quality of life in a group of people with MS receiving the professionally guided self-care programme, compared with a control group.",fulltext,"The hypotheses were that there would be signi cant improvements in (a) independence in daily living, (b) need for assistance with activities, (c) functional mobility and (d) quality of life in a group of people with MS receiving the professionally guided self-care programme, compared with a control group.",100.0
685,PRECIS-2,The intervention primarily comprised a discussion of self-care strategies supported by an information booklet developed for the study in line with consumer priorities.,fulltext, primarily comprised a discussion of self-care strategies supported by an information booklet developed for the study in line with consumer priorities.,90.41916167664671
685,PRECIS-2,"The intervention comprised discussion of self-care based on client priorities, using an information booklet about self-care.",fulltext,"The intervention comprised discussion of self-care based on client priorities, using an information booklet about self-care.",100.0
686,PRECIS-2,"For patients in the IMD group, the multidisciplinary integrated outpatient clinic was planned at our MS clinic within a maximum three-month period after inclusion.",fulltext,"re 1). For patients in the IMD group, the multidisciplinary integrated outpatient clinic was planned at our MS clinic within a maximum three-month period after inc",95.70552147239265
686,PRECIS-2,The potential benefit of a multidisciplinary intervention has not been assessed.,fulltext,The potential benefit of a multidisciplinary intervention has not been assessed.,100.0
686,PRECIS-2,"However, whether this multidisciplinary approach is more beneficial for the patient than more usual type of care, where interventions are not integrated but proposed through successive referrals to needed medical and allied health professionals, is unknown.",fulltext,"However, whether this multidisciplinary approach is more beneficial for the patient than more usual type of care, where interventions are not integrated but proposed through successive referrals to needed medical and allied health professionals, is unknown.",100.0
686,PRECIS-2,How different is the flexibility in how the intervention is delivered and the flexibility likely in usual care?,prompt,How different is the flexibility in how the intervention is delivered and the flexibility likely in usual care?,100.0
686,PRECIS-2,Several reports have suggested the value of rehabilitation stays on disability and on some aspects of QoL.,fulltext,Several reports have suggested the value of rehabilitation stays on disability and on some aspects of QoL.,100.0
686,PRECIS-2,"How different are the resources, provider expertise and the organisation of care delivery in the intervention arm of the trial and those available in usual care?",prompt,"How different are the resources, provider expertise and the organisation of care delivery in the intervention arm of the trial and those available in usual care?",100.0
686,PRECIS-2,"Two treatment strategies were compared: (i) an integrated multidisciplinary (IMD) approach, consisting of a half-day individually tailored comprehensive assessment in the MS clinic;",fulltext,"Two treatment strategies were compared: (i) an integrated multidisciplinary (IMD) approach, consisting of a half-day individually tailored comprehensive assessment in the MS clinic;",100.0
686,PRECIS-2,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",prompt,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",100.0
686,PRECIS-2,"The primary outcome was the change in QoL from inclusion to M6, assessed by the Multiple Sclerosis Impact Scale (MSIS-29) self-questionnaire.",fulltext,"The primary outcome was the change in QoL from inclusion to M6, assessed by the Multiple Sclerosis Impact Scale (MSIS-29) self-questionnaire.",100.0
686,PRECIS-2,An integrated intervention within a multidisciplinary outpatient clinic gathering the different team members is thought to offer the best management of MS.,fulltext,An integrated intervention within a multidisciplinary outpatient clinic gathering the different team members is thought to offer the best management of MS.,100.0
686,PRECIS-2,To what extent is the trial's primary outcome relevant to participants?,prompt,To what extent is the trial's primary outcome relevant to participants?,100.0
686,PRECIS-2,Patients who were not living independently in the community were excluded.,fulltext,Patients who were not living independently in the community were excluded.,100.0
686,PRECIS-2,"Primary and secondary outcomes were assessed at inclusion, and after six (M6) and 12 (M12) months.",fulltext,"Primary and secondary outcomes were assessed at inclusion, and after six (M6) and 12 (M12) months.",100.0
686,PRECIS-2,MS patients from the outpatient clinic of the Neurology Department of Pitie´-Salpeˆtrie`re Hospital were prospectively enrolled in the study between March 2010 and July 2012.,fulltext,MS patients from the outpatient clinic of the Neurology Department of Pitie´-Salpeˆtrie`re Hospital were prospectively enrolled in the study between March 2010 and July 2012.,100.0
686,PRECIS-2,How different is the intensity of measurement and follow-up of participants in the trial and the likely follow-up in usual care?,prompt,How different is the intensity of measurement and follow-up of participants in the trial and the likely follow-up in usual care?,100.0
686,PRECIS-2,To what extent are all data included in the analysis of the primary outcome?,prompt,To what extent are all data included in the analysis of the primary outcome?,100.0
686,PRECIS-2,"The INTERMED score, an observer-rated instrument that scores information in four domains: biological, psychological, social, and health care, and has been used to identify patients in need of multidisciplinary care in different neurological diseases including MS, was calculated at inclusion.",fulltext,"sion. The INTERMED score, an observer-rated instrument that scores information in four domains: biological, psychological, social, and health care, and has been used to identify patients in need of multidisciplinary care in different neurological diseases including MS, 2 was calculated at incl",97.94520547945206
686,PRECIS-2,"The MSIS-29 is a validated, reproducible and specific MS QoL scale that consists of 29 simple questions including six different subdomains (fatigue, cognitive function, urinary and bowel trouble, social, emotional and mobility).",fulltext,"nnaire. The MSIS-29 is a validated, reproducible and specific MS QoL scale 35 that consists of 29 simple questions including six different subdomains (fatigue, cognitive function, urinary and bowel trouble, social, emotional and mo",96.49122807017544
686,PRECIS-2,The primary outcome was the impact of the strategy on quality of life (QoL) measured using the MSIS-29 scale at inclusion and after six months.,fulltext,The primary outcome was the impact of the strategy on quality of life (QoL) measured using the MSIS-29 scale at inclusion and after six months.,100.0
686,PRECIS-2,How different is the flexibility in how participants must adhere to the intervention and the flexibility likely in usual care?,prompt,How different is the flexibility in how participants must adhere to the intervention and the flexibility likely in usual care?,100.0
687,PRECIS-2,Thirty community dwelling adults moderately affected by MS (Expanded Disability Status Scale 5-6.5).,fulltext,Thirty community dwelling adults moderately affected by MS (Expanded Disability Status Scale 5-6.5).,100.0
687,PRECIS-2,"Participants were advised to undertake the exercise programme a minimum of twice a week and to complete their online exercise diary which was seen remotely by the physiotherapist. Participants were contacted by the physiotherapist each week to discuss progress and update their exercise programme as appropriate by changing any combination of exercises, level of difficulty or number of repetitions.",fulltext,"Participants were advised to undertake the exercise programme a minimum of twice a week and to complete their online exercise diary which was seen remotely by the physiotherapist. Participants were contacted by the physiotherapist each week to discuss progress and update their exercise programme as appropriate by changing any combination of exercises, level of difficulty or number of repetitions.",100.0
687,PRECIS-2,"The primary outcome measure, the timed 25 foot walk, has good reliability and validity in the MS population.",fulltext,"The primary outcome measure, the timed 25 foot walk, 14 has good reliability and validity in the MS population.",100.0
687,PRECIS-2,Outcome measures were recorded at baseline and at the end of the intervention period (week 13).,fulltext,Outcome measures were recorded at baseline and at the end of the intervention period (week 13).,100.0
687,PRECIS-2,"Individualised therapeutic exercise programs were developed for participants in Group 1, with exercises selected based on their baseline assessment and personal goals. Participants were given unique log-in details to view their own, online personalised exercise programme.",fulltext,"Individualised therapeutic exercise programmes were developed for participants in Group 1, with exercises selected based on their baseline assessment and personal goals. Participants were given unique log-in details to view their own, online personalised exercise programme.",100.0
687,PRECIS-2,Setting: Rehabilitation centre and participants’ homes.,fulltext,Setting: Rehabilitation centre and participants’ homes.,100.0
687,PRECIS-2,"Letters were sent to 138 patients from the Multiple Sclerosis Service database, thought to be suitable for the study, inviting them to participate. Of those 37 people expressed an interest in taking part.",fulltext,"Letters were sent to 138 patients from the Multiple Sclerosis Service database, thought to be suitable for the study, inviting them to participate. Of those 37 people expressed an interest in taking part.",100.0
687,PRECIS-2,"All participants provided written informed consent. During the intervention there were three adverse events (fractured elbow, hospital admission due to infection, breast cancer diagnosis). All were reported to Research Ethics and Research and Development who deemed them to be unrelated to the intervention and the study continued as planned.",fulltext,". During the intervention there were three adverse events (fractured elbow, hospital admission due to infection, breast cancer diagnosis). All were reported to Research Ethics and Research and Development who deemed them to be unrelated to the intervention and the study continued as planned.",85.38011695906434
687,PRECIS-2,Not applicable as there is no compliance issue after consent has been given.,prompt,Not applicable as there is no compliance issue after consent has been given.,100.0
688,PRECIS-2,To what extent are the participants in the trial similar to those who would receive this intervention if it was part of usual care?,prompt,To what extent are the participants in the trial similar to those who would receive this intervention if it was part of usual care?,100.0
688,PRECIS-2,"For example, score 5 for very pragmatic criteria essentially identical to those in usual care; score 1 for a very explanatory approach with lots of exclusions (e.g. those who don’t comply, respond to treatment, or are not at high risk for primary outcome, are children or elderly), or uses many selection tests not used in usual care.",prompt,"For example, score 5 for very pragmatic criteria essentially identical to those in usual care; score 1 for a very explanatory approach with lots of exclusions (e.g. those who don’t comply, respond to treatment, or are not at high risk for primary outcome, are children or elderly), or uses many selection tests not used in usual care.",100.0
688,PRECIS-2,"For example, score 5 for a very pragmatic choice involving no more than usual encouragement to adhere to the intervention; score 1 for a very explanatory approach that involves exclusion based on adherence, and measures to improve adherence if found wanting. In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",prompt,"For example, score 5 for a very pragmatic choice involving no more than usual encouragement to adhere to the intervention; score 1 for a very explanatory approach that involves exclusion based on adherence, and measures to improve adherence if found wanting. In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",100.0
688,PRECIS-2,How different is the flexibility in how the intervention is delivered and the flexibility likely in usual care?,prompt,How different is the flexibility in how the intervention is delivered and the flexibility likely in usual care?,100.0
688,PRECIS-2,"For example, score 5 for a very pragmatic choice where the outcome is of obvious importance to participants; score 1 for a very explanatory approach using a surrogate, physiological outcome, central adjudication or use assessment expertise that is not available in usual care, or the outcome is measured at an earlier time than in usual care.",prompt,"For example, score 5 for a very pragmatic choice where the outcome is of obvious importance to participants; score 1 for a very explanatory approach using a surrogate, physiological outcome, central adjudication or use assessment expertise that is not available in usual care, or the outcome is measured at an earlier time than in usual care.",100.0
688,PRECIS-2,"The home based care multidisciplinary team included two neurologists, a urologist, a rehabilitation physician, a psychologist, a physical therapist, a nurse, a social worker, and a coordinator. These were provided with cell phones and could easily be reached for advice (telephone intervention) or direct face to face intervention when required.",fulltext,"The home based care multidisciplinary team included two neurologists, a urologist, a rehabilitation physician, a psychologist, a physical therapist, a nurse, a social worker, and a coordinator. These were provided with cell phones and could easily be reached for advice (telephone intervention) or direct face to face intervention when required.",100.0
688,PRECIS-2,"How different are the resources, provider expertise and the organisation of care delivery in the intervention arm of the trial and those available in usual care?",prompt,"How different are the resources, provider expertise and the organisation of care delivery in the intervention arm of the trial and those available in usual care?",100.0
688,PRECIS-2,"Eligible patients were assessed for suitability by the coordinator of the home based care team (LP). Written informed consent was obtained for entry into the trial from the patients and, when appropriate, from their carers.",fulltext,"Eligible patients were assessed for suitability by the coordinator of the home based care team (LP). Written informed consent was obtained for entry into the trial from the patients and, when appropriate, from their carers.",100.0
688,PRECIS-2,How different is the setting of the trial and the usual care setting?,prompt,How different is the setting of the trial and the usual care setting?,100.0
688,PRECIS-2,"For example, score 5 for a very pragmatic choice with identical flexibility to usual care; score 1 for a very explanatory approach if there is a strict protocol, monitoring and measures to improve compliance, with specific advice on allowed co-interventions and complications.",prompt,"For example, score 5 for a very pragmatic choice with identical flexibility to usual care; score 1 for a very explanatory approach if there is a strict protocol, monitoring and measures to improve compliance, with specific advice on allowed co-interventions and complications.",100.0
688,PRECIS-2,"Based on individual needs, patients randomised to home based care were followed through home visits and telephone follow up. A dedicated phone number was available five days a week from 9 am to 5 pm, where an operator addressed questions or concerns from patients and caregivers and contacted the different specialists according to the specific requirement.",fulltext,"Based on individual needs, patients randomised to home based care were followed through home visits and telephone follow up. A dedicated phone number was available five days a week from 9 am to 5 pm, where an operator addressed questions or concerns from patients and caregivers and contacted the different specialists according to the specific requirement.",100.0
688,PRECIS-2,To what extent is the trial's primary outcome relevant to participants?,prompt,To what extent is the trial's primary outcome relevant to participants?,100.0
688,PRECIS-2,"For example, score 5 for very pragmatic recruitment through usual appointments or clinic; score 1 for a very explanatory approach with targeted invitation letters, advertising in newspapers, radio plus incentives and other routes that would not be used in usual care.",prompt,"For example, score 5 for very pragmatic recruitment through usual appointments or clinic; score 1 for a very explanatory approach with targeted invitation letters, advertising in newspapers, radio plus incentives and other routes that would not be used in usual care.",100.0
688,PRECIS-2,"The statistical analysis of the trial included a two sample t test to detect a standardised difference of 0.5 standard deviations on the SF-36 general health perception domain, assuming a standard deviation of 10 for the pre-post differences in SF-36 general health perception domain and a five-point difference between the two groups, which is the smallest change in score considered clinically relevant.",fulltext," to detect a standardised difference of 0.5 standard deviations on the SF-36 general health perception domain. The figure was obtained assuming a standard deviation of 10 for the pre-post differences in SF-36 general health perception domain and a five point difference between the two groups, which is the smallest change in score considered clinically relevant.",83.7037037037037
688,PRECIS-2,The study was conducted in Rome and was approved by the ethics committee of La Sapienza University.,fulltext,The study was conducted in Rome and was approved by the ethics committee of La Sapienza University.,100.0
688,PRECIS-2,"Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.",fulltext,"Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.",100.0
688,PRECIS-2,"The multidisciplinary team collaborated with the patient, physician, and caregiver in designing individualised clinical care and in coordinating home services as appropriate for the individual patient. The type of care was more than is normally available in the community through National Health Service care.",fulltext,"The multidisciplinary team collaborated with the patient, physician, and caregiver in designing individualised clinical care and in coordinating home services as appropriate for the individual patient. The type of care was more than is normally available in the community through National Health Service care.",100.0
688,PRECIS-2,How much extra effort is made to recruit participants over and above what that would be used in the usual care setting to engage with patients?,prompt,How much extra effort is made to recruit participants over and above what that would be used in the usual care setting to engage with patients?,100.0
688,PRECIS-2,"For example, score 5 for a very pragmatic approach with no more than usual follow up; score 1 for a very explanatory approach with more frequent, longer visits, unscheduled visits triggered by primary outcome event or intervening event, and more extensive data collection.",prompt,"For example, score 5 for a very pragmatic approach with no more than usual follow up; score 1 for a very explanatory approach with more frequent, longer visits, unscheduled visits triggered by primary outcome event or intervening event, and more extensive data collection.",100.0
688,PRECIS-2,"For example, score 5 for a very pragmatic choice that uses identical organisation to usual care; score 1 for a very explanatory approach if the trial increases staff levels, gives additional training, require more than usual experience or certification and increase resources.",prompt,"For example, score 5 for a very pragmatic choice that uses identical organisation to usual care; score 1 for a very explanatory approach if the trial increases staff levels, gives additional training, require more than usual experience or certification and increase resources.",100.0
688,PRECIS-2,"For example, score 5 for a very pragmatic approach using intention to treat with all available data; score 1 for a very explanatory analysis that excludes ineligible post-randomisation participants, includes only completers or those following the treatment protocol.",prompt,"For example, score 5 for a very pragmatic approach using intention to treat with all available data; score 1 for a very explanatory analysis that excludes ineligible post-randomisation participants, includes only completers or those following the treatment protocol.",100.0
688,PRECIS-2,How different is the intensity of measurement and follow-up of participants in the trial and the likely follow-up in usual care?,prompt,How different is the intensity of measurement and follow-up of participants in the trial and the likely follow-up in usual care?,100.0
688,PRECIS-2,To what extent are all data included in the analysis of the primary outcome?,prompt,To what extent are all data included in the analysis of the primary outcome?,100.0
688,PRECIS-2,The primary outcome of the trial was to compare the effectiveness and the costs of multidisciplinary home based care in multiple sclerosis with hospital care in a prospective randomised controlled trial with a one year follow up.,fulltext, To compare the effectiveness and the costs of multidisciplinary home based care in multiple sclerosis with hospital care in a prospective randomised controlled trial with a one year follow up.,84.27947598253274
688,PRECIS-2,"At the end of a one year follow up period, all patients underwent the same comprehensive interview as at baseline.",fulltext,"At the end of a one year follow up period, all patients underwent the same comprehensive interview as at baseline.",100.0
688,PRECIS-2,How different is the flexibility in how participants must adhere to the intervention and the flexibility likely in usual care?,prompt,How different is the flexibility in how participants must adhere to the intervention and the flexibility likely in usual care?,100.0
688,PRECIS-2,"For example, score 5 for a very pragmatic choice using identical settings to usual care; score 1, for a very explanatory approach with only a single centre, or only specialised trial or academic centres.",prompt,"For example, score 5 for a very pragmatic choice using identical settings to usual care; score 1, for a very explanatory approach with only a single centre, or only specialised trial or academic centres.",100.0
689,PRECIS-2,A cost-utility analysis was performed to compare the value for money of functional electrical stimulation with ankle-foot orthoses (usual care). A National Health Service and Personal Social Services perspective analyses was adopted and a discount rate of 3.5% to future costs and health benefits was applied as recommended by the National Institute for Clinical Excellence.,fulltext,A cost-utility analysis was performed to compare the value for money of functional electrical stimulation with ankle-foot orthoses (usual care). A National Health Service and Personal Social Services perspective analyses was adopted and a discount rate of 3.5% to future costs and health benefits was applied as recommended by the National Institute for Clinical Excellence.,100.0
689,PRECIS-2,FES may offer value for money alternative to usual care.,fulltext,FES may offer value for money alternative to usual care.,100.0
689,PRECIS-2,Potential participants were informed of the study and issued with a participant information sheet. Potential participants contacted the researchers if they were interested in participating.,fulltext, were informed of the study and issued with a participant information sheet. Potential participants contacted the researchers if they were interested in participating.,88.35978835978835
689,PRECIS-2,"Participants randomized to the usual care group were fitted with a custom-made, solid, ankle-foot orthosis by an orthotist, within four weeks of their initial assessment. The recommendations made by the Best Practice Statement for ankle-foot orthoses following stroke were applied.",fulltext,"Participants randomized to the usual care group were fitted with a custom-made, solid, ankle-foot orthosis by an orthotist, within four weeks of their initial assessment. The recommendations made by the Best Practice Statement for ankle-foot orthoses following stroke were applied.",100.0
689,PRECIS-2,"Participants required to have a clinical diagnosis of Multiple Sclerosis, persistent foot drop (lasting a minimum of three months) observed during a 5-minute walk test, stable disease (no change in the Extended Disability Status Score or relapse in previous three months), 5° of passive dorsiflexion and tolerance of functional electrical stimulation.",fulltext,"Participants required to have a clinical diagnosis of Multiple Sclerosis, persistent foot drop (lasting a minimum of three months) observed during a 5-minute walk test, stable disease (no change in the Extended Disability Status Score 12 or Renfrew et al. 3 relapse in previous three months), 5° of passive dorsiflexion and tolerance of functional electrical stimulation.",100.0
689,PRECIS-2,"A Restricted Maximum Likelihood approach to fitting mixed models was employed to allow intention to treat assumptions to cope with missing data. All analysis was performed on IBM SPSS v24, using a 5% level of significance (IBM, New York, USA).",fulltext,"A Restricted Maximum Likelihood approach to fitting mixed models was employed to allow intention to treat assumptions to cope with missing data. All analysis was performed on IBM SPSS v24, using a 5% level of significance (IBM, New York, USA).",100.0
689,PRECIS-2,"Participants were randomly assigned (1:1) to receive an ankle-foot orthosis or functional electrical stimulation device, by selecting the next envelope from 85 randomly ordered prefilled sealed opaque envelopes.",fulltext,"Participants were randomly assigned (1:1) to receive an ankle-foot orthosis or functional electrical stimulation device, by selecting the next envelope from 85 randomly ordered prefilled sealed opaque envelopes.",100.0
689,PRECIS-2,"Outcome measures were administered by two unblinded assessors (Rebecca Hunter and A.L.) at baseline (0), 3, 6 and 12 months, except for the Psychological Impact of Assistive Devices Score, which was administered at 12 months only.",fulltext,"Outcome measures were administered by two unblinded assessors (Rebecca Hunter and A.L.) at baseline (0), 3, 6 and 12 months, except for the Psychological Impact of Assistive Devices Score 15 which was administered at 12 months only.",100.0
689,PRECIS-2,The primary outcome was walking speed as measured by the 5-minute self-selected walk test.,fulltext,The primary outcome was walking speed as measured by the 5-minute self-selected walk test.,100.0
689,PRECIS-2,"Participants randomized to the functional electrical stimulation group were assessed and fitted with an Odstock Dropped Foot Stimulator Pace (OML, Salisbury) device by a physiotherapist experienced in functional electrical stimulation.",fulltext,"Participants randomized to the functional electrical stimulation group were assessed and fitted with an Odstock Dropped Foot Stimulator Pace (OML, Salisbury) device by a physiotherapist experienced in functional electrical stimulation ",100.0
689,PRECIS-2,"Participants were excluded if they had previously used functional electrical stimulation or an ankle-foot orthosis for foot drop, moderate to severe cognitive impairment (scored < 26, Montreal Cognitive Assessment), foot drop due to other disorders, other conditions significantly affecting gait, contraindications to functional electrical stimulation, marked proximal weakness, plantar flexor spasticity, stance phase instability or severe lower limb/trunk ataxia affecting gait.",fulltext,"Participants were excluded if they had previously used functional electrical stimulation or an ankle-foot orthosis for foot drop, moderate to severe cognitive impairment (scored < 26, Montreal Cognitive Assessment), 13 foot drop due to other disorders, other conditions significantly affecting gait, contraindications to functional electrical stimulation, marked proximal weakness, plantar flexor spasticity, stance phase instability or severe lower limb/trunk ataxia affecting gait.",100.0
689,PRECIS-2,"Both groups walked faster at 12 months with device (P < 0.001; AFO, 0.73 (0.24); FES, 0.79 (0.24) m/s) but no difference between groups.",fulltext,"Both groups walked faster at 12 months with device (P < 0.001; AFO, 0.73 (0.24); FES, 0.79 (0.24) m/s) but no difference between groups.",100.0
689,PRECIS-2,Participants in both groups were instructed to gradually increase the wear of their devices over the first six weeks.,fulltext,Participants in both groups were instructed to gradually increase the wear of their devices over the first six weeks.,100.0
689,PRECIS-2,The study was conducted in seven Multiple Sclerosis outpatient centers across Scotland.,fulltext,Setting: Seven Multiple Sclerosis outpatient centres across Scotland.,74.71264367816092
690,PRECIS-2,The POS-S-MS (primary outcome measure) and the core POS were developed and validated for use in PC.,fulltext,The POS-S-MS (primary outcome measure) and the core POS were developed and validated for use in PC.,100.0
690,PRECIS-2,"The SEIQoL-DW is administered in an interview in which respondents nominate the five areas of life that are most important in determining their QoL, and rate the satisfaction/functioning and weight/importance in each of these areas.",fulltext,"The SEIQoL-DW is administered in an interview in which respondents nominate the five areas of life that are most important in determining their QoL, and rate the satisfaction/functioning and weight/ A Solari, A Giordano et al. journals.sagepub.com/home/msj 3 importance in each of these areas.",100.0
690,PRECIS-2,Nurses of the Milan and Rome centers had degrees and worked full time in PC; the Catania nurse attended a week-long individual training course.,fulltext,Nurses of the Milan and Rome centers had degrees and worked full time in PC; the Catania nurse attended a week-long individual training course.,100.0
690,PRECIS-2,"Participants were non-institutionalized adults (age ⩾ 18 years) with severe MS and their primary carers. Other patient inclusion criteria were primary or secondary progressive MS, EDSS score ⩾ 8.0, complex symptoms, and ⩾2 unmet care needs.",fulltext,"Participants were non-institutionalized adults (age ⩾ 18 years) with severe MS and their primary carers. Other patient inclusion criteria were primary or secondary progressive MS, 1,13 Expanded Disability Status Scale (EDSS) score ⩾ 8.0, 14 complex symptoms, 15 and ⩾2 unmet care needs.",100.0
690,PRECIS-2,"All team activities were recorded in the PeNSAMI patient study record, which was kept at the patient’s home and available to all HPs/caregivers.",fulltext,"All team activities were recorded in the PeNSAMI patient study record, which was kept at the patient’s home and available to all HPs/caregivers.",100.0
690,PRECIS-2,"Subsequently, the team verified program implementation and reviewed it as necessary.",fulltext,"Subsequently, the team verified program implementation and reviewed it as necessary.",100.0
690,PRECIS-2,"To what extent is the trial's primary outcome relevant to participants? For example, score 5 for a very pragmatic choice where the outcome is of obvious importance to participants; score 1 for a very explanatory approach using a surrogate, physiological outcome, central adjudication or use assessment expertise that is not available in usual care, or the outcome is measured at an earlier time than in usual care.",prompt,"To what extent is the trial's primary outcome relevant to participants? For example, score 5 for a very pragmatic choice where the outcome is of obvious importance to participants; score 1 for a very explanatory approach using a surrogate, physiological outcome, central adjudication or use assessment expertise that is not available in usual care, or the outcome is measured at an earlier time than in usual care.",100.0
690,PRECIS-2,UC consisted of the health and social services provided by the Italian National Health Service in the study area.,fulltext,UC consisted of the health and social services provided by the Italian National Health Service in the study area.,100.0
690,PRECIS-2,"After visits 2 and 3, examiners were asked to guess dyad assignment.",fulltext,"After visits 2 and 3, examiners were asked to guess dyad assignment.",100.0
690,PRECIS-2,"Prior to study start, all team members were trained in the HPA intervention; 3 and 6 months after trial initiation they met again to share experiences, fine-tune the protocol, and discuss difficult cases.",fulltext,"Prior to study start, all team members were trained in the HPA intervention; 3 and 6 months after trial initiation they met again to share experiences, fine-tune the protocol, and discuss difficult cases.",100.0
690,PRECIS-2,"Dyads were randomly assigned (2:1) to receive HPA or UC. Allocation to treatment groups was done using a third-party, web-based computerized randomization procedure with stratified minimization for EDSS score (8.0--8.5, 9.0--9.5), presence of severe cognitive compromise (clinical judgment), and center.",fulltext,"Dyads were randomly assigned (2:1) to receive HPA or UC. Allocation to treatment groups was done using a third-party, web-based computerized randomization procedure with stratified minimization for EDSS score (8.0–8.5, 9.0–9.5), presence of severe cognitive compromise (clinical judgment), and center ",99.33993399339934
690,PRECIS-2,"Based on the principles of PC, each center had a HPA team consisting of a physician (neurologist or physiatrist), a nurse (case manager and team leader), a psychologist, and a social worker.",fulltext,"Based on the principles of PC, 17 each center had a HPA team consisting of a physician (neurologist or physiatrist), a nurse (case manager and team leader), a psychologist, and a social worker.",100.0
690,PRECIS-2,"In this randomized, examiner-blind, controlled study, we recruited patients from three Italian centers.",fulltext,"In this randomized, examiner-blind, controlled study, we recruited patients from three Italian centers.",100.0
690,PRECIS-2,"After a comprehensive assessment of the dyad needs based on direct observation and on visit 1 information (available via the eCRF), the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician (the intervention was not intended to replace existing services).",fulltext,"After a comprehensive assessment of the dyad needs based on direct observation and on visit 1 information (available via the eCRF), the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician (the intervention was not intended to replace existing services).",100.0
690,PRECIS-2,"All randomly assigned patients were included in the main intention-to-treat analysis, provided that at least one contact with the team occurred (HPA group). The average effect of the intervention over time on all outcomes was evaluated between the two groups using generalized estimating equations (GEE, repeated-measures analysis of covariance with exchangeable correlation). All analyses were adjusted for the base-line value of the outcome. Besides intervention group (HPA, UC) and time visit (3-month, 6-month), all analyses included as a pre-specified covariate center (Milan, Rome, Catania), as the intervention was delivered by teams that operated in different socio-cultural contexts.",fulltext,". All randomly assigned patients were included in the main intention-to-treat analysis, provided that at least one contact with the team occurred (HPA group). The average effect of the intervention over time on all outcomes was evaluated between the two groups using generalized estimating equations (GEE, repeatedmeasures analysis of covariance with exchangeable correlation). All analyses were adjusted for the baseline value of the outcome. Besides intervention group (HPA, UC) and time visit (3-month, 6-month), all analyses included as a pre-specified covariate center (Milan, Rome, Catania), as the intervention was delivered by teams that operated in different socio-cultural context",99.42196531791907
690,PRECIS-2,All patient-carer dyads gave written informed consent before study enrollment.,fulltext,All patient-carer dyads gave written informed consent before study enrollment.,100.0
690,PRECIS-2,"The blind examiners used a web-based case report form (eCRF), so that visit 1--3 data were available to HPA teams and coordination unit.",fulltext,"The blind examiners used a web-based case report form (eCRF), so that visit 1–3 data were available to HPA teams and coordination unit.",99.26470588235294
690,PRECIS-2,"The carer (a family member, relative, or friend of the patient) was his or her next of kin and was designated by the patient except for patients with severe cognitive compromise.",fulltext,"The carer (a family member, relative, or friend of the patient) was his or her next of kin and was designated by the patient except for patients with severe cognitive compromise.",100.0
690,PRECIS-2,"The pre-specified primary endpoints were changes in patient quality of life (SEIQoL-DW) and symptom burden (PC Outcome Scale-Symptoms-MS, POS-S-MS).",fulltext,"The pre-specified primary endpoints were changes in patient quality of life (SEIQoL-DW) and symptom burden (PC Outcome Scale-Symptoms-MS, POSS-MS).",99.32432432432432
691,PRECIS-2,"Data were analysed using IBM SPSS, V.18.",fulltext,"Data were analysed using IBM SPSS, V.18.",100.0
691,PRECIS-2,Facilitators were all qualified to a senior/advanced level (in the UK minimum of a Band 7 on the NHS Agenda for Change (AfC) grading structure).,fulltext,Facilitators were all qualified to a senior/advanced level (in the UK minimum of a Band 7 on the NHS Agenda for Change (AfC) grading structure).,100.0
691,PRECIS-2,"Each session follows the same general format, namely, facilitator-delivered presentations, flipchart discussions, group activities and homework.",fulltext,"Each session follows the same general format, namely, facilitator-delivered presentations, flipchart discussions, group activities and homework.",100.0
691,PRECIS-2,"The main exclusion criteria were: (1) having taken part in a fatigue programme in the last year, (2) cognitive impairments, (3) a relapse in the pre-previous 3 months or (4) having started treatment with disease modifying or antidepressant drugs within the previous 3 months.",fulltext,"The main exclusion criteria were: (1) having taken part in a fatigue programme in the last year, (2) cognitive impairments, (3) a relapse in the previous 3 months or (4) having started treatment with disease modifying or antidepressant drugs within the previous 3 months.",98.54545454545455
691,PRECIS-2,"Apart from one MS specialist nurse, facilitators were either occupational therapists or physiotherapists.",fulltext,"Apart from one MS specialist nurse, facilitators were either occupational therapists or physiotherapists.",100.0
691,PRECIS-2,"The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale total score >4) and (3) ambulatory.",fulltext,"The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale total score >4) 16 and (3) ambulatory.",100.0
691,PRECIS-2,"FACETS was delivered in hotel meeting-room facilities, with the exception of one centre, where it was held in a rehabilitation hospital.",fulltext,"FACETS was delivered in hotel meeting-room facilities, with the exception of one centre, where it was held in a rehabilitation hospital.",100.0
691,PRECIS-2,"The intervention was delivered in hotel meeting-room facilities, with the exception of one centre, where it was held in a rehabilitation hospital.",fulltext,"S was delivered in hotel meeting-room facilities, with the exception of one centre, where it was held in a rehabilitation hospital.",89.04109589041096
691,PRECIS-2,Participants receiving the intervention continued to have access to services available as part of their usual local care.,fulltext,Participants receiving the intervention continued to have access to services available as part of their usual local care.,100.0
691,PRECIS-2,"All questionnaire outcomes were self-reported for both groups, presented in a booklet format with a large font and administered and returned through the post.",fulltext,"All questionnaire outcomes were self-reported for both groups, presented in a booklet format with a large font and administered and returned through the post.",100.0
691,PRECIS-2,The main analysis was intention-to-treat but we also conducted a ‘per protocol’ analysis (excluding participants who attended fewer than four FACETS sessions).,fulltext,The main analysis was intention-to-treat but we also conducted a ‘per protocol’ analysis (excluding participants who attended fewer than four FACETS sessions).,100.0
691,PRECIS-2,"The manualised group-based FACETS programme is described elsewhere and is based upon a conceptual framework integrating elements from cognitive behavioural, social-cognitive, energy effectiveness, self-management and self-efficacy theories.",fulltext,"The manualised group-based FACETS programme is described elsewhere 13 and is based upon a conceptual framework integrating elements from cognitive behavioural, social-cognitive, energy effectiveness, self-management and self-efficacy theories.",100.0
691,PRECIS-2,"Participants were recruited in three UK centres (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.",fulltext,"Participants were recruited in three UK centres (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.",100.0
691,PRECIS-2,Recruitment took place from May 2008 to November 2009.,fulltext,Recruitment took place from May 2008 to November 2009.,100.0
691,PRECIS-2,"For those allocated to the FACETS arm, outcomes were measured 1 week (baseline) before the start of FACETS and 1 month (follow-up 1) and 4 months (follow-up 2) after the final session.",fulltext,"For those allocated to the FACETS arm, outcomes were measured 1 week (baseline) before the start of FACETS and 1 month (follow-up 1) and 4 months (follow-up 2) after the final session.",100.0
691,PRECIS-2,"Primary outcomes were fatigue severity (Global Fatigue Severity (GFS) subscale of the Fatigue Assessment Instrument (FAI)), disease-specific quality of life (QOL) (total score on the Multiple Sclerosis Impact Scale, V.1 (MSIS-29, V.1)) and self-efficacy for managing fatigue (Multiple Sclerosis-Fatigue Self-Efficacy scale—adapted from the Control subscale of the MS Self-Efficacy scale).",fulltext,"Primary outcome measures These were: (1) fatigue severity (Global Fatigue Severity (GFS) subscale of the Fatigue Assessment Instrument (FAI)), 18 (2) disease-specific quality of life (QOL) (total score on the Multiple Sclerosis Impact Scale, V.1 (MSIS-29, V.1)) 19 and (3) self-efficacy for managing fatigue (Multiple Sclerosis-Fatigue Self-Efficacy scale—adapted from the Control subscale of the MS Self-Efficacy scale).",100.0
692,PRECIS-2,"Mindfulness-Based Intervention group (MBI) participants received daily Mindfulness training in the form of prerecorded sessions (6 sessions of 10 minutes each equal to one hour/day) using TailorBuilder application, aiming at developing awareness of emotions and sensations. Mindfulness practice took place individually at home six times per week, without any assistance.",fulltext,"Mindfulness-Based Intervention group (MBI) (n = 12) received daily Mindfulness training in the form of prerecorded sessions (6 sessions of 10 minutes each equal to one hour/day) using TailorBuilder (TB) application, aiming at developing awareness of emotions and sensations. Mindfulness practice took place individually at home six times per week, without any assistance.",97.02702702702702
692,PRECIS-2,Implementation Intention group (II) participants were asked to establish a concrete if-then plan (the ‘if ’ component followed by the ‘then’ component) once a week and share them through the TB application.,fulltext,Implementation Intention group (II) (n = 11) was asked to establish a concrete if-then plan (the ‘if ’ component 1 https://www.tailorbuilder.com/en/about.html followed by the ‘then’ component) once a week and share them through the TB application.,93.20388349514563
692,PRECIS-2,"Participant’s clinical characteristics are provided in Table 1. Instruments Demographic Information Age, gender, marital status (currently married vs. all other) and education level (in years) were all obtained from single-item queries.",fulltext,"Participant’s clinical characteristics are provided in Table 1. Instruments Demographic Information Age, gender, marital status (currently married vs. all other) and education level (in years) were all obtained from singleitem queries.",99.57627118644068
692,PRECIS-2,"The primary outcomes, fatigue, mobility and quality of life, were examined at baseline prior to randomization, and then 8-weeks after the intervention (following the online intervention).",fulltext,"The primary outcomes, fatigue, mobility and quality of life, were examined at baseline prior to randomization, and then 8-weeks after the intervention (following the online intervention).",100.0
692,PRECIS-2,"Participants were persevering in Physical Activity. Only, three of them dropped out the PA program before the end.",fulltext,"ic. Patients were persevering in Physical Activity. Only, three of them dropped out the PA program before the end.",95.6140350877193
692,PRECIS-2,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",fulltext,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",100.0
692,PRECIS-2,"This clinical and multicentric trial took place from July 2017 to January 2020, in two hospitals in the Parisian Region, France (Hospitals – CHI Poissy St Germain-en-Laye and R. Poincaré, Garches).",fulltext,"This clinical and multicentric trial took place from July 2017 to January 2020, in two hospitals in the Parisian Region, France (Hospitals – CHI Poissy St Germain-en-Laye and R. Poincaré, Garches).",100.0
692,PRECIS-2,A specialized trainer in adapted physical activity delivered experimental interventions and the telephone calls.,fulltext,A specialized trainer in adapted physical activity delivered experimental interventions and the telephone calls.,100.0
692,PRECIS-2,"Outcomes and information collected from the telephone calls sessions were recorded on a data sheet, different for each participant.",fulltext,"Outcomes and information collected from the telephone calls sessions were recorded on a data sheet, different for each participant.",100.0
692,PRECIS-2,"Participants were recruited and gave their written consent to participate to this study. Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors (3) aged between 18 and 65 (4) able to give informed consent and to understand French. We excluded those who were receiving drug treatment for fatigue started less than three months ago or acute hospital or nursing home, those who were having psychiatric disorders.",fulltext," were recruited and gave their written consent to participate to this study. Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors (3) aged between 18 and 65 (4) able to give informed consent and to understand French. We excluded those who were receiving drug treatment for fatigue started less than three months ago or acute hospital or nursing home, those who were having psychiatric disorders.",97.74436090225565
692,PRECIS-2,"In the Implementation Intention group, participants were able to modify their plans depending on their physical condition and availability. These plans were verified and approved by the trainer. Implementation Intention assessment was carried out weekly via internet questionnaire. Participants were asked to specify the number and duration of each session, sensations, facilitators, and barriers encountered to sustain their practice.",fulltext,". Participants were able to modify their plans depending on their physical condition and availability. These plans were verified and approved by the trainer. Implementation Intention assessment was carried out weekly via internet questionnaire. Participants also received a weekly telephone call lasted up to 15 min, during which a detailed report concerning the session(s) performed was reviewed and refined if required. Participants were asked to specify the number and duration of each session, sensations, facilitators, and barriers encountered to sustain their practice.",91.49425287356323
692,PRECIS-2,Individuals were approached by the study coordinator and asked if they would be willing to participate in it.,fulltext,Individuals were approached by the study coordinator and asked if they would be willing to participate in it.,100.0
692,PRECIS-2,"Of the 35 patients, 25 were diagnosed with relapsing-remitting MS: 7 in II group; 8 in MBI group and 10 in the CG (control group); three were diagnosed with primary progressive MS: 1 in II group 1 in MBI group and 1 in the CG; seven were diagnosed with secondary progressive MS: 3 in II group; 3 in MBI group and 1 in the CG. They had a mean score of disability of [3.24, Expanded Disability Status Scale (EDSS)<5.5] and were able to consult at the outpatient clinic. Patients were persevering in Physical Activity.",fulltext,"Of the 35 patients, 25 were diagnosed with relapsingremitting MS: 7 in II group; 8 in MBI group and 10 in the CG (control group); three were diagnosed with primary progressive MS: 1 in II group 1 in MBI group and 1 in the CG; seven were diagnosed with secondary progressive MS: 3 in II group; 3 in MBI group and 1 in the CG. They had a mean score of disability of [3.24, Expanded Disability Status Scale (EDSS)<5.5] and were Frontiers in Psychology | www.frontiersin.org 3 December 2021 | Volume 12 | Article 767784 Torkhani et al. Efficacy Psychological Interventions MS People able to consult at the outpatient clinic. Patients were persevering in Physical Activity.",99.80582524271846
692,PRECIS-2,"Two measurement times are carried out in pre-post intervention, at baseline and after eight weeks.",fulltext,"Two measurement times are carried out in pre-post intervention, at baseline and after eight weeks.",100.0
693,PRECIS-2,"We evaluated spasticity, cognitive function, mood and fatigue before and after both programs, that lasted 10 weeks, with standardized assessment methods.",fulltext,"We evaluated spasticity, cognitive function, mood and fatigue before and after both programs, that lasted 10 weeks, with standardized assessment methods.",100.0
693,PRECIS-2,"Data were analyzed by SPSS program for Windows®, version 17.0. Wilcoxon signed ranks test was used to compare the difference before and after each program. Statistical significance was set at p ≤ 0.05.",fulltext,"alysis Data were analyzed by SPSS program for Windows ® , version 17.0. Wilcoxon signed ranks test was used to compare the difference before and after each program. Statistical significance was set at p ",96.51741293532339
693,PRECIS-2,Yoga and SC might improve some of the MS symptoms and should be considered in the future as possible complementary treatments.,fulltext,Yoga and SC might improve some of the MS symptoms and should be considered in the future as possible complementary treatments.,100.0
693,PRECIS-2,"20 subjects with relapsing–remitting or progressive MS, 26–50 years of age, with EDSS ≤ 6 and EDSS pyramidal functions score (EDSSpyr) > 2 were enrolled in a randomized prospective study.",fulltext,"20 subjects with relapsing–remitting or progressive MS, 26–50 years of age, with EDSS ≤ 6 and EDSS pyramidal functions score (EDSSpyr) > 2 were enrolled in a randomized prospective study.",100.0
693,PRECIS-2,"The participants were randomly divided into SC and yoga group. We evaluated spasticity, cognitive function, mood and fatigue before and after both programs, that lasted 10 weeks, with standardized assessment methods.",fulltext,"The participants were randomly divided into SC and yoga group. We evaluated spasticity, cognitive function, mood and fatigue before and after both programs, that lasted 10 weeks, with standardized assessment methods.",100.0
693,PRECIS-2,"SC took place in the Training, Occupation and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee License. The climbing wall with an inclination of 90◦ and the height of 5 m was adjusted for patients with physical disabilities by adding numerous and bigger holds.",fulltext,"sions. SC took place in the Training, Occupation and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee License. The climbing wall with an inclination of 90 ◦ and the height of 5 m was adjusted for patients with physical disabilities by adding numerous and bigger",97.74193548387096
693,PRECIS-2,"Hatha yoga took place in the facilities of Institute of Rehabilitation, Republic of Slovenia. The program was adjusted for MS patients and was held by a MS specialist nurse who is a yoga instruc-tor with a license for patients with physical disabilities.",fulltext,"point. Hatha yoga took place in the facilities of Institute of Rehabilitation, Republic of Slovenia. The program was adjusted for MS patients and was held by a MS specialist nurse who is a yoga instructor with a license for patients with physical disabi",96.85039370078741
694,PRECIS-2,"Covariance analysis of the primary endpoint resulted in a mean difference in BBS change of 2.33 (95% confidence interval (CI): 0.03-4.63, p = 0.047) between intervention (n = 32) and control (n = 38) groups.",fulltext,"Covariance analysis of the primary endpoint resulted in a mean difference in BBS change of 2.33 (95% confidence interval (CI): 0.03-4.63, p = 0.047) between intervention (n = 32) and control (n = 38) groups.",100.0
694,PRECIS-2,"Patients who had received hippotherapy within the last 12 months, a body weight over 90 kg, no balance while sitting, and acute exacerbation during the 4-week period before start of the therapy were excluded.",fulltext,"Patients who had received hippotherapy within the last 12 months, a body weight over 90 kg, no balance while sitting, and acute exacerbation during the 4-week period before start of the therapy were excluded.",100.0
694,PRECIS-2,The hippotherapy for patients with multiple sclerosis (MS-HIPPO) trial is primarily based on the results of Hippotherapy for patients with multiple sclerosis: A multicenter randomized controlled trial (MS-HIPPO).,fulltext,The hippotherapy for patients with multiple sclerosis (MS-HIPPO) trial is primarily based on the results of Hippotherapy for patients with multiple sclerosis: A multicenter randomized controlled trial (MS-HIPPO).,100.0
694,PRECIS-2,The primary endpoint was the change in the Berg Balance Scale (BBS) after 12 weeks.,fulltext," Primary outcome was the change in the Berg Balance Scale (BBS) after 12 weeks,",89.1566265060241
694,PRECIS-2,Patients were recruited in five German centers and randomly allocated to the intervention group (12 weeks of hippotherapy) or the control group.,fulltext,S were recruited in five German centers and randomly allocated to the intervention group (12 weeks of hippotherapy) or the control group.,95.13888888888889
694,PRECIS-2,"In some trials, eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",prompt,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",99.63898916967509
694,PRECIS-2,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6-7 weeks (interim assessment) and after 12 weeks (final assessment).",fulltext,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6-7 weeks (interim assessment) and after 12 weeks (final assessment).",100.0
694,PRECIS-2,"Patients of the intervention group received hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR)) once a week for 12 weeks as an add-on therapy to their standard care, which remained unchanged.",fulltext,"Patients of the intervention group received hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR)) 8 once a week for 12 weeks as an addon therapy to their standard care, which remained unchanged.",99.62825278810409
694,PRECIS-2,MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS) score between 4 and 6.5 were eligible for inclusion.,fulltext,MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS) 9 score between 4 and 6.5 were eligible for inclusion.,100.0
694,PRECIS-2,"Over the study period, symptomatic drug treatment, immunotherapy, and physiotherapy were kept unchanged in both groups.",fulltext,"Over the study period, symptomatic drug treatment, immunotherapy, and physiotherapy were kept unchanged in both groups.",100.0
694,PRECIS-2,"The study was conducted at five sites in Germany, all of which have hippotherapy experience as stipulated by the rules of the German Consortium for Therapeutic Riding.",fulltext,"The study was conducted at five sites in Germany, all of which have hippotherapy experience as stipulated by the rules of the German Consortium for Therapeutic Riding.",100.0
695,PRECIS-2,"Within six weeks of the baseline visit, participants in the EG received an education visit from the research OT, who provided personalized advice and information based on the expert panel discussion, a tailored version of the standard information package, and a specially constructed leaflet offering information about the participant's condition and about self-help organizations.",fulltext,"Within six weeks of the baseline visit, participants in the EG received an education visit from the research OT, who provided personalized advice and information based on the expert panel discussion, a tailored version of the standard information package, and a specially constructed leaflet offering information about the participant's condition and about self-help organizations.",100.0
695,PRECIS-2,"In some trials, such as surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given.",prompt,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given,",96.7479674796748
695,PRECIS-2,"CoG participants raising any specific queries during the information visit were advised to consult routine sources of advice such as their GP, so as to avoid providing a personalized educational intervention.",fulltext,"CoG participants raising any specific queries during the information visit were advised to consult routine sources of advice such as their GP, so as to avoid providing a personalized educational intervention.",100.0
695,PRECIS-2,"Participants were recruited from general practices in Nottingham, including 53 with Parkinson's disease and 45 with multiple sclerosis.",fulltext,"Participants: One hundred and fourteen people with progressive neurological conditions recruited from general practices in Nottingham, including 53 with Parkinson's disease and 45 with multiple sclerosis,",99.25925925925925
695,PRECIS-2,"Participants were randomized to either the education group (EG) or the comparison group (CoG), within five diagnostic categories: MS, PD, Huntington's, motor neurone disease and other progressive neurological conditions.",fulltext,"participants were randomized to either the education group (EG) or the comparison group (CoG), within five diagnostic categories: MS, PD, Huntington's, motor neurone disease and other progressive neurological conditions.",100.0
695,PRECIS-2,We did not carry out a formal sample size determination. Our initial estimate was that we would recruit about 300 people in total.,fulltext,We did not carry out a formal sample size determination. Our initial estimate was that we would recruit about 300 people in total.,100.0
695,PRECIS-2,"Group comparisons were made by the chi-squared or Mann-Whitney U-tests. For comparisons over time, we used the Wilcoxon signed rank or the paired t -test.",fulltext,Group comparisons were made by the chi-squared or Mann-Whitney U-tests. For comparisons over time we used the Wilcoxon signed rank or the paired t -test.,99.35064935064936
695,PRECIS-2,Participants were assessed at baseline and 12 months later.,fulltext,Participants were assessed at baseline and 12 months later.,100.0
695,PRECIS-2,Each participant was allocated consecutively to a group by consulting a computer-generated random number series.,fulltext,Each participant was allocated consecutively to a group by consulting a computer-generated random number series.,100.0
695,PRECIS-2,"From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282000). Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",fulltext,"From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282000). Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",100.0
695,PRECIS-2,"In order to preserve a focus on primarily physical disabilities, dementing disorders such as Alzheimer's disease were not included.",fulltext,"In order to preserve a focus on primarily physical disabilities, dementing disorders such as Alzheimer's disease were not included.",100.0
695,PRECIS-2,"Information on adverse events was collected by phone at two-monthly intervals between baseline and 12-month assessments, when a general enquiry was made without specific reference to falls or sores.",fulltext,"Information on adverse events was collected by phone at two-monthly intervals between baseline and 12-month assessments, when a general enquiry was made without specific reference to falls or sores.",100.0
695,PRECIS-2,"All statistical tests employed were two-sided and were performed using SPSS version 9 (SPSS Inc, Chicago, IL, USA).",fulltext,"All statistical tests employed were two-sided and were performed using SPSS version 9 (SPSS Inc, Chicago, IL, USA).",100.0
695,PRECIS-2,Primary outcome measures were reports of one or more falls or skin sores.,fulltext,Primary outcome measures were reports of one or more falls or skin sores.,100.0
695,PRECIS-2,"The educational intervention consisted of a baseline assessment visit from a trained interviewer with no health or social care qualifications, followed by an education visit from a research occupational therapist who provided personalized advice and information based on the expert panel discussion.",fulltext,"ed an education visit from the research OT, who provided personalized advice and information based on the expert panel discussion,",42.47491638795987
695,PRECIS-2,"EG participants showed a significant rise in this score over the study period of 1.62 (95% Cl 0.69-2.55, p=0.002).",fulltext,"EG patients showed a significant rise in this score over the study period of 1.62 (95% Cl 0.69-2.55, p=0.002).",95.6140350877193
695,PRECIS-2,"The comparison group received the same baseline assessment as the EG, followed by an information package on generic services and condition-specific self-help organizations delivered to their home by the research OT.",fulltext, Comparison group procedures The CoG received the same baseline assessment as the EG. Six weeks later an information package on generic services and condition-specific self-help organizations was delivered to the home by the research OT.,93.95348837209302
695,PRECIS-2,"Participants whose clinical features appeared incompatible with the recorded diagnosis were excluded, as were those with neurological complications of primarily non-neurological conditions or additional causes of severe disability.",fulltext,"Participants whose clinical features appeared incompatible with the recorded diagnosis were excluded, as were those with neurological complications of primarily non-neurological conditions such as diabetes mellitus, or additional causes of severe disability.",100.0
696,PRECIS-2,"Fifty patients with relapsing MS, followed at the Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA, were enrolled in this study.",fulltext,"Fifty patients with relapsing MS, followed at the Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA, were enrolled in this study.",100.0
696,PRECIS-2,Participants who satisfied the inclusion criteria were randomised at baseline (week 0) to either the IDG or the TG according to a concealed computer-generated randomisation schedule.,fulltext,Participants who satisfied the inclusion criteria were randomised at baseline (week 0) to either the IDG or the TG according to a concealed computer-generated randomisation schedule.,100.0
696,PRECIS-2,"IDG: Patients who discontinued natalizumab therapy at once and initiated another DMT (interferon, GA therapy or an oral DMT-fingolimod, dimethyl fumarate or teriflunomide) at 1-6 months following the last natalizumab infusion (1-2 months for the injectable DMTs and 3-6 months for the oral DMTs) and tapered group (TG): patients administered two additional natalizumab infusions, one at 6 weeks and one at 8 weeks (14 weeks from study entry). Clinical and MRI assessments in this group were scheduled as 3, 6 and 12 months after their last natalizumab infusion.",fulltext,"IDG: Patients who discontinued natalizumab therapy at once and initiated another DMT (interferon, GA therapy or an oral DMTfingolimod, dimethyl fumatate or teriflunomide) at 1–6 months following the last natalizumab infusion (1–2 months for the injectable DMTs and 3–6 months for the oral DMTs) and tapered group (TG): patients administered two additional natalizumab infusions, one at 6 weeks and one at 8 weeks (14 weeks from study entry). Clinical and MRI assessments in this group were scheduled as 3, 6 and 12 months after their last natalizumab infusion.",99.64349376114082
696,PRECIS-2,Candidates were excluded from the study if active disease was identified at baseline per clinical (presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).,fulltext,Candidates were excluded from the study if active disease was identified at baseline per clinical ( presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).,100.0
696,PRECIS-2,"Standardised MRI was performed at baseline, 6 and 12 months from the last natalizumab infusion.",fulltext,"Standardised MRI was performed at baseline, 6 and 12 months from the last natalizumab infusion.",100.0
696,PRECIS-2,Fifty relapsing patients with multiple sclerosis (MS) who had been on natalizumab therapy ≥24 months and were contemplating natalizumab discontinuation were enrolled.,fulltext,Fifty relapsing patients with multiple sclerosis (MS) who had been on natalizumab therapy ≥24 months and were contemplating natalizumab discontinuation were enrolled.,100.0
696,PRECIS-2,"The following sequences were acquired with consistent voxel size (48 slices at 3 mm slice thickness, field of view (FOV)=25.6 cm, and matrix=256×256): two-dimensional dual fast spin echo proton density (PD)/T2; fluid-attenuated inversion recovery; and spin echo T1 with and without using a single-dose intravenous bolus gadolinium (Gd-DTPA, 0.1 mmol/kg). In addition, three-dimensional high-resolution T1-weighted image (WI) using a fast spoiled gradient echo (FSPGR) with magnetisation-prepared inversion recovery pulse was also acquired (echo time (TE)/inversion time (TI)/repetition time (TR)=2.8/900/5.9 ms, flip angle=10°) using 184 1 mm slices, resulting in isotropic resolution.",fulltext,"The following sequences were acquired with consistent voxel size (48 slices at 3 mm slice thickness, field of view (FOV)=25.6 cm, and matrix=256×256): two-dimensional dual fast spin echo proton density (PD)/T2; fluid-attenuated inversion recovery; and spin echo T1 with and without using a single-dose intravenous bolus gadolinium (Gd-DTPA, 0.1 mmol/kg). In addition, threedimensional high-resolution T1-weighted image (WI) using a fast spoiled gradient echo (FSPGR) with magnetisation-prepared inversion recovery pulse was also acquired (echo time (TE)/inversion time (TI)/repetition time (TR)=2.8/900/5.9 ms, flip angle=10°) using 184 1 mm slices, resulting in isotropic resolution.",99.85401459854015
696,PRECIS-2,"Participants were randomised to either the immediate discontinuation group (IDG) or the tapered group (TG). IDG discontinued natalizumab at once and initiated another disease modifying therapy (DMT) following the last natalizumab infusion, while the TG received two more natalizumab infusions, at 6 and 8 weeks (14 weeks from study entry) before initiating another DMT.",fulltext,"Participants were randomised to either the immediate discontinuation group (IDG) or the tapered group (TG). IDG discontinued natalizumab at once and initiated another disease modifying therapy (DMT) following the last natalizumab infusion, while the TG received two more natalizumab infusions, at 6 and 8 weeks (14 weeks from study entry) before initiating another DMT.",100.0
697,PRECIS-2,The center- and home-based groups completed an 8-week progressive functional and balance training exercise program.,fulltext,The center- and home-based groups completed an 8-week progressive functional and balance training exercise program.,100.0
697,PRECIS-2,The center-based groups of four to six were supervised by a physiotherapist. The home-based group was provided with telephone support.,fulltext,The center-based groups of four to six were supervised by a physiotherapist. The home-based group was provided with telephone support.,100.0
697,PRECIS-2,The primary outcome was gait speed (10-meter walk test).,fulltext,The primary outcome was gait speed (10-meter walk test).,100.0
705,PRECIS-2,"The Hockey FIT program was delivered over 12 weekly, 90-min sessions by Hockey FIT coaches (coach to participant ratio 2:20) from the central research team.",fulltext,"The Hockey FIT program was delivered over 12 weekly, 90-min sessions by Hockey FIT coaches (coach to participant ratio 2:20) from the central research team ",100.0
705,PRECIS-2,"Participants were encouraged to continue with their lifestyle prescriptions and sustain their behavior changes with the support of free-of-charge eHealth tools: 1) HealtheSteps smartphone app providing tools to track and sustain PA (<www.healthesteps.ca>) and 2) Hockey FIT social network, a secure Web-based network tailored to each site and including only group members and coaches.",fulltext,"Participants were encouraged to continue with their lifestyle prescriptions and sustain their behavior changes with the support of free-ofcharge eHealth tools: 1) HealtheSteps smartphone app providing tools to track and sustain PA (www.healthesteps.ca) and 2) Hockey FIT social network, a secure Web-based network tailored to each site and including only group members and coaches.",99.21875
705,PRECIS-2,The planned primary outcome for the definitive trial was the difference between groups in mean weight loss (kg) and percentage weight change from baseline to 12 wk.,fulltext,The planned primary outcome for the definitive trial was the difference between groups in mean weight loss (kg) and percentage weight change from baseline to 12 wk.,100.0
705,PRECIS-2,"Twice throughout the program, participants completed the validated Step Test and Exercise Prescription to receive a personalized target heart rate to strive for during aerobic activities (22).",fulltext,"Twice throughout the program, participants completed the validated Step Test and Exercise Prescription to receive a personalized target heart rate to strive for during aerobic activities (22).",100.0
705,PRECIS-2,"Recruitment occurred using a variety of methods (e.g., hockey team e-mail blasts and social media accounts, study Web site (<http://hockeyfansintraining.org/>), posters, traditional media advertisements, word of mouth, direct contact at team arena).",fulltext,"Recruitment occurred using a variety of methods (e.g., hockey team e-mail blasts and social media accounts, study Web site (http://hockeyfansintraining.org/), posters, traditional media advertisements, word of mouth, direct contact at team arena).",99.19678714859438
705,PRECIS-2,"Measurement at baseline and 12 wk (both groups) and 12 months (intervention group only) included clinical outcomes (e.g., weight) and self-reported physical activity, diet, and self-rated health.",fulltext,"Measurement at baseline and 12 wk (both groups) and 12 months (intervention group only) included clinical outcomes (e.g., weight) and self-reported physical activity, diet, and self-rated health.",100.0
705,PRECIS-2,"Incentives were also provided as part of the program to encourage program at-tendance and engagement (e.g., free promotional materials from hockey teams and attendance raffle for hockey-related prizes held during session 12).",fulltext,"Incentives were also provided as part of the program to encourage program attendance and engagement (e.g., free promotional materials from hockey teams and attendance raffle for hockey-related prizes held during session 12).",99.55555555555556
705,PRECIS-2,"Blinded assessor conducted weight measurements in a separate, private area, to reduce the likelihood that group allocation would be revealed.",fulltext,"blinded assessor conducted weight measurements in a separate, private area, to reduce the likelihood that group allocation would be revealed.",100.0
705,PRECIS-2,"Program sessions com-prised the following: 1) classroom-based teaching of behavior change techniques and simple information sharing on PA and healthy eating, delivered to encourage participant interaction and mutual learning, and 2) exercise sessions where men performed aerobic, strength, and flexibility exercises, incorporating their passion for hockey off the ice.",fulltext,"Program sessions comprised the following: 1) classroom-based teaching of behavior change techniques and simple information sharing on PA and healthy eating, delivered to encourage participant interaction and mutual learning, and 2) exercise sessions where men performed aerobic, strength, and flexibility exercises, incorporating their passion for hockey off the ice.",99.72826086956522
705,PRECIS-2,"We used a pragmatic approach for the program venue at each site, using a combination of the hockey team_s arena and an affiliated health club facility.",fulltext,"We used a pragmatic approach for the program venue at each site, using a combination of the hockey team_s arena and an affiliated health club facility.",100.0
705,PRECIS-2,"Across both sites, the most successful methods of recruitment in-cluded communication from the hockey team via e-mail or social media (e.g., Twitter) and word of mouth, where 40% and 36% of men were recruited, respectively.",fulltext,"Across both sites, the most successful methods of recruitment included communication from the hockey team via e-mail or social media (e.g., Twitter) and word of mouth, where 40% and 36% of men were recruited, respectively.",99.55156950672645
712,PRECIS-2,The acupressure was applied on the sanyinjiao point during the contractions for 20 minutes.,fulltext,The acupressure was applied on the sanyinjiao point during the contractions for 20 minutes.,100.0
712,PRECIS-2,The primary outcome was to analyze the effects of acupressure on the SP6 point for the pain in child birth for expectant mothers in public maternity units.,fulltext, was to analyze the effects of acupressure on the SP6 point for the pain in child birth for expectant mothers in public maternity units.,87.74193548387098
712,PRECIS-2,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",prompt,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",100.0
712,PRECIS-2,"We included expectant mothers of different ages and states from the 37th week in where child birth was expected any time (induced or conduced) having: dilations at ≥ 4 cm, two or more contractions in 10 minutes, skin covering the whole of the SP6 bilateral point and with a live fetus with a cephalic vertex and in good condition.",fulltext,"We included expectant mothers of different ages and states from the 37th week in where child birth was expected any time (induced or conduced) having: dilations at ≥ 4 cm, two or more contractions in 10 minutes, skin covering the whole of the SP6 bilateral point and with a live fetus with a cephalic vertex and in good condition.",100.0
712,PRECIS-2,"We selected 156 pregnant women in their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes.",fulltext,"We selected 156 pregnant women in their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes.",100.0
712,PRECIS-2,"The pregnant women were randomly divided into three groups at a university hospital in the suburbs of Sao Paulo, Brazil, in order to receive either acupressure treatment, a placebo or participate as part of a control group.",fulltext,"The pregnant women were randomly divided into three groups at a university hospital in the suburbs of Sao Paulo, Brazil, in order to receive either acupressure treatment, a placebo or participate as part of a control group.",100.0
712,PRECIS-2,"The intensity of the pain was evaluated using the Visual Analogue Scale (VAS) immediately after the treatment (VAS20) and 60 minutes after the treatment, once consent had been given by the pregnant women in labor to participate in the study.",fulltext," immediately after the treatment (VAS20) and 60 minutes after the treatment, once consent had been given by the pregnant women in labor to participate in the study.",68.04979253112033
713,PRECIS-2,"Data collection was carried out by research nurses. An invitation letter signed by the patient’s physician was sent to potential participants explaining that the study was a clinical, family trial and that as a client of the physician, the person had been identified as a possible participant and that in addition, participation by a close family member was requested.",fulltext,"Data collection was carried out by research nurses. An invitation letter signed by the patient’s physician was sent to potential participants explaining that the study was a clinical, family trial and that as a client of the physician, the person had been identified as a possible participant and that in addition, participation by a close family member was requested.",100.0
713,PRECIS-2,The sample size was determined from a paired comparison in either experimental or control group as there was particular interest in changes within a group between two time points.,fulltext,The sample size was determined from a paired comparison in either experimental or control group as there was particular interest in changes within a group between two time points.,100.0
713,PRECIS-2,The treatment site was a clinical research centre located on a university-hospital campus.,fulltext,The treatment site was a clinical research centre located on a university-hospital campus.,100.0
713,PRECIS-2,Data collection lasted from June 2009–March 2013.,fulltext,Data collection lasted from June 2009–March 2013.,100.0
713,PRECIS-2,Data collection was carried out in the experimental group at month 6 after the last treatment session.,fulltext,Data collection was carried out in the experimental group at month 6 after the last treatment session.,100.0
713,PRECIS-2,"Data were collected at baseline and at month 12. Additionally, data collection was carried out in the experimental group at month 6 after the last treatment session.",fulltext,"Data were collected at baseline and at month 12. Additionally, data collection was carried out in the experimental group at month 6 after the last treatment session.",100.0
713,PRECIS-2,The intervention was an addition to traditional health care which the control group received.,fulltext,The intervention was an addition to traditional health care which the control group received.,100.0
713,PRECIS-2,The aim of this study was to evaluate the effectiveness of a partnership-based self-management programme for patients with mild and moderate COPD.,fulltext,The aim of this study was to evaluate the effectiveness of a partnership-based self-management programme for patients with mild and moderate COPD.,100.0
713,PRECIS-2,Participants were invited from primary healthcare settings and the offices of private lung physicians in the Reykjavik capital area of Iceland.,fulltext,Participants All potentially relevant patients (n = 291) were contacted for enrolment in the study from primary healthcare settings (n = 8) and the offices of private lung physicians (n = 6) in the Reykjavik capital area of Iceland.,98.6013986013986
713,PRECIS-2,The intervention was provided for 6 months with a subsequent follow-up for additional 6 months. The control group received usual care.,fulltext,The intervention was provided for 6 months with a subsequent follow-up for additional 6 months. The control group received usual care.,100.0
713,PRECIS-2,"The theoretical framework, Partnership with people with COPD and their families (Ingadottir & Jonsdottir 2010, Jonsdottir & Ingadottir 2011a,b), was the basis for this intervention.",fulltext,"The theoretical framework, Partnership with people with COPD and their families (Ingadottir & Jonsdottir 2010, Jonsdottir & Ingadottir 2011a,b), was the basis for this intervention.",100.0
713,PRECIS-2,"Participants were advised to use first line medication; Nicotine Replacement Therapy, Bupropion and Varenicline. If used, they would pay for them.",fulltext,"Participants were advised to use first line medication; Nicotine Replacement Therapy, Bupropion and Varenicline. If used, they would pay for them.",100.0
713,PRECIS-2,"Excluded were individuals who had another major disease, who were non-Icelandic speaking, not capable of travelling to the treatment site and those who had participated in a structured rehabilitation programme for people with COPD 6 months prior to the screening.",fulltext,"Excluded were individuals who had another major disease (among them individuals with asthma who had more than 200 ml or 12% increase in FEV 1 after inhalation of 200 lg albuterol in the postbronchodilator spirometry), who were non-Icelandic speaking, not capable of travelling to the treatment site and those who had participated in a structured rehabilitation programme for people with COPD 6 months prior to the screening.",100.0
714,PRECIS-2,Clinical care and follow up were the same as for the intervention group but without a telephone option.,fulltext,Clinical care and follow up were the same as for the intervention group but without a telephone option.,100.0
714,PRECIS-2,Follow up questionnaires on morbidity and satisfaction with the consultation were sent to the patients at three months.,fulltext,Follow up questionnaires on morbidity and satisfaction with the consultation were sent to the patients at three months.,100.0
714,PRECIS-2,"Primary outcome measures were the proportion of participants who were reviewed within three months of randomisation and disease specific quality of life, as measured by the Juniper mini asthma quality of life questionnaire.",fulltext,"Primary outcome measures were the proportion of participants who were reviewed within three months of randomisation and disease specific quality of life, as measured by the Juniper mini asthma quality of life questionnaire.",100.0
714,PRECIS-2,"Details about the consultation, including failed attempts at phone calls and the duration of the consultation, were recorded immediately after the review on a piloted consultation record.",fulltext,"Details about the consultation, including failed attempts at phone calls and the duration of the consultation, were recorded immediately after the review on a piloted consultation record.",100.0
714,PRECIS-2,The trial’s primary outcome was to determine whether routine review by telephone of patients with asthma improves access and is a good alternative to face to face reviews in general practices.,fulltext, To determine whether routine review by telephone of patients with asthma improves access and is a good alternative to face to face reviews in general practices.,83.85416666666666
714,PRECIS-2,Participants were older than the overall eligible population (mean age 55.5 versus 48.6 years; P < 0.001).,fulltext,Participants were older than the overall eligible population (mean age 55.5 versus 48.6 years; P < 0.001).,100.0
714,PRECIS-2,Patients were free to arrange any consultations they wished.,fulltext,Patients were free to arrange any consultations they wished.,100.0
714,PRECIS-2,From their computerised asthma registers the practices identified adults (>18 years) who had asked for a bronchodilator inhaler prescription in the previous 6 months but who had not had a routine asthma review in the preceding 11 months.,fulltext,From their computerised asthma registers the practices identified adults (>18 years) who had asked for a bronchodilator inhaler prescription in the previ,64.55696202531645
714,PRECIS-2,Nurses arranged any follow up consultations (whether in the surgery or by telephone) they deemed clinically necessary.,fulltext,Nurses arranged any follow up consultations (whether in the surgery or by telephone) they deemed clinically necessary.,100.0
714,PRECIS-2,All four general practices that took part in the study had nurses who were trained and experienced in providing proactive asthma care.,fulltext,All four general practices that took part in the study had nurses who were trained and experienced in providing proactive asthma care.,100.0
714,PRECIS-2,We wrote to all eligible patients inviting them to take part in the study.,fulltext,We wrote to all eligible patients inviting them to take part in the study.,100.0
714,PRECIS-2,Nurses were told to make up to four attempts to contact the patient by phone.,fulltext,Nurses were told to make up to four attempts to contact the patient by phone.,100.0
714,PRECIS-2,"An 80% power, at the 5% significance level (two tailed test), of detecting a 20% difference in the proportion of patients reviewed required 206 patients.",fulltext,"An 80% power, at the 5% significance level (two tailed test), of detecting a 20% difference in the proportion of patients reviewed ",85.62091503267975
714,PRECIS-2,Participants were randomised to either telephone review or face to face consultation with the asthma nurse.,fulltext,Participants were randomised to either telephone review or face to face consultation with the asthma nurse.,100.0
714,PRECIS-2,We used Student’s t test to compare normally distributed continuous data and the Mann-Whitney U test to compare non-parametric data.,fulltext,We used Student’s t test to compare normally distributed continuous data and the Mann-Whitney U test to compare non-parametric data.,100.0
714,PRECIS-2,The trial was conducted in four general practices in England.,fulltext,d trial. Setting Four general practices in England.,75.40983606557377
714,PRECIS-2,Three months after randomisation the two groups did not differ in the Juniper score (risk difference − 0.07 (95% confidence interval − 0.40 to 0.27)) or in satisfaction with the consultation (risk difference − 0.07 ( − 0.27 to 0.13)).,fulltext,Three months after randomisation the two groups did not differ in the Juniper score (risk difference − 0.07 (95% confidence interval − 0.40 to 0.27) or in satisfaction with the consultation (risk difference − 0.07 ( − 0.27 to 0.13)).,99.57264957264957
714,PRECIS-2,Nurses were given no instructions about the content of the review except that it should reflect their normal practice and be appropriate to each patient’s clinical need.,fulltext,Nurses were given no instructions about the content of the review except that it should reflect their normal practice and be appropriate to each patient’s clinical need.,100.0
714,PRECIS-2,"Patients were excluded if the diagnosis of asthma had been made within the previous year, if they had chronic obstructive pulmonary disease, if communication difficulties made a telephone consultation impossible, or (at the general practitioner’s request) for major social or medical reasons.",fulltext,"Patients were excluded if the diagnosis of asthma had been made within the previous year, if they had chronic obstructive pulmonary disease, if communication difficulties made a telephone consultation impossible, or (at the general practitioner’s request) for major social or medical reasons.",100.0
715,PRECIS-2,"After gaining patient consent, demographics and disease activity score in 28 joints (DAS28), patients were randomly assigned using a remote secure telephone randomisation service provided by Leeds University Clinical Trials Research Unit.",fulltext,"After gaining patient consent, demographics and disease activity score in 28 joints (DAS28), patients were randomly assigned using a remote secure telephone randomisation service provided by Leeds University Clinical Trials Research Unit.",100.0
715,PRECIS-2,"The rheumatologists and CNS delivering the interventions did not have any special training as they were expected to undertake their 'normal' practice, having agreed to follow the study protocol.",fulltext,"The rheumatologists and CNS delivering the interventions did not have any special training as they were expected to undertake their 'normal' practice, having agreed to follow the study protocol.",100.0
715,PRECIS-2,"The NLC interventions usually include allocated 30-min time slots in which the CNS takes history, performs physical examination, pain control, prescribing or recommending medication and dosage changes, intra-articular or intramuscular steroid injections, provision of patient education, psychosocial support and ordering blood tests or X-rays.",fulltext,"The NLC interventions usually include allocated 30-min time slots in which the CNS takes history, performs physical examination, pain control, prescribing or recommending medication and dosage changes, intra-articular or intramuscular steroid injections, provision of patient education, psychosocial support and ordering blood tests or X-rays.",100.0
715,PRECIS-2,"Participants were 181 adults with RA randomly assigned to either NLC or rheumatologist-led care (RLC), both arms carrying out their normal practice.",fulltext,"Participants were 181 adults with RA randomly assigned to either NLC or rheumatologist-led care (RLC), both arms carrying out their normal practice.",100.0
715,PRECIS-2,"The primary outcome was the disease activity score (DAS28) assessed at baseline, weeks 13, 26, 39 and 52; the non-inferiority margin being DAS28 change of 0.6.",fulltext,"The primary outcome was the disease activity score (DAS28) assessed at baseline, weeks 13, 26, 39 and 52; the non-inferiority margin being DAS28 change of 0.6.",100.0
715,PRECIS-2,The study was conducted in outpatient clinics of 10 rheumatology centres across the UK.,fulltext,The study was conducted in outpatient clinics of 10 rheumatology centres across the UK.,100.0
715,PRECIS-2,"The interventions did not have any special training as they were expected to undertake their 'normal' practice, having agreed to follow the study protocol.",fulltext,"The interventions did not have any special training as they were expected to undertake their 'normal' practice, having agreed to follow the study protocol.",100.0
715,PRECIS-2,"Referrals for ward admissions, to the rheumatologist or other health professionals, were carried out as appropriate.",fulltext,"Referrals for ward admission, to the rheumatologist or other health professionals, were carried out as appropriate.",99.13793103448276
715,PRECIS-2,"The health economic questionnaire including EuroQoL (EQ5D) and healthcare resource data were collected at weeks 0, 13, 26, 39 and 52.",fulltext,"The health economic questionnaire including EuroQoL (EQ5D) 36 and healthcare resource data were collected at weeks 0, 13, 26, 39 and 52.",100.0
715,PRECIS-2,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",prompt,"In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.",100.0
715,PRECIS-2,The primary endpoint shows that NLC was not inferior to RLC at any follow-up time point. This suggests that NLC could manage most RA patients without loss of efficacy in terms of disease activity.,fulltext,The primary endpoint shows that NLC was not inferior to RLC at any follow-up time point. This suggests that NLC could manage most RA patients without loss of efficacy in terms of disease activity.,100.0
715,PRECIS-2,"The independent assessors, performing the joint counts for DAS28, were masked.",fulltext,"The independent assessors, performing the joint counts for DAS28, were masked.",100.0
715,PRECIS-2,"Ninety-two per cent (83/90) of patient under NLC attended all five clinic sessions, with a mean total consultation time of 111 min compared to 85% (77/91) of the RLC group who had a mean total consultation time of 71 min.",fulltext,"Ninety-two per cent (83/90) of patient under NLC attended all five clinic sessions, with a mean total consultation time of 111 min compared to 85% (77/91) of the RLC group who had a mean total consultation time of 71 min.",100.0
715,PRECIS-2,"When patients arrived at the clinic, the independent assessor performed 'joint counts' for DAS28 and then oversaw the completion of self-reported pain visual analogue scale (pain-VAS), fatigue-VAS and duration of morning stiffness.",fulltext,"When patients arrived at the clinic, the independent assessor performed ‘joint counts’ for DAS28 and then oversaw the completion of self-reported pain visual analogue scale (pain-VAS), fatigue-VAS and duration of morning stiffness.",100.0
715,PRECIS-2,The economic evaluation (NHS and healthcare perspectives) estimated cost relative to change in DAS28 and quality-adjusted life-years (QALY) derived from EQ5D.,fulltext,The economic evaluation (NHS and healthcare perspectives) estimated cost relative to change in DAS28 and quality-adjusted life-years (QALY) derived from EQ5D.,100.0
715,PRECIS-2,Evaluation focused on the incremental cost-effectiveness ratio—ratio of the mean difference in cost to the mean difference in effect (denoting the extra average cost per unit gain in effect); or otherwise dominance of one treatment over the other with respect to lower mean cost and greater mean effect.,fulltext,-up). Evaluation focused on the incremental cost-effectiveness ratio—ratio of the mean difference in cost to the mean difference in effect (denoting the extra average cost per unit gain in effect); or otherwise dominance of one treatment over the other with respect to lower mean cost and greater mean e,98.01980198019803
715,PRECIS-2,"The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria), age 18 years or older and the ability to complete questionnaires unaided.",fulltext,"The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria), 29 age 18 years or older and the ability to complete questionnaires unaided.",100.0
715,PRECIS-2,The null hypothesis of zero difference was used in testing patient satisfaction and cost.,fulltext,The null hypothesis of zero difference was used in testing patient satisfaction and cost.,100.0
715,PRECIS-2,"The role components of NLC include an assessment of disease activity, monitoring effects of therapy, prescribing or recommending medication or dosage changes including intramuscular/intra-articular steroid injections, provision of patient education, psychological support, providing patients with a contactable knowledgeable and accessible professional through telephone advice lines, coordinating complex care and referring to other health professionals.",fulltext,"The role components of NLC include an assessment of disease activity, monitoring effects of therapy, prescribing or recommending medication or dosage changes including intramuscular/ intra-articular steroid injections, provision of patient education, psychological support, providing patients with a contactable knowledgeable and accessible professional through telephone advice lines, coordinating complex care and referring to other health professionals.",100.0
715,PRECIS-2,"The improvement in disease activity (change in DAS28) over follow-up was better in the NLC group than the RLC group, and significance for non-inferiority was reached in the PP and ITT analyses at all individual follow-up time points and for the primary endpoint (ie, average DAS change).",fulltext,"The improvement in disease activity (change in DAS28) over follow-up was better in the NLC group than the RLC group, and significance for non-inferiority was reached in the PP and ITT analyses at all individual follow-up time points and for the primary endpoint (ie, average DAS change).",100.0
715,PRECIS-2,"All interventions, referrals and the duration of the consultations were recorded in a standard 'consultation checklist' designed for this study.",fulltext,"All interventions, referrals and the duration of the consultation were recorded in a standard ‘consultation checklist’ designed for this study.",99.30555555555556
715,PRECIS-2,The economic evaluation addressed both cost-effectiveness analysis (in relation to the ΔDAS28) and cost utility (in relation to quality-adjusted life-years (QALY) derived from area under the curve calculation of the EQ5D from baseline to last follow-up).,fulltext," health economic evaluation addressed both cost-effectiveness analysis (in relation to the 1976 Ndosi M, et al. Ann Rheum Dis 2014;73:1975–1982. doi:10.1136/annrheumdis-2013-203403 Clinical and epidemiological research copyright. on July 17, 2023 at University of Basel. Protected by http://ard.bmj.com/ Ann Rheum Dis: first published as 10.1136/annrheumdis-2013-203403 on 27 August 2013. Downloaded from ΔDAS28) and cost utility (in relation to quality-adjusted lifeyears (QALY) derived from area under the curve calculation of the EQ5D from baseline to last follo",96.85039370078741
715,PRECIS-2,The CNS have experience in running nurse-led clinics and usually have a postgraduate qualification in rheumatology nursing and/or prescribing.,fulltext,The CNS have experience in running nurse-led clinics and usually have a postgraduate qualification in rheumatology nursing and/ or prescribing.,100.0
722,PRECIS-2,A total of 623 participants were randomized from 33 centres (12 Aboriginal Medical Services) between January 2010 and May 2012.,fulltext,A total of 623 participants were randomized from 33 centres (12 Aboriginal Medical Services) between 9,79.52755905511812
722,PRECIS-2,"Prescription and dispensing of the polypill occurred in the same way as for other medications. This mostly involved doctors providing patients with written prescriptions, and patients presenting the prescriptions to designated local pharmacies where all drugs (including the polypill) were dispensed.",fulltext,"Prescription and dispensing of the polypill occurred in the same way as for other medications. This mostly involved doctors providing patients with written prescriptions, and patients presenting the prescriptions to Patel et al. 921 Downloaded from https://academic.oup.com/eurjpc/article/22/7/920/5927084 by Inactive user on 17 July 2023 designated local pharmacies where all drugs (including the polypill) were dispensed.",100.0
722,PRECIS-2,"Those allocated to the polypill-based strategy were prescribed one of the polypills at the discretion of their doctor, to be taken at a time suggested by the doctor. No attempt was made to influence any other aspect of their management.",fulltext,"Those allocated to the polypill-based strategy were prescribed one of the polypill versions at the discretion of their doctor, to be taken at a time suggested by the doctor. No attempt was made to influence any other aspect of their management.",100.0
722,PRECIS-2,"Participants randomized to the ‘polypill-based strategy’ received a polypill containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg and either atenolol 50 mg or hydrochlorothiazide 12.5 mg. Participants randomized to ‘usual care’ continued with separate medications and doses as prescribed by their doctor.",fulltext,"Participants randomized to the ‘polypill-based strategy’ received a polypill containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg and either atenolol 50 mg or hydrochlorothiazide 12.5 mg. Participants randomized to ‘usual care’ continued with separate medications and doses as prescribed by their doctor.",100.0
722,PRECIS-2,"Out-of-pocket expenses for the polypill were incurred identically to those for any other drug listed in the Pharmaceutical Benefits Scheme, which is the government subsidy programme through which most drugs are obtained in Australia.",fulltext,"Out-of-pocket expenses for the polypill were incurred identically to those for any other drug listed in the Pharmaceutical Benefits Scheme, which is the government subsidy programme through which most drugs are obtained in Australia.",100.0
722,PRECIS-2,"Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter. All participants were also reviewed one month post-randomization and at intervening six month intervals, but these could be conducted by telephone.",fulltext,"Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter. All participants were also reviewed one month post-randomization and at intervening six month intervals, but these could be conducted by telephone.",100.0
722,PRECIS-2,"At one extreme, patients ineligible for any concessions were charged the standard co-payment (approximately AUD$35/month for each medication). At the other extreme, the polypill was dispensed without charge at Indigenous health services operating under the Section 100 scheme of the National Health Act.",fulltext,"At one extreme, patients ineligible for any concessions were charged the standard co-payment (approximately AUD$35/month for each medication). At the other extreme, the polypill was dispensed without charge at Indigenous health services operating under the Section 100 scheme of the National Health Act.",100.0
722,PRECIS-2,"Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and 2 BP lowering therapies for 4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.",fulltext,"Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and 2 BP lowering therapies for 4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.",100.0
722,PRECIS-2,"The doctor could, at any time, change prescription to the alternative polypill version, add drugs on top of the polypill, or withdraw the polypill and substitute individual drugs of their choice.",fulltext,"The doctor could, at any time, change prescription to the alternative polypill version, add drugs on top of the polypill, or withdraw the polypill and substitute individual drugs of their choice.",100.0
722,PRECIS-2,All participants were treated by their regular doctor following randomization. No attempt was made to influence the management of usual care participants.,fulltext,All participants were treated by their regular doctor following randomization. No attempt was made to influence the management of usual care participants.,100.0
722,PRECIS-2,"The relative risk of self-reported use of combination treatment at study end was calculated using log-binomial regression including randomized treatment. Analyses of change in systolic BP and total cholesterol were conducted using longitudinal linear mixed models including all values collected during follow-up. Models included treatment, visit, treatment-by-visit interaction, and the baseline systolic BP or total cholesterol. Correlations between repeated measurements were modelled using a compound-symmetry structure.",fulltext,"The relative risk of self-reported use of combination treatment at study end was calculated using log-binomial regression including randomized treatment. Analyses of change in systolic BP and total cholesterol were conducted using longitudinal linear mixed models including all values collected during follow-up. Models included treatment, visit, treatment-by-visit interaction, and the baseline systolic BP or total cholesterol. Correlations between repeated measurements were modelled using a compound-symmetry structure.",100.0
722,PRECIS-2,"BP (measured with the Omron 705CP II device) and fasting lipids (measured at local laboratories) levels were obtained at baseline, 12 months, 24 months and the final visit.",fulltext,"BP (measured with the Omron 705CP II device) and fasting lipids (measured at local laboratories) levels were obtained at baseline, 12 months, 24 months and the final visit.",100.0
722,PRECIS-2,"Each participant had to have, in their doctor’s view, indications for all and no contra-indications to any component of at least one of two polypills – version 1 (containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg, atenolol 50 mg) or version 2 (containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg, hydrochlorothiazide 12.5 mg). Participants were excluded if it was felt clinically inappropriate to alter medications.",fulltext,"Each participant had to have, in their doctor’s view, indications for all and no contraindications to any component of at least one of two polypills – version 1 (containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg, atenolol 50 mg) or version 2 (containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg, hydrochlorothiazide 12.5 mg). Participants were excluded if it was felt clinically inappropriate to alter medications.",99.77116704805492
722,PRECIS-2,The study specifically included a substantial number of Indigenous Australians attending Aboriginal Medical Services.,fulltext, study specifically included a substantial number of Indigenous Australians attending Aboriginal Medical Services.,97.43589743589743
725,PRECIS-2,The primary clinical analyses were repeated by a second blinded statistician using different statistical software.,fulltext,The primary clinical analyses were repeated by a second blinded statistician using different statistical software.,100.0
725,PRECIS-2,"It was emphasized that good standards of care, both surgical and nonsurgical, should be provided throughout the treatment pathway for the injury, including surgical care or management of the sling, postoperative care, and rehabilitation in both groups.",fulltext,"It was emphasized that good standards of care, both surgical and nonsurgical, should be provided throughout the treatment pathway for the injury, including surgical care or management of the sling, postoperative care, and rehabilitation in both groups.",100.0
725,PRECIS-2,Participating hospitals did not introduce new or experimental interventions for these fractures during the study.,fulltext,Participating hospitals did not introduce new or experimental interventions for these fractures during the study.,100.0
725,PRECIS-2,"The PROFHER collaborators recruited patients for this pragmatic, open, multicenter, parallel-group, superiority, randomized clinical trial between September 2008 and April 2011 from orthopedic departments (fracture clinics or wards) at 32 acute UK National Health Service hospitals.",fulltext,"The PROFHER collaborators recruited patients for this pragmatic, open, multicenter, parallel-group, superiority, randomized clinical trial between September 2008 and April 2011 from orthopedic departments (fracture clinics or wards) at 32 acute UK National Health Service hospitals.",100.0
725,PRECIS-2,All analyses were on an intention-to-treat basis and included all randomized patients in the groups to which they were randomized. Significance tests were 2-sided at the 5% significance level.,fulltext,All analyses were on an intention-to-treat basis and included all randomized patients in the groups to which they were randomized. Significance tests were 2-sided at the 5% significance level.,100.0
725,PRECIS-2,"Data collection was via hospital forms (baseline characteristics and details of surgery, details of inpatient stay, treatment confirmation at 1 month, physiotherapy and end of physiotherapy, 1-year and 2-year follow-up, and adverse events and review), baseline x-rays, and patient questionnaires at 3, 6, 12, and 24 months.",fulltext,"Data collection was via hospital forms (baseline characteristics and details of surgery, details of inpatient stay, treatment confirmation at 1 month, physiotherapy and end of physiotherapy, 1-year and 2-year follow-up, and adverse events and review), baseline x-rays, and patient questionnaires at 3, 6, 12, and 24 months.",100.0
725,PRECIS-2,"Excluded patients had associated dislocation of the injured shoulder joint, open fracture, insufficient mental capacity to understand the trial or instructions for rehabilitation, comorbidities precluding surgery or anesthesia, clear indication for surgery such as severe soft-tissue compromise, multiple injuries (upper limb fractures), pathological fracture (other than osteoporotic), terminal illness, or were not a resident in the hospital catchment area.",fulltext,"Excluded patients had associated dislocation of the injured shoulder joint, open fracture, insufficient mental capacity to understand the trial or instructions for rehabilitation, comorbidities precluding surgery or anesthesia, clear indication for surgery such as severe soft-tissue compromise, multiple injuries (upper limb fractures), pathological fracture (other than osteoporotic), terminal illness, or were not a resident in the hospital catchment area.",100.0
725,PRECIS-2,"Rehabilitation care was provided by physiotherapists in inpatient, outpatient, and community settings.",fulltext,"Rehabilitation care was provided by physiotherapists in inpatient, outpatient, and community settings.",100.0
725,PRECIS-2,Follow-up was up to 2 years (until April 2013) for all patients.,fulltext,Follow-up was up to 2 years (until April 2013) for all patients.,100.0
725,PRECIS-2,"Physiotherapy treatment log data demonstrated equal access and implementation between groups, with similarly high numbers of participants recorded as performing home exercises (109 in surgical group vs 103 in nonsurgical group) in both groups.",fulltext,". Physiotherapy treatment log data demonstrated equal access and implementation between groups, with similarly high numbers of participants recorded as performing home exercises (109 in surgical group vs 103 in nonsurgical group) in both group",99.1769547325103
725,PRECIS-2,"The primary outcome was the Oxford Shoulder Score (OSS), which is a shoulder-specific outcome measure validated in a UK population. The OSS provides a total score based on the patient’s subjective assessment of pain and function. It contains 12 items, each with 5 categories of response, and a range of total scores of 0-48 (higher scores indicate better outcomes). The OSS was collected by postal questionnaires at 6, 12, and 24 months. There was no trial-related clinical assessment or radiological follow-up of patients.",fulltext,"The primary outcome was the Oxford Shoulder Score (OSS), which is a shoulder-specific outcome measure validated in a UK population. 12 The OSS provides a total score based on the patient’s subjective assessment of pain and function. It contains 12 items, each with 5 categories of response, and a range of total scores of 0 (worst outcome) to 48 (best outcome). 13 The OSS was collected by postal questionnaires at 6, 12, and 24 months. There was no trial-related clinical assessment or radiological follow-up of patients.",95.79349904397706
725,PRECIS-2,"Delivery of care and rehabilitation, which was freely available for all patients, incorporated the following 3 set measures to ensure good standards of care within the National Health Service: provision of an information leaflet on personal care during sling immobilization; a basic treatment protocol to guide physiotherapy; and promotion of home exercises.",fulltext,"Delivery of care and rehabilitation, which was freely available for all patients, incorporated the following 3 set measures to ensure good standards of care within the National Health Service: provision of an information leaflet on personal care during sling immobilization; a basic treatment protocol to guide physiotherapy; and promotion of home exercises.",100.0
725,PRECIS-2,"Patients received their allocated treatment from the recruiting hospital. Care pathways for all patients included outpatient- and community-based rehabilitation, which primarily comprised 1 or more 1-on-1 sessions with a physiotherapist that focused on restoring function.",fulltext,"Patients received their allocated treatment from the recruiting hospital. Care pathways for all patients included outpatientand community-based rehabilitation, which primarily comprised 1 or more 1-on-1 sessions with a physiotherapist that focused on restoring function.",99.26470588235294
725,PRECIS-2,Patients were recruited for the trial if they were aged 16 years or older and presented within 3 weeks after sustaining a displaced fracture of the proximal humerus that involved the surgical neck. The degree of displacement had to be sufficient for the treating surgeon to consider surgical intervention but did not have to meet the displacement criteria of Neer for inclusion in the trial.,fulltext,"Patients were eligible for inclusion if they were aged 16 years or older and presented within 3 weeks after sustaining a displaced fracture of the proximal humerus that involved the surgical neck. The degree of displacement had to be sufficient for the treating surgeon to consider surgical intervention but did not have to meet the displacement criteria of Neer 10 (1 cm or 45° angulation of displaced parts, or both) for inclusion in the trial.",96.67519181585678
725,PRECIS-2,"Participants allocated to surgery received either internal fracture fixation (eg, with plate and screws) that preserved the humeral head or humeral head replacement (hemiarthroplasty). Participants allocated to nonsurgical treatment were given a sling for the injured arm for as long as deemed necessary (3 weeks was suggested), followed by active rehabilitation.",fulltext,"Participants allocated to surgery received either internal fracture fixation (eg, with plate and screws) that preserved the humeral head or humeral head replacement (hemiarthroplasty). Participants allocated to nonsurgical treatment were given a sling for the injured arm for as long as deemed necessary (3 weeks was suggested), followed by active rehabilitation.",100.0
725,PRECIS-2,Patients were eligible for inclusion if they were aged 16 years or older and presented within 3 weeks after sustaining a displaced fracture of the proximal humerus that involved the surgical neck. The degree of displacement had to be sufficient for the treating surgeon to consider surgical intervention but did not have to meet the displacement criteria of Neer for inclusion in the trial.,fulltext,"Patients were eligible for inclusion if they were aged 16 years or older and presented within 3 weeks after sustaining a displaced fracture of the proximal humerus that involved the surgical neck. The degree of displacement had to be sufficient for the treating surgeon to consider surgical intervention but did not have to meet the displacement criteria of Neer 10 (1 cm or 45° angulation of displaced parts, or both) for inclusion in the trial.",100.0
733,PRECIS-2,"The project described in this article was funded by the Health Technology Assessment stream of the National Institute for Health Research (NIHR) (project number 06/36/04). The funders proposed modifications to the original study design, which were incorporated, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.",fulltext,"The project described in this article was funded by the Health Technology Assessment stream of the National Institute for Health Research (NIHR) (project number 06/36/04). The views expressed here are those of the authors, not of the Department of Health or the NIHR. The funders proposed modifications to the original study design, which were incorporated, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.",100.0
